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CHAPTER I 
INTRODUCTION 
 
Overview of Project 
Significance 
Trauma is the fifth overall leading cause of death in the United States 
according to the most recent report from the National Center of Vital Statistics 
released in April 2009 (Heron et al., 2009).  The "Leading Causes of Death 
Report" for the year 2006 indicates that trauma is also the leading cause of death 
of young people between the ages of 1 to 44 years (WISQARS, 2009).  For 
example, motor vehicle death was responsible for 55.7% of all unintentional 
injury deaths of individuals between the ages of 20 to 30 in the year 2006.  Most 
such deaths result either from the initial blood loss or from secondary reperfusion 
injury following resuscitation (Cocchi et al., 2007; Sauaia et al., 1995; Takasu et 
al., 2005). 
The cardiovascular response to blood loss is complex and multiphasic 
(Figure 1).  At the beginning of blood loss, arterial pressure is maintained 
primarily through a primary compensatory response characterized by increased 
sympathetic-mediated vascular resistance (Chalmers et al., 1967; Cornish et al., 
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1988; Evans et al., 1993b; Schadt and Ludbrook, 1991).  After significant blood 
loss (in human ~20% to 30%; ~14% in rats), this primary compensatory response 
is reversed, resulting in a sympatholytic response which is characterized as 
hypotension, bradycardia and sympathoinhibition (Hasser and Schadt, 1992; 
Ludbrook and Ventura, 1994, , 1996).  The cumulative effect is similar to fainting, 
with a hemodynamic character reminiscent of vasovagal syncope.  Such a 
response is often referred to as the syncopal response (Sander-Jensen et al., 
1987).  If blood loss continues, circulatory shock develops as a consequence of 
inadequate perfusion of the peripheral tissue (Haljamae, 1984).  During 
development of circulatory shock, a secondary compensatory response develops 
as sympathetic activity is slowly re-established to regain normal perfusion 
pressure.  This is the stage at which patients are normally seen in the emergency 
room or at the scene of a trauma.  Failure to resuscitate patients adequately 
during this phase can lead to decompensation, which is characterized by a 
cascade of metabolic events that leads to loss of proper vasoconstrictor function, 
circulatory collapse and eventually death (Chaudry et al., 1990).   
Currently, the standard treatment for hypovolemic shock includes rapid 
and massive volume resuscitation. This has remained the gold standard of 
treatment over the last 65 years despite the significant pathology associated with 
its use.  Catecholamines, including epinephrine (EPI), norepinephrine (NE) and 
dopamine, as well as other vasoconstrictors such as vasopressin are also used 
to raise perfusion pressure in patients in circulatory shock (Balogh et al., 2003a; 
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Balogh et al., 2003b; Garrison et al., 2004; Peitzman et al., 1995).  There are 
major disadvantages to the use of either volume resuscitation or vasoconstrictor 
treatments.  Either treatment alone may not be sufficient to increase perfusion 
pressure, and both can exacerbate reperfusion injury (Greenway and Lawson, 
1966; Martel et al., 2002; Meier-Hellmann et al., 1997).  Both treatments also 
require technical training and close monitoring to apply safely to patients.  
Therefore, adequate treatment is often delayed, resulting in prolonged ischemia, 
which can, in turn, worsen reperfusion injury.  Alternative therapies that can be 
applied quickly with minimal training and do not exacerbate reperfusion injury are 
needed to improve patient outcomes after severe hemorrhage. 
We recently found that intravenous (iv.) injection of the 5-HT1A-receptor 
agonist, 8-hydroxy-2-n-di[propylamino] tetralin (8-OH-DPAT), increases systemic 
perfusion pressure in rats subjected to hypovolemic shock by stimulation of 
sympathetic-mediated increases in venous tone.  The drug does not increase 
total peripheral resistance, indicating that the pressor effect (i.e., increased blood 
pressure) of the drug is mediated almost exclusively by increased cardiac output 
(Tiniakov and Scrogin, 2006).  8-OH-DPAT also improves acid-base balance in 
animals subjected to hemorrhagic shock prior to volume restitution (Tiniakov et 
al., 2007).  These data suggest that serotonergic agonists may be a promising 
alternative to the vasoconstrictors currently used in resuscitation from 
hypovolemic shock.  However, the location of the 5-HT1A receptor population that 
mediates this response is not known.  Activation of 5-HT1A receptors by the 
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administration of 8-OH-DPAT in the vicinity of the dorsal hindbrain surface rapidly 
re-establishes normal perfusion pressure following blood loss in unanaesthetized 
rats (Scrogin, 2003).  These findings suggest the possibility that 5-HT1A receptor 
agonists may act in the dorsomedial hindbrain where arterial baroreceptor and 
peripheral chemoreceptor afferents terminate to mediate their beneficial effects 
during hypovolemia.  Prior studies indicate that caudal raphe serotonin neurons 
are activated by hemorrhage.  In preliminary studies we found that lesion of 
these neurons also attenuated the secondary compensatory phase following 
hemorrhage.  It is not known whether endogenous serotonin released during 
hemorrhage acts on 5-HT1A receptors to produce a compensatory hemodynamic 
response to blood loss.  Studies performed in this dissertation investigated the 
cardiovascular effects of endogenous serotonin and 5-HT1A-receptor agonists in 
hemorrhaged rats in an effort to better determine the mechanisms of the potential 
benefits of serotonin manipulation in hypovolemic shock. 
 
Main Hypothesis 
In this project, several studies were performed to test the following 
OVERALL HYPOTHESIS: Hindbrain serotonergic neurons activate 5-HT1A 
receptors in the nucleus tractus solitarius (NTS) to facilitate sympathetic and 
respiratory recovery following hypotensive hemorrhage. The following specific 
aims were pursued to test this hypothesis. 
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Specific Aim 1:  To test the hypothesis that caudal medullary serotonergic 
neurons facilitate sympathetic recovery after acute hypotensive hemorrhage in 
conscious rats.  
 
Rationale:  We and others have shown that serotonergic neurons of the 
ventrolateral periaqueductal  gray (vlPAG), raphe obscurus (RO), raphe magnus 
(RM) and its lateral extension around the parapyramidal region (PPY) are 
activated selectively by hypotensive hemorrhage (Dean and Woyach, 2004; 
Ruszaj et al., 2006).  To determine if serotonin neurons in these regions 
influence hemodynamic responses to hemorrhage, we selectively lesioned 
serotonin nuclei activated by hypotensive hemorrhage and showed that the 
lesions attenuated the secondary compensatory recovery of blood pressure (BP) 
and heart rate (HR) following hypotensive hemorrhage (Ruszaj et al., 2006).  
However, it was not known if these serotonergic nuclei contributed to the 
secondary compensatory recovery of HR and arterial pressure by augmenting 
sympathetic recovery.  Moreover, it was not known whether the effects of 
serotonin on these hemodynamic parameters were accompanied by altered 
blood gases.  To test this, we examined sympathetic recovery during the 
secondary compensatory phase as well as changes in blood gases after 
hypotensive hemorrhages in rats subjected to selective lesion of caudal 
medullary serotonergic neurons in the RO, RM, and PPY.  Given recent evidence 
that caudal medullary serotonergic neurons are important in central 
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chemoreception and that central chemoreceptors may be activated by 
hemorrhage (Richerson, 2004), we also determined whether the lesion interfered 
with sympathetic and ventilatory responses to central chemoreflex stimulation.   
 
Experiment:  
A) It was determined if selective destruction of caudal medullary 
serotonergic neurons activated by hypotensive hemorrhage attenuates 
sympathetic and ventilatory recovery after hypotensive hemorrhage. 
   
B) It was determined if selective destruction of caudal medullary 
serotonergic neurons attenuates sympathetic and ventilatory responses to 
central chemoreflex stimulation. 
 
Specific Aim 2:  To test the hypothesis that 5-HT1A-receptor agonists act 
on receptors expressed on non-serotonergic cells to accelerate sympathetic 
recovery after hypotensive hemorrhage in conscious rats. 
 
Rationale:  We have found that 5-HT1A-receptor agonists accelerate 
sympathetic recovery during the secondary compensatory phase of hypotensive 
hemorrhage (Scrogin, 2003).  5-HT1A receptors are found on non-serotonergic 
cells where they act as post-synaptic targets of serotonin neurons.  They are also 
found on serotonergic neurons where they act as autoreceptors to hyperpolarize 
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the serotonin cell membrane.  Previous studies indicate that depletion of 
serotonin prevents the sympatholytic and depressor (decreased blood pressure) 
responses to hemorrhage (Elam et al., 1985).  Therefore, it is possible that 5-
HT1A-receptor agonists reverse the sympatholytic response to hemorrhage by 
inhibiting endogenous serotonin release.  To test this, we examined the effect of 
systemic 5-HT1A-receptor agonist administration in rats subjected to serotonin 
lesion in order to eliminate 5-HT1A autoreceptors.  It was reasoned that if 5-HT1A-
receptor agonists stimulate sympathetic recovery by inhibiting serotonin neurons, 
then lesion of serotonin neurons should prevent or attenuate the sympatholytic 
phase of hemorrhage and a 5-HT1A-receptor agonist should not further augment 
sympathetic recovery during the secondary compensatory phase.  
 
Experiments: 
A) It was determined if global destruction of serotonergic neurons 
attenuates the sympatholytic response following recovery of 
hypotensive hemorrhage. 
B) It was determined if global destruction of serotonin neurons attenuates 
the sympathoexcitatory response to 5-HT1A receptor agonist in rats 
subjected to hypotensive hemorrhage. 
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Specific Aim 3: To test the hypothesis that serotonergic neurons activate 
5-HT1A receptors in the NTS to stimulate recovery of sympathetic activity after 
hypotensive hemorrhage in conscious rats.   
 
Rationale:  Prior work has shown that 5-HT1A-receptor agonists injected 
into the cisterna magna produce a very rapid and robust increase in sympathetic 
activity in animals subjected to hypotensive hemorrhage.  These data suggest 
that activation of 5-HT1A receptors near the dorsal surface of the caudal hindbrain 
contributes to the sympathoexcitatory effect of 8-OH-DPAT in hypovolemic rats 
(Scrogin, 2003).  We have also shown that the full sympathoexcitatory effect of 8-
OH-DPAT is dependent upon intact sinoaortic afferents that carry arterial 
baroreceptor and peripheral chemoreceptor afferents and project to the NTS 
(Osei-Owusu and Scrogin, 2004).  The caudal NTS is the projection site of 
arterial baroreceptor and peripheral chemosensory afferents, and both the 
arterial baroreflex and chemoreflex are engaged by hypotensive hemorrhage.  A 
high density of serotonergic nerve terminals has been observed within the 
commissural subnucleus of the NTS (comNTS) where cardiovascular and 
chemosensory afferents terminate (Manaker and Verderame, 1990).  Recent 
work has shown that glutamatergic input to the ventrolateral aspect of the lateral 
parabrachial nucleus (VL-LPBN) is necessary for sympathetic-mediated recovery 
of BP following hypotensive hemorrhage (Blair and Mickelsen, 2006).  The NTS 
provides the majority of glutamatergic input to the VL-LPBN, suggesting that the 
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NTS may also play a critical role in recovery of perfusion pressure following 
hypotensive hemorrhage. 
It is not known if serotonin nerve terminals within the NTS contribute to 
sympathetic recovery during the secondary compensatory phase of acute 
hypotensive hemorrhage in conscious rats.  Studies in this aim addressed this 
question by determining if selective lesion of serotonergic projections to NTS 
regions that receive arterial baroreceptor and peripheral chemoreceptor afferent 
innervation influenced sympathetic recovery following hemorrhage.  Because 
both the baroreflex and the peripheral chemoreflex are engaged during 
hypotensive hemorrhage, additional studies were conducted to determine if the 
same lesion of serotonin nerve terminals in the NTS influenced arterial baroreflex 
or peripheral chemoreflex sensitivity. 
 
Experiments: 
A.1) It was determined if destruction of serotonin nerve terminals in the 
NTS attenuated sympathetic recovery after hypotensive hemorrhage.  
 
A.2) It was determined if destruction of serotonin nerve terminals in the 
NTS inhibited peripheral chemoreceptor sensitivity.  
 
A.3) It was determined if destruction of serotonin nerve terminals in the 
NTS inhibited arterial baroreflex sensitivity (BRS). 
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B) Attempts were made to determine whether pharmacological blockade 
of 5-HT1A receptors in the NTS blocked sympathetic recovery after 
hypotensive hemorrhage.  
 
C) Attempts were made to determine whether pharmacological blockade 
of 5-HT1A receptors in the NTS prevented the sympathoexcitatory effect 
of systemically administered 5-HT1A-receptor agonist after hypotensive 
hemorrhage.  
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CHAPER II 
REVIEW OF RELATED LITERATURE 
A. Current treatment for hemorrhagic shock  
Hypovolemic shock result from inadequate perfusion of peripheral organs 
such that the physiologic needs of the tissue is not met.    The current treatment 
for hemorrhagic shock includes infusion of a large volume of fluid such as 
lactated Ringer’s solution or isotonic saline as early and as rapidly as possible 
(Stern, 2001).  The aim of this treatment strategy is to rapidly restore 
intravascular volume to maintain vital organ perfusion.  However, studies suggest 
that aggressive fluid resuscitation alone may be harmful (Leppaniemi et al., 
1996).  For instance, rapid fluid resuscitation can lead to sudden tissue re-
oxygenation after ischemia, which can generate inflammatory responses that 
contribute to organ damage and failure.  
Due to the numerous sequelæ associated with aggressive volume 
resuscitate, an alternative treatment that combines lower-volume resuscitation 
with whole blood or blood substitutes, and/ or colloid solutions to raise 
intravascular volume and perfusion pressure to subnormal levels has recently 
gained favor (Hess and Thomas, 2003; Leppaniemi et al., 1996; Repine et al., 
2006; Stern, 2001).  Unfortunately, blood products are not always readily 
   12 
  
available outside the hospital or on the battlefield.  Hemoglobin-based oxygen 
carriers have been shown to enhance tissue perfusion and reduce oxygen debt, 
and improve resuscitation outcomes in animals.  Although experimental studies 
indicate that administration of the bovine hemoglobin-based oxygen carrier, 
HBOC-21, in hemorrhagic shock is effective and improves outcome, the potential 
toxic effects of the treatment such as vasoconstriction and acute renal failure 
have reduced enthusiasm for its clinical use (Alayash, 1999; Arnaud et al., 2005; 
Fitzpatrick et al., 2005; Moore et al., 2004).   
Therapeutic hypothermia has also been used as an adjuvant treatment to 
low-volume infusion of whole blood.  This method can protect the organism 
against the ischemic effects of hemorrhage.  Investigators found that lactate 
levels were significantly lower in hypothermia-treated animals subjected to 
hypovolemic shock suggesting an improved balance of tissue oxygen supply and 
demand (Prueckner et al., 2001; Takasu et al., 2000).  Wladis et al. reported that 
hypothermia slowed HR and induced a further reduction of cardiac output and 
cardiac work in hemorrhaged animals (Wladis et al., 2001).  Nevertheless, 
hypothermic treatment did not change mortality during hemorrhage. 
Another controversial treatment is the use of vasoconstrictor agents to 
help raise perfusion pressure.  Dopamine, dobutamine, NE and vasopressin 
have all been used to treat hypovolemic shock (Hamed et al., 1983; Kellum and 
Pinsky, 2002; Neiberger and Passmore, 1979).  Complications of these 
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vasoconstrictor agonists are related to excessive arterial vasoconstriction and 
exacerbation of organ ischemia (Kellum and Pinsky, 2002).   
No one resuscitation treatment strategy has been found to improve 
outcomes beyond the protocols established decades ago.  Therefore, new novel 
methodologies are needed.  Such methods should be easy to implement and 
increase perfusion pressure without further exacerbating end organ ischemia. 
 
 
B. Autonomic response to hemorrhage  
Progressive blood loss in conscious animals produces a complex 
multiphasic response of the autonomic nervous system (Figure 1).  At the 
beginning of blood loss, arterial pressure is well maintained primarily through 
unloading of baroreceptors, which reduces cardiac vagal drive and increases 
sympathetic drive (Chalmers et al., 1967; Cornish et al., 1988; Evans et al., 1992; 
Schadt and Ludbrook, 1991).  This phase is called the primary compensatory 
phase.  After a significant amount of blood loss (~20% to 30% in human; ~15% in 
unanaesthetized rats) these compensatory responses suddenly decline, resulting 
in decreased sympathetic outflow and a rapid fall in BP (Hasser and Schadt, 
1992; Ludbrook and Ventura, 1996).  This response, similar in hemodynamic 
character to vasovagal syncope, is also called the sympatholytic phase (Sander-
Jensen et al., 1987).  This is a transient phase that is thought to protect cerebral 
perfusion by promoting a posture in which the head lies at the same level as the 
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heart, thereby reducing the perfusion pressure needed to deliver blood to the 
brain (Van Lieshout et al., 2003).  If blood loss does not cease after vasovagal 
syncope, circulatory shock develops as a consequence of reduced peripheral 
organ perfusion (Haljamae, 1984).  The beginning of circulatory shock is 
characterized by a slow rise of sympathetic activity and HR.  Therefore, this 
phase is called the secondary compensatory phase.  If blood loss continues to 
progress, vascular permeability eventually increases, vascular reactivity declines, 
and sympathetic activation is no longer able to maintain pressure.  This fourth 
phase is known as decompensation and is extremely difficult to treat.   
The mechanisms that contribute to the different phases of circulatory 
shock are not known but remain an active area of investigation.  As a 
consequence important reflex mechanisms have been found to contribute to the 
various phases of shock, but the triggers that activate and terminate these 
responses are not well understood. 
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Figure 1: The hemodynamic responses to hemorrhage initiated at time 0 in a 
conscious rat.  1.  Primary compensatory phase, 2. Sympatholytic phase, 3. 
Secondary compensatory phase, and 4. Decompensation.  Arterial pressure 
(AP), heart rate (HR), renal sympathetic nerve activity (RSNA) 
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C. Overview of baro-, chemo- and cardiopulmonary reflexes during 
hypotensive hemorrhage 
Baro- and chemo reflexes are a dual system of sensors and neural 
reflexes that control mean arterial pressure (MAP).  The primary sensors of the 
arterial baroreceptors are stretch receptors located on the vascular walls of the 
carotid sinuses and aortic arch.  During the primary compensatory phase, blood 
volume reductions reduce tension on the vascular wall.  As a consequence 
baroreceptors are unloaded stretch is reduced, leading to a series of feedback 
responses that result in increased sympathetic mediated vascular constriction, 
increased HR and consequently increased BP.   
Peripheral chemoreceptor activation may also play a role in maintaining 
BP.  Baroreceptor unloading results in increased sympathetic drive which can 
then reduce blood flow to peripheral chemoreceptors in the carotid bodies of the 
carotid sinus.  Peripheral chemoreceptors sense a decrease in tissue PaO2, 
which in turn elicits a chemoreflex response that includes increased sympathetic 
activity and ventilation.   
Another set of baroreceptors, the so called low-pressure cardiopulmonary 
baroreceptors, are located in the pulmonary artery and the atria.  Stretch of these 
receptors depends largely on the blood volume returned to the heart or the 
venous return.  These mechanoreceptors detect the “fullness” of the circulation 
and further control the circulating volume of blood.  During hypotensive 
hemorrhage there is less distention of the atria.  In an effort to correct a low or 
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reduced effective circulating volume these receptors also stimulate the renin-
angiotensin-aldosterone system (RAAS) to promote sodium retention through 
communication with the adrenal medulla.  Increased sympathetic activity to the 
kidney reduces renal blood flow and stimulates renin release leading to reduced 
sodium excretion.   
Other hormones involved in BP control during hemorrhage include 
vasopressin and atrial natriuretic peptide (ANP).  Neural input from the medullary 
brainstem stimulates the paraventricular nucleus of the hypothalamus to signal 
the posterior pituitary to increase secretion of vasopressin, which in turn 
circulates to the kidney to inhibit water exertion, and to the vasculature to 
promote vasoconstriction.  Atrial natriuretic peptide is synthesized and stored by 
atrial myocytes and is normally released in response to stretch of low-pressure 
volume sensors.  Atrial natriuretic peptide circulates to the kidney to promote 
natriuresis (Na+ excretion).  Thus, the reduced effective circulating volume that 
develops during hemorrhage inhibits the release of ANP and reduces Na+ 
excretion.  By executing all these hormonal or neuronal pathways, 
cardiopulmonary receptors help to control circulating blood volume and thus 
cardiac output.   
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 Central pathways in control of baroreflex 
Arterial BP is maintained within relatively strict limits by an important 
homeostatic reflex mechanism, the arterial baroreflex or arterial baroreceptor 
reflex.  When arterial BP is elevated, the reflex is activated and inhibits 
sympathetic output and thus causes BP to decrease.  Likewise, when arterial BP 
decreases, baroreceptors are unloaded, leading to increased sympathetic activity 
and a BP rise.  
 
 Anatomy of the arterial baroreflex 
Stretch receptors located in the aortic arch and carotid sinus monitor the 
degree of vessel wall stretching, which is directly related to the pressure in the 
carotid arteries.  Both aortic arch and carotid sinus regions serve as 
pressure/stretch sensors and are thus called the baroreceptors (Heymans, 
1968).  Action potentials are generated by stretch, and the greater the stretch, 
the greater the frequency of action potentials generated.   
As shown in Figure 2, stretch in the carotid sinus and aortic arch 
generates action potentials that travel through the glossopharyngeal and vagus 
nerves, respectively, to the caudal NTS in the medulla.  Second order NTS 
neurons that receive afferent input from the baroreceptors send excitatory 
glutamatergic fibers to the caudal ventrolateral medulla (CVLM).  The CVLM 
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sends inhibitory γ-Aminobutyric acid (GABA) projections to the rostroventrolateral 
medulla (RVLM).  An anatomical study using combined anterogradely- and 
retrogradely transported tracers demonstrated that terminals originating from cell 
bodies within the CVLM were contiguous with bulbospinal neurons in the RVLM 
(Li et al., 1992).  The bulbospinal neurons in the RVLM, in turn, send excitatory 
glutamatergic projections to the sympathetic preganglionic neurons in the 
intermedio-lateral cell column of thoracic and upper lumbar segments of the 
spinal cord which activate the sympathetic neurons that control vasoconstriction 
and HR.  Therefore, when baroreceptors are activated by increased BP, the NTS 
activates the CVLM, which in turn inhibits the RVLM, thus reducing the 
sympathetic outflow to the heart, arterioles and veins.  The NTS also sends 
excitatory projections to the nucleus ambiguus (NA), which houses the 
parasympathetic motor neurons that project to the heart.  Thus, parasympathetic 
outflow to the heart is increased during increased baroreceptor stretch.  Similarly, 
a decrease in baroreceptor firing rate results a decrease in parasympathetic drive 
to the heart.  
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Figure 2: Central pathway of the arterial baroreflex.  Arterial baroreceptors 
innervate the NTS.  Excitatory projections from the NTA project to the CVLM. 
Inhibitory GABAergic neurons in the CVLM inturn inhibit the RVLM to modulate 
sympathetic drive to the heart and blood vessels.   NTS: nucleus tractus 
solitarius; CVLM : caudal ventral lateral medulla ;  RVLM : rostroventrolateral 
medulla ; IML: intermediolateral cell collumn 
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Peripheral chemoreflex  
Peripheral chemoreceptors primarily respond to reduced arterial blood 
oxygen and increased blood pH and act accordingly to increase or decrease 
ventilation.  In addition, peripheral chemoreceptors also detect arterial carbon 
dioxide (CO2) levels (PaCO2)  However, CO2 is primarily detected by central 
chemoreceptors, since these receptors appear to be more sensitive to changes 
in arterial blood CO2 levels then are peripheral chemoreceptors.     
The peripheral chemoreceptors are located in a collection of cells known 
as the aortic and carotid bodies, which are located on the arch of the aorta and 
the sinus of the carotid artery, respectively.  The carotid body is composed of 
several cell types, one of which, the glomus cell, can activate nerve fibers that 
join the glossopharyngeal nerve.  The aortic glomus cells activate nerves that 
travel through the vagus nerve.  The carotid bodies have an extraordinarily high 
blood flow and small arteriovenous differences in PO2, PCO2 and pH indicate that 
the blood flow is in high excess of metabolic demand.  Glomus cells are the 
chemosensitive cells that detect changes in arterial PO2 and PCO2 or pH. They 
stimulate afferent nerves to increase their firing rate in response to low arterial 
PO2 or pH and high arterial PCO2.  Signals from carotid and aortic bodies are 
sent to the comNTS via the glossopharyngeal and vagus nerves.  The comNTS 
then integrates signals from both sets of afferent nerves and appropriately 
modulates respiration patterns and sympathetic activity.   
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Moreira and colleagues (2006) have proposed a model that explains how 
peripheral chemoreceptor activation increases ventilation and sympathetic 
activity.  Specifically, a subset of cells of the comNTS sends excitatory 
projections directly to the RVLM to produce an overall increase in pre-
sympathetic neuronal activity during hypoxia (Figure 3). More recently Takakura 
and colleagues used an anterograde tracer and immunohistochemistry methods 
to demonstrate that hypoxia activates comNTS glutamatergic neurons that 
innervate the retrotrapezoid nucleus (RTN), a nucleus containing pH sensitive 
neurons that may integrate peripheral and central chemoreception (Takakura et 
al., 2006).  In addition, the comNTS is thought to innervate and activate a 
ventilatory central pattern generator (CPG) in the pre-Bötzinger complex located 
at the caudal pole of the CVLM (Figure 4).  When excited by the comNTS, the 
CPG increases excitatory input to respiratory motor neurons in the spinal cord, 
and at the same time produces oscillations of inhibitory input to the pre-
sympathetic neurons of the RVLM that then become entrained to respiration.  As 
a consequence, hypoxia increases ventilation and sympathetic activity; and the 
increase in sympathetic activity develops a pronounced ventilatory rhythm.   
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Figure 3: Illustration of central pathway of peripheral chemoreflex activation of 
sympathetic drive during hypoxia or decreased pH.  Peripheral chemoreceptors 
convey their information to neurons in the NTS which directly activate the RVLM 
to mediate sympathetic out flow to the heart and blood vessels.  NTS: nucleus 
tractus solitarius; CVLM : caudalventrolateral medulla ;  RVLM : 
rostralventrolateral medulla ; IML: intermediolateral cell collumn 
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Figure 4: Illustration of central pathway of peripheral chemoreflex activation of 
ventilation during hypoxia or decreased pH.  Peripheral chemoreceptor afferents 
convey their information to neurons in the NTS which directly innervate and 
activate cells of the Pre-Bötzinger complex.  The Pre-Bötzinger complex 
activates the phrenic motor nucleus that, in turn, contracts the diaphragm to 
increase ventilation.  NTS: nucleus tractus solitarius; CVLM : caudalventrolateral 
medulla ;  RVLM : rostralventrolateral medulla ; IML: intermediolateral cell 
collumn 
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Central chemoreflex  
In contrast to peripheral chemoreceptors which primarily sense low PaO2, 
the central chemoreceptors mainly sense low pH in the brain, which generally 
reflects a high arterial PCO2.  Arterial CO2 can readily diffuse across the blood 
brain barrier where it acidifies brain tissue and thereby stimulates the central 
chemoreceptors to modulate breathing and increase sympathetic activity.  
The exact location of central chemoreceptors is not well understood. Over 
the years, researchers have identified several potential sites in the central 
nervous system.  Evidence suggests that they are located on the ventral 
medullary surface.  Applying acidic solutions to the RVLM or CVLM leads to a 
prompt increase in ventilation (Loeschcke et al., 1963).  Moreover, focally cooling 
these areas to 20°C to reversibly inhibit neurons blunts the ventilatory response 
to respiratory acidosis (Loeschcke, 1982).  These earlier studies led to the 
widespread acceptance that the ventral lateral medulla was the sole location of 
central respiratory chemoreceptors.  More recently, studies have shown other 
possible locations of central chemoreceptors.  These include the NTS, locus 
coeruleus, cells of the mid-line medullary raphe, the rostral aspect of the ventral 
respiratory group (the pre-Bötzinger complex) and the RTN (Ballantyne and 
Scheid, 2001; Gray et al., 2001; Nattie and Li, 2002a, 2002b; Putnam, 2001; 
Richerson, 2004).  Data from Moreira and colleagues suggest that increased CO2 
may stimulate sympathetic drive by directly exciting pre-sympathetic neurons of 
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the RVLM that may be intrinsically sensitive to pH.  Alternatively or in addition, 
RVLM neurons may receive excitatory input from neighboring RTN pH- sensitive 
cells.  The CPG is also thought to be pH sensitive.  Therefore, an increase in 
CO2  may lead to increased sympathetic activity with a prominent ventilatory 
rhythm due to the simultaneous increase in activity of the pre-sympathetic RVLM 
cells and concurrent rhythmic inhibitory input from the respiratory CPG (Moreira 
et al., 2006).  
In addition, serotonin neurons have been found to play a prominent role in 
chemoreception in awake animals.  Serotonergic medullary raphe neurons are 
good candidates for central chemoreception because of their location.  A subset 
of medullary raphe neurons are located very close to the basilar artery, the major 
artery perfusing the brainstem (Bradley et al., 2002).  Many serotonergic neurons 
lie close to the vessel walls and may actually partially penetrate the walls and get 
close enough to the vessel lumen to detect PaCO2 (Richerson, 2004).  Using 
patch-clamp recordings from in vitro brain slices, it was shown that neurons 
within the medullary raphe nuclei are intrinsically sensitive to increased CO2 
(Richerson, 1995).  Furthermore, primary neuronal cultures isolated from the 
medullary raphe could be differentiated based on their response to CO2 (Wang et 
al., 1998).  Those cells stimulated by CO2 were found to be serotonergic, while 
those inhibited by CO2 did not appear to contain serotonin (Wang et al., 2001).  
Evidence from in vivo experiments supports the hypothesis the medullary 
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serotonergic neurons are central chemoreceptors.  For example, inhalation of 
CO2 increases c-Fos expression in cells of the medullary raphe of cats (Larnicol 
et al., 1994).  It was later confirmed that CO2-activated neurons in the medulla of 
rats expressed serotonin and tryptophan hydroxylase (TPH) (Haxhiu et al., 2001; 
Johnson et al., 2003).  Also adult rats subjected to a neonatal lesion of the 
medullary serotonergic neurons showed elevated PaCO2 under eucapnic 
conditions and a blunted ventilatory response to increased CO2 (Mueller et al., 
1984, , 1985).  Also, 8-OH-DPAT microdialyzed into the medullary raphe of adult 
rats to selectively suppress serotonin neuron activity resulted in a substantial 
attenuation of the ventilatory response to hypercapnia.  In addition, selective 
lesion of the medullary raphe serotonergic neurons using microinjections of the 
toxin saporin conjugated to antibodies against the serotonin transporter also 
caused depression of ventilatory responses to inhaled CO2 (Messier et al., 2004; 
Nattie et al., 2004).  Collectively, these data indicate that medullary serotonergic 
neurons are either central respiratory chemoreceptors or are involved in the 
processing of chemoreceptor input (Figure 5).   
There is a high concentration of serotonin immunoreactive (5-HT-ir) nerve 
terminals within the main respiratory nuclei.  These include the NA, the NTS, 
Bötzinger complex, pre-Bötzinger complex, phrenic motor nucleus, and the 
hypoglossal nucleus (Holtman, 1988; Jacobs and Azmitia, 1992; Voss et al., 
1990; Zhan et al., 1989).  The specific pathways by which serotonin augments 
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central chemoreflex function is are still not yet clear.  However, the serotonin 
projections to the pre-Bötzinger complex suggest that activation of serotonin cells 
during acidosis may augment ventilation in some way (Figure 6). 
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Figure 5: Illustration of central pathway of central chemoreflex to increase 
sympathetic drive during blood loss.  Acid is generated in the peripheral tissue 
due to anaerobic metabolism during blood loss. Hydrogen ions are converted to 
CO2 which readily cross the blood brain barrier.  Caudal serotonin raphe neurons 
sense the change in pH and CO2 and activate multiple nuclei including the 
nucleus tractus solitarius (NTS), rostroventrolateral medulla (RVLM) and 
intermediolateral cell column (IML) in the spinal cord to increase sympathetic 
activity.   Caudal ventrolateral medulla (CVLM). 
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Figure 6: Illustration of central pathway of central chemoreflex in the ventilatory 
response to blood loss.  Peripheral tissue generates acid due to anaerobic 
metabolism during blood loss. Protons were converted to CO2 where readily 
passes the blood brain barrier.  Caudal serotonin raphe neurons sense changes 
in pH and CO2, and may activate multiple respiratory nuclei including the pre-
Bötzinger and phrenic motor nucleus to increase ventilation.    
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Cardiopulmonary reflex   
Cardiopulmonary receptors are low pressure baroreceptors found in the 
atria and pulmonary vessels that are involved with the regulation of blood volume.  
Stretch of the receptors sends signals to the ventro lateral subnucleus of the NTS 
via non-myelinated and myelinated vagal afferent fibers (Berger, 1979; Kalia and 
Welles, 1980).  Activation of these receptors decreases sympathetic drive to the 
kidney and increases sympathetic drive to the sinus node to increase HR (Bishop 
et al., 1983; Fox et al., 1977).  The primary purpose of the cardiopulmonary reflex 
is to regulate volume.  It does so through changes in long-term fluid regulation 
and so may be less important in the acute response to hemorrhage. 
 
D. Hormonal response to hemorrhage  
A number of hormones are released during hemorrhage. They include 
catecholamines and vasoactive peptides such as ANGII (Mathai et al., 1997; 
Stocker et al., 2001), neuropeptide Y (NPY) (Qureshi et al., 1998), vasopressin 
(Laycock et al., 1979), and stress hormones including adrenocorticotropic 
hormone (ACTH), corticosterone (cortisol in human), and oxytocin (Kadekaro et 
al., 1990; Kasting and Wilkinson, 1987). 
Catecholamines, including EPI and NE, are released by chromaffin cells of 
the adrenal medulla into the bloodstream.  Norepinephrine and EPI act on ß1-
adrenergic receptors on cardiomyocytes to increase cardiac contractility.  Both 
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EPI and NE also stimulate α-adrenergic receptors of vascular smooth muscle to 
produced arterial and venous vasoconstriction.  Sympathetic increases that 
develop during the primary compensatory phase of hemorrhage lead to an 
increase in plasma EPI and NE, and the amount of hormone released is 
correlated to the amount of blood loss.  Low volume hemorrhage leads to little or 
no change in hormone responses,  while more severe blood loss leads to a near 
2000 fold increase in EPI (Bereiter et al., 1984; Darlington et al., 1986; Dempsher 
and Gann, 1983).  In conscious rats or anesthetized dogs and cats it is 
hypothesized that baroreceptors must be unloaded before hemorrhage can elicit 
an adrenocorticotropin hormone (ACTH) response (Darlington et al., 1986; 
Munzner et al., 1981).  Adrenocorticotropin hormone is derived from pro-
opiomelanocortin in the anterior pituitary gland.  Anterior pituitary secretion of 
ACTH is dependent on stimulation of corticotrophin-releasing hormone (CRH) 
and vasopressin.  Circulating ACTH, in turn, acts on melanocortin-2 receptors on 
the adrenal cortex to stimulate the production and release of glucocorticoid 
hormones (cortisol in human and corticosterone in rats).  The melanocortin-2 
receptor is coupled to a heterotrimeric G protein and stimulates adenyly cyclase.  
This resulting increase in cAMP activates PKA, which phosphorylates a variety of 
proteins.  As a result important proteins are activated, such as the P-450 
enzymes that are needed for cortisol synthesis.  The hemodynamic effect of 
cortisol is an increase in BP and tissue perfusion during the secondary 
compensatory phase of hemorrhage, which is thought to result from increased 
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sensitivity to NE (Haggendal et al., 1976; Hellman et al., 1982).  
Adrenocorticotropin hormone also stimulates the synthesis of NE.  In addition, 
cortisol circulates to the adrenal medulla where it regulates phenylethanolamine-
N-methyltransferase (PNMT) in chromaffin cells.  Phenylethanolamine-N-
methyltransferase is the rate limiting enzyme in EPI production.  The stress of 
hemorrhage that is sensed and propagated by the CRH-ACTH-cortisol axis 
sustains the EPI response as well.   
Vasopressin has been reported to be secreted immediately during the 
primary compensatory phase of hemorrhage in rats (Kadekaro et al., 1990; 
Kasting, 1988).  Plasma levels of vasopressin also increase during unloading of 
the baroreceptors at this phase of hemorrhage (Laycock et al., 1979; Quail et al., 
1987).  Vasopressin maintains BP following hemorrhage through activation of V1 
receptors located in arterial vascular smooth muscle where it causes 
vasoconstriction and increased peripheral resistance (Johnson et al., 1988).  In 
addition, circulating vasopressin may influence autonomic regulation during 
hemorrhage through both V1 and V2 receptors in the brainstem.   Peuler et al. 
reported that vasopressin contributes to the sympatholytic responses observed 
after hypotensive hemorrhage (Peuler et al., 1990).  Several reports have also 
shown that vasopressin exerts cardio-stimulatory and vasodilatory actions via the 
V2 receptor (Brooks and Hatton, 1991; Liard, 1988, , 1990).  Fujisawa et al. 
reported that in conscious rats hemorrhage increased the plasma vasopressin 
concentration more than 50-fold (Fujisawa et al., 1994).  Vasopressin, via V1 
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receptors, contributes to BP recovery after hemorrhage both peripherally and 
centrally (Johnson et al., 1988).  Others have noted that specific brain regions 
including the area postrema (AP) and NTS are potential sites of action of 
vasopressin.  Specifically, the drug promotes exaggerated sympathoinhibition 
during vasopressin-mediated hypertension, an effect which is attenuated after AP 
lesion (Undesser et al., 1985).  Fujisawa and others observed that inhibition of V1 
receptors attenuated BP recovery in hemorrhaged rabbits.  Blockade of V2 
receptors did not affect the BP response but prolonged the sympatholytic 
response (Brizzee et al., 1991; Fujisawa et al., 1994).   
An important hormone system, the RAAS, regulates BP through direct 
vasoconstriction and fluid balance during the secondary compensatory phase of 
hemorrhage.  When blood volume is low, renin secreted from kidney converts 
angiotensinogen to angiotensin I, which is, in turn, converted to ANG II, by 
angiotensin converting enzyme.  ANG II also acts on the adrenal cortex to cause 
release of aldosterone, which causes the proximal tubules of the kidneys to 
increase the reabsorption of sodium, which ultimately results in enhanced water 
re-absorption.  During hypotensive hemorrhage, RAAS activity increases, 
resulting in elevated levels of ANG II and production of aldosterone.  As a result 
BP is increased by vasoconstriction (Averill et al., 1983; DeMaria et al., 1989; 
Essadki and Atkinson, 1981).  Angiotensin II type I receptor blockers given during 
hemorrhage exaggerate the depressor response to blood loss (Francis et al., 
2004). 
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Neuropeptide Y is a potent nonadrenergic vasoconstrictor peptide, and 
virtually all adrenergic neurons and a subset of A1 noradrenergic cells express 
NPY (Everitt et al., 1984; Sawchenko et al., 1985).  Neuropeptide Y is present in 
sympathetic nerves that innervate blood vessels, heart, brain, adrenal medulla, 
and the gut (Zukowska-grojec and Walestedt, 1993).  This peptide helps to 
maintain BP during stress via direct vasoconstrictor actions on selected vascular 
beds, and works with other vasoactive agents synergistically (McDermott et al., 
1993).  Morris and colleagues reported that NE and EPI plasma concentrations 
doubled immediately after the start of hemorrhage and climbed even higher after 
30 minutes.  However, NPY was only doubled by 10 minutes after hemorrhage 
and remained elevated for 1hr afterwards (Morris et al., 1987).  Though 
endogenous NPY has no role in maintaining BP under normal physiological 
conditions, it surely contributes to BP recovery following hemorrhage possibly via 
post-synaptic Y1 receptors (Qureshi et al., 1998).   
 
 
E. Overview of central serotonergic system 
Anatomy 
The serotonin system in the brain arises from specific nuclei mainly 
situated in the mid-line of the brainstem and midbrain.  Nine cell groups (B1-B9) 
have been identified with a high density of serotonergic cell bodies (Dahlstrom 
and Fuxe, 1964).  They include more rostral cell groups in the mid-brain known 
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as the dorsal (DR-B7) and median raphe (MR-B8).  Extensions of these nuclei 
are found more caudally in the pons as well (B5 and B6 respectively).  These 
serotonin cell groups project rostrally to many different regions in the forebrain 
including the hypothalamus, thalamus, hippocampus, striatum, and cortex (van 
de Kar and Lorens, 1979).  Serotonin cell groups located in the vlPAG project to 
the central nucleus of the amygdaloid complex and thalamus (Chen et al., 1992; 
Li et al., 1990).  Midbrain raphe nuclei that project throughout the forebrain are 
associated with arousal, anxiety, aggression and control of cerebral blood flow 
(Hendricks et al., 2003; Saper et al., 2001; Underwood et al., 1995).  
Three prominent midline raphe nuclei are located more caudally and 
project within the medulla and down to the spinal cord.  These include the RM, 
and a more ventral group raphe pallidus (RP), and a caudal mid-line group, the 
RO.  The RM also contains bilateral cells that extend around the pyramidal tracts 
and comprise the so called PPY.  Bago and colleagues also found that 
serotonergic neurons of the midline caudal raphe nuclei project to the RVLM, 
with a minor contribution also coming from the DR and vlPAG (Bago et al., 2002).  
They further found that after microinjection of the 5-HT1A-receptor antagonist, 
WAY-100635, into the pressor region of RVLM the sympatholytic response to 
hemorrhage was delayed and attenuated while renal sympathetic nerve activity 
(RSNA) was increased and maintained above baseline.  These findings led to the 
conclusion that serotonin acts on 5-HT1A receptors expressed by pre-sympathetic 
RVLM neurons to promote the sympatholytic phase of hypotensive hemorrhage. 
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Interestingly, activation of the vlPAG elicits sympathoinhibition, which is 
mediated, in part, through neurons in the caudal mid-line medulla (Bago and 
Dean, 2001; Dean, 2005).  We and others found that serotonin neurons in the 
RM, PPY and vlPAG are activated during the secondary compensatory phase of 
hemorrhage in conscious rats (Bago et al., 2002; Ruszaj et al., 2006).  These 
findings led to speculation that vlPAG neurons activated by hemorrhage may 
stimulate midline serotonergic neurons to inhibit the RVLM during hemorrhage.   
 Another important group of serotonin neurons is found along the extent of 
the ventral surface on the subependymal layer of the region lateral to the bottom 
of the pyramidal tract, hereafter referred to as subependymal region (SUB).  The 
SUB cell groups, especially its serotonergic component, project directly to the 
intermediolateral cell column (IML).  These cells are also activated by 
hypotensive hemorrhage.  Such neurons probably function as pre-sympathetic 
cells, although their sympathetic targets and function are not well defined 
(Jansen et al., 1995).   
Together the caudal hindbrain cell groups have been implicated in gating 
pain, modulating ventilation, and cardio-vascular control, as well as regulating 
sympathetic drive in the control of BP and thermogenesis (Jacobs and Azmitia, 
1992; Jacobs and Fornal, 1997; Lovick, 1997; Mason, 2001). 
The NTS is one of the major projection sites of serotonin neurons. Such 
projections originate from the caudal raphe nuclei (RM, RO, RP and PPY), the 
DR (Schaffar et al., 1988; Steinbusch, 1981; Thor and Helke, 1987), and 
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peripherally from the nodose ganglia which house the cell bodies of vagal 
sensory afferent nerves  (Gaudin-Chazal et al., 1982; Nosjean et al., 1990; Thor 
et al., 1988).  The densest region of serotonin immunoreactive (5-HT-ir) terminals 
is located in portions of the commissural and dorsomedial band of the 
parvocellular subdivision of the NTS.  The remainder of the commissural, lateral 
and medial subdivisions has a moderate density of serotonin nerve terminals.  
Only occasional fibers are observed in the ventrolateral subnucleus and the 
remainder of the parvocellular subdivisions of the NTS (Maley and Elde, 1982).    
The rostral serotonin nuclei (B5-B9) give rise to almost all ascending 
fibers, whereas the caudal groups (B1-B4), give rise to the majority of 
descending fibers (Aitken and Tork, 1988; Bowker et al., 1981).  Serotonin fibers 
and a high density of terminals are found throughout the gray matter of most 
spinal cord segments.  The caudal raphe have also been shown to project to the 
sympathetic pre-ganglionic neurons of the IML cell column, where they are 
important in stimulating sympathetic drive to brown adipose tissue to promote 
thermogenesis (Loewy, 1981; Loewy and McKellar, 1981). 
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 Co-transmitters 
Although serotonin is the primary neurotransmitter produced in 
serotonergic neurons, several co-transmitters of serotonergic neurons have been 
identified.  In 1984, Ottersen and Storm-Mathisen first reported that serotonin-
containing neurons of the rat and mouse brainstems were immunopositive for 
glutamate (Ottersen and Storm-Mathisen, 1984).  Later evidence from several 
reports showed that the same cell populations were also immunopositive for a 
glutamate biosynthetic enzyme (Kaneko and Hicks, 1990).  A separate group 
also reported glutamate-like immunoreactivity in serotonin neurons of rat and 
monkey brains (Nicholas et al., 1992).  In addition, evidence suggests that 
glutamate can be released as a co-transmitter together with serotonin in vitro 
(Johnson, 1994).   
Thyrotropin-releasing hormone and substance P are two major co-
transmitters that co-exist with serotonin in raphe neurons that project to the 
spinal cord and within the brainstem (Hokfelt et al., 1975; Lighton et al., 1984; 
Thor and Helke, 1989; Thor et al., 1988).  Thyrotropin-releasing hormone and 
serotonin are co-depleted by the 5-HT neurotoxin 5,7-dihydroxytryptamine (5,7-
DHT).  Injection of TRH and serotonin evoke similar motoric and behavioral 
abnormalities, i.e. strong responses in both extensor and flexor muscles of the 
hind limbs, increased body temperature, and induction of the “wet dog shake” 
phenomenon in rats (Bedard et al., 1979; Bedard and Pycock, 1977; Hensel, 
1973; Wei et al., 1975).  Thor and Helke used double labeling techniques to 
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identify serotonin- and substance P-containing projections from raphe nuclei to 
the NTS (Thor and Helke, 1987).  A subsequent study revealed that serotonin 
and substance P are colocalized in the NTS, the dorsal motor nucleus of the 
vagus (DMX), and AP, and a similar fiber density of both are found in the ventral 
horn of the cervical spinal cord and the hypoglossal nucleus.  Considerably fewer 
serotonin and substance P double-labeled varicosities are found in the NTS 
compared to ventral horn and hypoglossal nucleus.  In the NTS only 5% of the 
serotonin immunoreactive varicosities contain substance P, while less than 1% of 
the substance P-immunoreactive varicosities also contained serotonin 
immunoreactivity in the NTS (Thor et al., 1988).  Varicosities that contain both 
serotonin and substance P are not likely from the nodose or petrosal ganglia.  
Instead they appear to derive from PPY, RO, RP and MR (Thor and Helke, 
1987, , 1989; Thor et al., 1988).   
 
 
 Serotonin receptors 
Currently, a total of four major families of 5-HT receptors with at least 14 
subtypes are known (Hoyer et al., 1994).  They include G protein-coupled 
receptors of the 5HT1, 5HT2, 5-HT4, 5-ht5, 5-ht6, and 5-HT7 receptor families and 
ligand-gated ion channels of the receptor 5HT3 receptor family.  These receptors 
have distinct distributions and mediate a wide range of cellular responses. 
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The 5HT1 receptor family includes 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT1F 
receptors.  5-HT1A receptors are coupled to inhibitory G proteins and inhibit 
adenylyl cyclase.  The 5HT1A receptors are serotonin autoreceptors expressed 
on the cell body and dendrites of serotonin cells.  5HT1A receptors are also 
located on non-serotonergic cells.  Upon activation, 5HT1A receptors 
hypopolarize cell membranes by opening K+ channels or by decreasing calcium 
influx via voltage-gated calcium channels (Albert et al., 1996; Barnes and Sharp, 
1999).  The 5-HT3 receptors are ligand-gated ion channels located primarily on 
peripheral neurons and depolarize membranes by opening of a non-selective 
cation channel.  Many of the 14 identified serotonin receptor subtypes have been 
found in the NTS.  A high density of 5-HT1A, 5-HT1B receptors, 5-HT2A, 5-HT2C, 5-
HT3, 5-ht5A  and 5-HT7  receptors have been found in the NTS (Manaker and 
Verderame, 1990; Oliver et al., 2000; Pompeiano et al., 1994; Ramage and 
Villalon, 2008; Steward et al., 1993).  Application of serotonin to the NTS evokes 
falls in BP and HR (Laguzzi et al., 1984) or elevations in BP (Merahi et al., 1992).  
The 5-HT1A and 5-HT2 receptors are thought to be involved in the hypotensive 
effect of serotonin in the NTS (Itoh and Bunag, 1991), while the hypertension  
seems to involve 5-HT3 receptors (Merahi et al., 1992).  It has been suggested 
that activation of 5-HT1A receptors in the NTS stimulates ventilation in rats after 
spinal cord injury (Teng et al., 2003) and in intact cats and rats (Garner et al., 
1989; Mendelson et al., 1990).  It has also been demonstrated in anaesthetized 
rats that synaptic transmission of vagal afferent inputs to the NTS, including 
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those from non-myelinated cardiopulmonary afferents, can be increased by 
activation of 5-HT3 receptors (Jeggo et al., 2005).  5-HT7 receptors are also 
involved in the neurotransmission of vagal afferent input into the NTS in 
anaesthetized rats (Oskutyte et al., 2009). 
   
 
 Major functions of serotonin 
Central serotonin has been implicated in appetitive behaviors, 
neuroendocrine function, emotion, cognition, autonomic responses, 
thermoregulation, and motoric behaviors (Currie and Coscina, 1998; Jorgensen, 
2007; Morrison et al., 1999).  However, its cardiovascular effects are less well 
documented.  A dose-dependent increase in BP has been observed after 
unilateral application of serotonin into the NTS in anesthetized rats (Wolf et al., 
1981).  Serotonin antagonists significantly attenuate this presser effect, while 
fluoxetine, a serotonin uptake inhibitor, significantly enhances the magnitude of 
the pressor response (Wolf et al., 1981).  Lambert and colleagues also reported 
that serotonin injected into the 3rd ventricle in anesthetized rats produced a rise in 
BP coincident with a sympathetically mediated reduction in HR and ventilation 
(Lambert et al., 1978). 
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F. Serotonin and the 5HT 1A receptor in hemorrhage 
The amino acid L-tryptophan is the precursor for the synthesis of 
serotonin.  Initially L-tryptophan is transported from the interstitium into neurons 
and is converted to 5-hydroxytryptophan by the enzyme TPH.  Aromatic L-
amino acid decarboxylase is a soluble pyridoxal-5’-phosphate-dependent 
enzyme, which then converts 5-hydroxytryptophan to serotonin.  The product of 
serotonin breakdown by monoamine oxidase is 5-Hydroxyindoleacetic acid, 
which is excreted in the urine.  Global depletion of serotonin with p-
chlorophenylalanine (p-CPA), an inhibitor of TPH, attenuates the hypotensive, 
bradycardic and sympatholytic effects of hemorrhage in the anesthetized cat.  
Intravenous administration of the non-selective 5HT-receptor antagonist, 
methysergide, was also found to reverse the hypotensive response to blood 
withdrawal (Elam et al., 1985).  Similar results have also been observed in 
chloralose-anesthetized rats (Morgan et al., 1988).  Central administration of 
methysergide also prevented the fall of BP in rabbits subjected to caval vein 
occlusion (Evans et al., 1992).  More recent studies by Dean and Bago showed 
that injection of the 5HT1A-receptor antagonist, WAY-100635 directly into the 
pressor area of RVLM delayed and attenuated the fall in BP during the 
sympatholytic phase of hemorrhage in anesthetized rats (Dean and Bago, 
2002).  Together, these results suggested that endogenous serotonin acts on 5-
HT1A receptors in the RVLM to cause the bradycardic and sympatholytic 
responses to hemorrhage.  Our lab and others have investigated which 
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serotonin cell groups are activated by hypotensive hemorrhage by determining 
which of these cell groups express the immediate early gene c-FOS in response 
to blood withdrawal (Bago et al., 2002; Ruszaj et al., 2006).  We have found that 
specific serotonin cell groups, including the vlPAG, RO, PPY and SUB 
expressed c-Fos after exposure to hypotensive hemorrhage, but not after 
hypotension alone in the awake rat (Ruszaj et al., 2006).  Together, the existing 
data suggested that the vlPAG, RO, PPY or SUB mediate the sympatholytic 
phase of hypotensive hemorrhage.  However, this view remains controversial, 
since significant serotonin depletion fails to attenuate the sympatholytic 
response in unanaesthetized rabbits (Evans et al., 1992).   
We and others have also found that the selective 5-HT1A-receptor agonist, 
8-OH-DPAT, mimics the cardiovascular effects of methysergide in 
unanaesthetized hypovolemic cats and rats (Evans et al., 1993b; Scrogin et al., 
2000).  The ability of methysergide and 8-OH-DPAT to delay and attenuate the 
sympatholytic responses to hemorrhage was blocked by systemic administration 
of the selective 5-HT1A-receptor antagonist, WAY-100635 (Scrogin et al., 2000).  
Additional evidence indicates that systemic administration of the partial 5-HT1A 
agonist buspirone, or 8-OH-DPAT, can reverse the sympatholytic response to 
hemorrhage (Osei-Owusu and Scrogin, 2004).  8-OH-DPAT also stimulates 
sympathetic-dependent increases in venous tone, improves blood gases, and 
increases cardiac output as well as renal perfusion in conscious rats subjected to 
hypovolemic shock (Tiniakov and Scrogin, 2006).  Thus, activation of 5-HT1A 
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receptors by exogenous serotonin agonists produces sympathoexcitatory effects 
that are hemodynamically beneficial in hypovolemic shock.   
Our laboratory also found that the 5-HT1A-receptor agonist 8-OH-DPAT is 
more potent in restoring BP and sympathetic activity in hemorrhaged-rats when 
administered into the 4th cerebral ventricle compared to injections in to more 
rostral parts of the cerebroventricular system (Scrogin, 2003).  This led us to 
speculate that 8-OH-DPAT acts on receptors located near the dorsal surface of 
the medulla to reverse the sympatholytic responses to hemorrhage.  
Autoradiographic and electrophysiological studies have demonstrated a 
significant expression of functional 5-HT1A receptors near the dorsomedial 
surface of the medulla in the NTS (Thor et al., 1992a, 1992b).  The full 
sympathoexcitatory effect of 5-HT1A-receptor agonists is dependent on intact 
sinoaortic afferents that carry arterial baroreceptor and peripheral chemosensory 
afferents to the NTS (Osei-Owusu and Scrogin, 2006).  Together the data 
suggest that serotonin or 5-HT1A-receptor agonists may act on receptors that 
facilitate sympathetic responses elicited by arterial baroreceptors or peripheral 
chemoreceptors to induce recovery of sympathetic activity during the secondary 
compensatory phase of hemorrhage.  
 
  
G. Serotonin in central chemoreflex function   
Please refer to the central chemoreflex section (page 25).  
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H. Serotonin in peripheral chemoreflex function  
There is a dense serotonergic fiber projection from the caudal raphe nuclei 
(RM, RO, RP and PPY) to the comNTS where peripheral chemoreceptor 
afferents terminate (Schaffar et al., 1988; Steinbusch, 1981; Thor and Helke, 
1987).  The caudal NTS also contains a high density of various serotonin 
receptors subtypes including 5HT1A, 1B, 2, 3, and 7 receptors (Manaker and 
Verderame, 1990; Pazos et al., 1985; Pratt et al., 1990; Ramage and Villalon, 
2008).  In the NTS, 5HT1A receptors appear to be distributed in areas associated 
with the coordination of swallowing, respiration, and cardiovascular function, 
while 5HT1B sites appear preferentially distributed in areas of the NTS associated 
with gastrointestinal, hepatic, pancreatic, and cardiovascular function (Thor et al., 
1992a).  Little is known about the role of serotonin in modulating responses to 
hypoxia.  Studies suggest that serotonergic RO neurons that project to the NTS 
inhibit the cardiovagal or bradycardic component of the peripheral chemoreflex 
by releasing serotonin in the NTS, which, in turn activates 5HT3 receptors 
(Weissheimer and Machado, 2007).  However, the same receptors do not appear 
to modulate the ventilatory or sympathetic component of the reflex (Nosjean et 
al., 1995; Sevoz et al., 1997).  More recent work by Taylor et al. has shown that 
suppression of the caudal raphe serotonergic neurons has no effect on 
ventilatory response to hypoxia in awake rat (Taylor et al., 2005).  In addition, 
activation of chemoresponsive single units in the NTS during chemoreceptor 
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afferent activation was suppressed when the RM was stimulated (Perez and 
Ruiz, 1995).  Together, these findings suggest that caudal serotonin raphe 
neurons either do not influence peripheral chemoreception or possibly inhibit 
sensitivity to hypoxia. 
Studies in this dissertation will more carefully explore the role of 
endogenous serotonin and exogenous 5-HT1A receptors in the control of 
ventilation and sympathetic activity during hemorrhage and during the activation 
of reflex pathways that are normally engaged during hemorrhage. 
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CHAPTER III 
Serotonin neurons of the caudal raphe nuclei contribute to sympathetic 
recovery following the hypotensive hemorrhage 
 
Abstract 
Caudal medullary serotonergic neurons positively modulate sympathetic 
recovery after acute hypotensive hemorrhage in conscious rats.  Serotonin is 
thought to contribute to the sympatholytic syncopal-like response that develops 
during severe blood loss by inhibiting pre-sympathetic neurons of the RVLM.  
Previously, we determined that serotonergic neurons of the RO, RM, PPY, SUB 
and vlPAG region are activated by hypotensive hemorrhage, but not hypotension 
alone.  To determine if caudal hindbrain cells contribute to the sympatholytic 
response to blood loss, they were targeted for destruction with a selective 
serotonin neurotoxin.  We found that lesion of caudal hindbrain serotonergic cells 
sufficient to produce greater than 80% loss of serotonin nerve terminal 
immunoreactivity in the RVLM did not affect the sympatholytic response, but 
instead accelerated the RSNA fall during blood loss, attenuated the recovery of 
RSNA during the secondary compensatory phase of hemorrhage, and 
exaggerated metabolic acidosis.  Hindbrain serotonin lesion also attenuated 
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ventilatory and sympathetic responses to stimulation of central chemoreceptors 
but increased spontaneous arterial BRS and decreased BP variability.  Together, 
the data indicate that serotonin cells of the caudal hindbrain contribute to the 
secondary compensatory response following blood loss that helps to maintain 
oxygenation of peripheral tissue in the unanaesthetized rats.  This effect may be 
related to facilitation of the chemoreflex response to acidosis. 
 
Introduction 
Progressive hemorrhage leads to a complex, multiphasic autonomic 
response, the origins of which are not well understood.  The initial sympathetic 
activation that accompanies mild blood loss during the primary compensatory 
phase is mediated by arterial baroreceptor unloading and is quite likely 
augmented by cardiopulmonary reflex activation (Osei-Owusu and Scrogin, 
2006; Quail et al., 1987; Schreihofer et al., 1994).  After significant blood loss, 
these compensatory responses suddenly abate, resulting in a sympatholytic 
response that is characterized by rapid sympathetic withdrawal and cardiac vagal 
activation (Barcroft and Edholm, 1945; Osei-Owusu and Scrogin, 2006; Schadt 
and Ludbrook, 1991).  If blood loss continues, autonomic compensation is slowly 
re-established, eventually culminating in tachycardia and sympathoexcitation 
(Tiniakov and Scrogin, 2006).  However, if severe hypovolemia persists much 
beyond the point of maximal sympathetic activation, the vasculature becomes 
    
  
50
unresponsive to catecholamines leading to a decompensation that is difficult to 
treat (Liu et al., 2003). 
Several lines of evidence suggest that serotonin release in the central 
nervous system contributes to the early sympathetic withdrawal that 
accompanies significant blood loss in the sympatholytic phase.  For instance, the 
hypotensive response to hemorrhage is delayed and attenuated in anesthetized 
animals subjected to global serotonin depletion with systemic administration of 
the tryptophan hydroxylase inhibitor, p-CPA (Blum and Spath, 1986; Elam et al., 
1985; Morgan et al., 1988).  In accord, systemic administration of the broad-
spectrum serotonin receptor antagonist, methysergide, rapidly reverses the 
hypotensive response to blood loss and improves survival of anesthetized cats 
subjected to severe hemorrhage (Elam et al., 1985).  More recently it was found 
that unilateral injection of the 5-HT1A-receptor antagonist, WAY-100635, in the 
pressor region of the RVLM attenuated and delayed the sympatholytic response 
to blood loss in anesthetized rats (Dean and Bago, 2002).  Together, these 
findings suggest that a sympatholytic effect of 5-HT1A receptor activation in the 
RVLM mediates the sympathoinhibitory hemodynamic response to severe 
hemorrhage. 
However, this view remains controversial since significant serotonin 
depletion fails to produce an observable delay or attenuation of the depressor 
response in unanaesthetized rabbits subjected to central hypovolemia via caval 
vein occlusion (Evans et al., 1992).  Moreover, both systemic and 
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intracerebroventricular administration of serotonin 5-HT1A-receptor agonists, 
including the potent full 5-HT1A-receptor agonist 8-OH-DPAT, mimics the ability of 
methysergide to delay the onset of the sympatholytic response to blood loss in 
conscious rats (Scrogin et al., 2000).  The ability of either methysergide or 8-OH-
DPAT to delay hypotension is prevented by prior treatment with WAY-100635.  
As such, the effect of methysergide is most likely due to an agonist action on 5-
HT1A receptors, rather than blockade of endogenous serotonin.  More recent 
evidence indicates that systemic administration of partial and full 5-HT1A-receptor 
agonists can rapidly reverse the sympatholytic response to hemorrhage and 
dramatically improve blood gases in animals subjected to hypovolemic shock 
(Osei-Owusu and Scrogin, 2004; Tiniakov and Scrogin, 2006).  Thus, studies in 
unanaesthetized animals call into question the role of endogenous serotonin in 
the sympatholytic response to hemorrhage.  In fact, they suggest that serotonin 
receptor activation may instead contribute to the secondary sympathetic 
compensatory phase of hypotensive hemorrhage. 
However, it is possible that a redundant, non-serotonergic pathway that is 
normally suppressed during anesthesia contributes to the depressor response in 
unanaesthetized rats.  Alternatively, it is possible that in prior studies that utilized 
unanaesthetized models serotonin depletion was not sufficient to affect the 
sympatholytic response.  To further address these possibilities, we determined 
whether targeted destruction of serotonergic nuclei that are normally activated by 
hypotensive hemorrhage is required for normal sympathetic responses to 
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hemorrhage in unanaesthetized rats.  Indices of BRS were also assessed to 
determine the effect of lesion on baroreflex integrity.  Measures of central 
chemoreflex sensitivity were also performed to provide functional evidence of 
serotonin depletion based on recent evidence demonstrating the importance of 
ventromedial medullary serotonin cells on arterial PCO2 detection in conscious 
animals (Dias et al., 2007). 
 
Methods 
Animals 
Male Sprague-Dawley rats (300 - 350 g, Harlan, Indianapolis, IN) were 
acclimated to the housing facility while given ad libitum access to food and water 
at least 1 wk prior to surgery.  The facility was maintained at a constant 
temperature of 22 ± 2 °C with a light/dark cycle of 12:12 hrs.  All experiments 
were approved by the Institutional Animal Care and Use committee and were 
conducted in accordance with the Guide for the Care and Use of Laboratory 
Animals as adopted and promulgated by the US National Institutes of Health. 
 
Surgery 
Neurotoxin studies: major caudal hindbrain serotonin nuclei were initially 
targeted for selective serotonin lesion based on outcomes from our  previous c-
Fos study which showed that serotonin neurons of the RO, RM, RP, PPY, SUB, 
vlPAG nuclei expressed c-FOS in response to hypotensive hemorrhage 
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(Glasgow et al., 2009; Ruszaj et al., 2006).  All rats were pre-treated with the 
dopamine and NE re-uptake blocker, nomifensine (15 mg/kg in 20% β-
cyclodextran), at least 30 min prior to neurotoxin injection to prevent toxin-
induced destruction of noradrenergic and dopaminergic cells.  Rats were 
anesthetized with sodium pentobarbital (65 mg/kg, i.p.) and placed in a 
stereotaxic apparatus.  The incisor bar was placed 11 mm below the level of the 
interaural cavity.  The back of the skull was exposed and a portion of the occipital 
bone was removed to expose the brainstem.  The occipital membrane was 
incised and a micropipette injector (O.D. ~20 μm) was centered at the caudal tip 
of calamus scriptorus.  Injections of either 5,7-dihydroxytryptamine (5,7-DHT; 5 
mM in 0.1% ascorbic acid) or vehicle (0.1% ascorbic acid) were made in three 
rostro-caudal planes: 1.9, 2.9, and 3.9 mm rostral to the caudal end of calamus 
scriptorus.  Three 200-nl injections were made 3 mm below the dorsal surface of 
the brainstem (relative to calamus scriptorus) at each rostro-caudal plane, 1.1 
mm to the left and right of the midline and at the midline, for a total of 9 injections 
targeted to the ventromedial serotonergic cell groups of the caudal brainstem in 
each rat.  The neck muscle and skin were closed in separate layers. 
Two weeks later, all rats were re-anesthetized with sodium pentobarbital 
(65 mg/kg, i.p.) and implanted with vascular catheters one day prior to the 
experiment (Figure 7).  In these studies, catheters were placed bilaterally in the 
femoral arteries to enable direct measurement of arterial pressure and 
simultaneous arterial blood withdrawal.  A third catheter was placed unilaterally in 
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the femoral vein for drug injections.  Catheters were externalized at the nape of 
the neck and secured with sutures.  During the same surgery, dual recording 
electrode leads were placed around a renal sympathetic nerve fiber bundle and 
against the abdominal side of the diaphragm to enable recording of RSNA and 
diaphragmatic EMG (dEMG), respectively (Figure 8).  The electrode connector 
was externalized through the subcutaneous space at the nape of the neck along 
with the vascular catheters.  For RSNA recordings, a 1 to 2 mm segment of a 
sympathetic fiber bundle emanating from the aorticorenal ganglion was isolated 
and placed on a stainless steel, Teflon-coated (bare di =.005 in., A-M Systems 
Inc., Everett, WA) bipolar electrode implanted through a left flank incision.  
Viability of the nerve preparation was determined by auditory assessment of the 
bursting activity, after which the preparation was embedded in a quick drying, 
lightweight silicon (Kwik sil, World Precision Instruments).  The flank muscle 
incision was closed around the electrode lead wires.  Subsequently, the 
abdominal side of the diaphragm was exposed through a small laparotomy just 
below the most caudal left rib.  Stainless-steel Teflon-coated lead wires, like 
those described above, were fashioned to extend from the same microconnector 
and tied to the diaphragm using 6-0 nylon.  The lead wires were coiled in the 
subcutaneous space and the incisions closed in layers.  Animals were allowed to 
recover overnight prior to the experiment.  
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Data Acquisition 
Arterial pressure, HR, RSNA and dEMG were recorded on a Macintosh 
G4 Powerbook computer using PowerLab data acquisition software (Chart v. 
5.2.1, ADinstruments, Colorado Springs, CO).  Arterial pressure was measured 
with a disposable pressure transducer (Transpac® IV, Abbott Labs, North 
Chicago, IL) and a PowerLab bridge amplifier (ADinstruments, CO).  Heart rate 
was calculated using peak-to-peak detection of the pulse pressure wave.  
Sympathetic activity and dEMG were sampled (4,000 Hz) and amplified (10-
20,000x) with PowerLab Bioamplifiers (ADinstruments, CO).  The recorded 
neurograms were filtered (1-1000 Hz), rectified and integrated over a 20-ms time 
constant.  Background noise in the RSNA recordings was determined at the end 
of each experiment by measuring the remaining signal following ganglionic 
blockade (hexamethonium chloride, 30 mg/kg, i.v.).   Background noise was 
subtracted from nerve activity values to provide a measurement of RSNA.  
Background noise in the dEMG electrode recording was determined during 
expiration, when phrenic motor nerve activity was absent.  Measurements of 
RSNA and dEMG obtained during the experiment were normalized to baseline 
determined over a 10 min period directly prior to the start of interventions.  Only 
RSNA and dEMG data from animals with greater than a 2:1 signal to noise ratio 
in the respective neurograms were included in the data analysis.  Respiratory 
rate (RR) was determined by peak to peak detection of the integrated dEMG 
signal. 
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Spontaneous BRS was determined from 5-min segments of BP and HR 
collected prior to hemorrhage.  Data were analyzed with Nevrokard SA-BRS 
software v.3.2.4 to determine BRS by the sequence method (Padley et al., 2005).  
Gain was determined as the average slope of linear regressions obtained from a 
minimum of 3 sequences that satisfied the following constraints: 3 or more 
consecutive interbeat intervals (IBI) with variation in the same direction, >0.5 ms 
that correlated (r2 >0.85) with systolic, diastolic or mean arterial BP variations of 
>0.5 mmHg with a 3 beat delay.  These parameters were chosen based on prior 
analyses demonstrating that they retrieved the most sequences with the highest 
gain in intact male Sprague-Dawley rats of a similar age (Henze et al., 2008).  
Cross-spectral analyses were performed on IBI and BP data using a 128-point 
fast Fourier transformation with a smoothed Hamming window.  Coherence 
between IBI and BP variability was determined as the square root of the ratio of 
the IBI and BP power spectra with 50% overlap and zero padding of 8.  Values 
are reported as the alpha index in the low frequency (alpha LF) (0.06-0.6 Hz) and 
high frequency (alpha HF) (0.6-3.0) domains.  In addition, BP variability was 
determined in the low frequency domain (LF power) and in the time domain, the 
latter of which was determined as the standard deviation of BP between normal 
beats (BP SDNN). 
Alveolar - arterial O2 differences were calculated to estimate the degree of 
ventilation perfusion mismatch in blood samples taken during hemorrhage.  
Alveolar O2 was estimated using the equation PaO2= FIO2 * (Pb-Pwv)-PaCO2/R, 
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where the fraction of inspired oxygen (FIO2) was estimated as 0.21, barometric 
pressure (Pb) as 760 mm Hg, water vapor pressure (Pwv) as 47 mm Hg and the 
respiratory quotient (R) as 0.8.  Arterial O2 and CO2 were determined from 
arterial blood gas measurements obtained before and during hemorrhage 
(Strittmatter and Schadt, 2007).  Arterial blood gases were determined using an 
I-STAT 1 blood gas analyzer (ISTAT, East Windsor, NJ). 
 
Experimental Protocols: 
Central chemoreflex and hemorrhage experiments 
At least 2 hrs prior to hemorrhage, rats subjected to sham- or hindbrain 
serotonin lesion were exposed to hyperoxic hypercapnia to determine their 
central chemoreflex sensitivity.  The rats were placed unrestrained in a plastic 
box (4.5 inches deep, 11 inches long and 5 and 7/8 inches wide) flushed with 
100% O2.  Blood pressure, HR, RSNA and dEMG were determined throughout 
the experiment.  After at least 1 hr habituation, rats were exposed to 5% CO2 
added to the O2 for 5 min after which a 100 µl arterial blood sample was taken for 
measurement of blood gases.  The CO2 level was raised to 8% for an additional 
5 min, after which a second arterial sample was taken.  Ambient CO2 levels in the 
box were recorded using a capnometer (Vacu·Med, Ventura, CA.).  Immediately 
following the hypercapnia experiment the rats were moved back to their home 
cage.  
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After at least 2 hrs of recovery from exposure to hypercapnia the rats were 
connected to a withdrawal pump and an arterial pressure transducer through an 
overhead swivel system.  Rats were habituated after instrumentation for at least 
1 hr while they rested unrestrained in their home cage.  After habituation, arterial 
blood was withdrawn using an automated withdrawal pump set at a rate of 3.2 
ml/min/kg for 6 min and adjusted to a slower withdrawal rate of 0.52 ml/min for 4 
additional minutes.  This procedure produces a consistent hypotensive response 
after approximately 3.5 min and maintains pressure at 40-50 mmHg for the 
remainder of active blood withdrawal.  Data acquisition was begun 15 min prior to 
the experiment and continued throughout the hemorrhage and for an additional 
50 min following termination of hemorrhage.  Arterial and venous blood samples 
(150 μl) were taken at least 30 min before hemorrhage, at the end of 
hemorrhage, and 60 min after the start of hemorrhage for determination of blood 
gases, hematocrit and plasma protein.  At the end of the experiment rats were 
given hexamethonium chloride (30 mg/kg, i.v.) for determination of background 
noise in the sympathetic recording.  Animals were then rapidly anesthetized with 
sodium pentobarbital (65 mg/kg, i.v.) and quickly perfused transcardially with 90 
ml of sodium nitrite (0.1 M) in 6.7 mM phosphate buffer followed by 90 ml 4% 
paraformaldehyde in 0.1 M PBS.  The brains were removed and post-fixed for 
1hr.  The brainstem was blocked and post-fixed for an additional hour and 
subsequently dehydrated in 30% sucrose.  Brains were cut in 40 μm sections 
and collected serially into 6 wells.  Sections were saved in cryoprotectant (30% 
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sucrose and 30% ethylene glycol in phosphate buffered saline) and stored at -
20ºC.  
 
Immunohistochemistry: Tryptophan hydroxylase (TPH), Tyrosine 
hydroxylase (TH), serotonin (5HT) 
Brain sections from rats were processed to expose tryptophan 
hydroxylase  immunoreactivity (TPH-ir) in order to verify the extent of lesion.  
One of every six sections was incubated in 0.2% Triton X (40 min), 3% H2O2 (10 
min), 6% goat serum and sheep anti-TPH primary antibody (1:1000, Chemicon) 
for 48 hrs at 4ºC.  Sections were then incubated in biotinylated goat anti-rabbit 
IgG (1:1000, Vector) for 1 hr at room temperature followed by incubation with 
avidin-biotin complex (Vector) for 50 min.  Immunoreactivity was exposed with 
nickel sulfate-intensified 3, 3’–diaminobenzadine tetrahydrochloride (DAB) 
chromagen to produce a black nuclear label.  To verify that the neurotoxin did not 
affect noradrenergic neurons, an additional set of sections was incubated in the 
same solution as describe above, except that 6% horse serum and mouse-anti-
TH (1:1000, Chemicon) antibody were substituted for goat serum and anti-TPH 
antibody.  Sections were washed and incubated in the appropriate biotinylated 
IgG made in horse for 1 hr and incubated with avidin-biotin complex as described 
above.  Sections were rinsed in PBS, mounted on gel-coated slides, dried with 
xylene and coverslipped with DPX mountanting media.  The specificity of the 
primary antibodies was verified by characteristic labeling of known serotonergic 
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and adrenergic cell groups of the brainstem.  Omission of the primary antibodies 
completely prevented cell labeling. 
Serotonin nerve terminal density was determined in rats subjected to 
hindbrain lesion.  Rabbit anti-serotonin antibody (1:200,000, Immunostar) was 
pre-incubated with 6 mM reduced L-glutathione (Sigma) in 1mM tris-EDTA buffer 
(pH 8) for 1hr at room temperature prior to incubation with the tissue (Rogers et 
al., 2006).  One in six sections from lesioned- and sham-lesioned rats was 
incubated in 0.2% Triton X and the primary antibody for at least 48 hr at 4ºC.  
Sections were then washed and incubated in 6% donkey serum, 0.2%Triton X 
and donkey anti-rabbit Dylight 649 (1:200, Jackson ImmunoResearch) for 2 hr.  
Sections were rinsed in PBS, mounted on gel-coated slides and immediately 
coverslipped with fluoromount (Sigma).  Sections were stored at 4ºC for 14 days 
prior to microscopy.  Some sections containing the RVLM were double-labeled 
for serotonin and PNMT to enable examination of serotonin fiber density in the 
C1 region.  In this case the above protocol was followed except that mouse anti-
PNMT antibody (1:4000, Abnova) was added to the primary incubation step and 
donkey anti-mouse Cy3 (1:200, Jackson ImmunoResearch) was added to the 
second incubation. 
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Microscopy 
Tryptophan hydroxylase and serotonin immunoreactivity in lesion studies 
Given our experience that cell bodies of serotonergic neurons are better 
visualized with a TPH label, cell bodies showing TPH-ir were counted throughout 
the same raphe regions as described above.  Every 6th section throughout the 
anatomical extent of each serotonin-rich nucleus or region was counted.  These 
regions included the DR and MR nuclei, the vlPAG region, the RM and PPY, the 
RO, the SUB region and RP (Steinbusch, 1981).  
 Given that serotonin nerve terminals are better visualized with a serotonin 
label, 5-HT-ir was also assessed in terminal projections to brainstem areas 
known to regulate autonomic function, including the RVLM and the NTS.  
Serotonin immunoreactive fiber density in the NTS was determined unilaterally at 
the level of the medial and comNTS subnuclei approximately 13.4 and 14.1 mm 
caudal to Bregma, respectively.  Serotonin fiber density was also determined in 
the RVLM at 3 levels; 11.8, 12.2 and 12.8 mm caudal to bregma.  Fiber density 
was determined by thresholding a composite image made from thirty 1 µm 
deconvolved optical sections taken from each tissue section.  Images were taken 
with an Olympus inverted IX81 epifluorescence microscope with a motor driven 
stage and a 10x objective.  Background levels were determined from unlabeled 
neuropil measured at the same rostro-caudal level averaged from 3-5 tissue 
sections obtained from different sham-lesioned animals.  All images obtained 
from the same region were subjected to the same degree of background 
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subtraction prior to thresholding.  Tissues from equal numbers of lesioned and 
sham-lesioned animals were processed in parallel in two separate cohorts.  All 
images were acquired at the same exposure length, on the same day, 14 days 
after immunohistochemical processing.  Deconvolution was performed within 
each optical section using Vaytek Microtome software and the rapid nearest 
neighbor method.  Deconvolved optical sections were merged into a single 
composite image using Image Pro analysis software (version 6.3).  
Measurements of serotonin nerve terminal content were made from images in 
which the sections were carefully oriented to keep the mid-line of the section 
aligned in a vertical plane with the camera.  An area of interest (AOI) was placed 
over the 8-bit image and the percent area of the thresholded image that was 
occupied by thresholded signal was determined using NIH Image J software.  For 
measurements of the comNTS an AOI box 825 pixel wide and 518 pixel high was 
placed such that the lower left corner of the AOI touched the most dorsomedial 
point of the central canal.  For measurement of the medial NTS an AOI oval, with 
a maximal pixel width of 900 and maximal pixel height of 600 was centered such 
that the leading left edge of the AOI was centered over the right lateral border of 
the 4th ventricle where it met the right NTS.  For measurements in the RVLM, an 
AOI 900 pixels in width and 800 pixels in height was placed 450 pixels from the 
mid-line such that the right lower corner touched the right ventrolateral 
subependymal surface of the section.  Using this method, AOIs were consistently 
centered over the pressor region of the RVLM as determined by the density and 
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orientation of PNMT-positive cells which make up the C1 bulbospinal neurons 
that project to pre-ganglionic sympathetic cells of the spinal cord. 
 
Data Analysis 
The effect of lesion on BP, HR, RSNA, integrated dEMG (as an index of 
central respiratory drive), RR and 5-HT-ir nerve terminal fiber density and TPH-ir 
cell number was determined by two-way ANOVA with repeated measures.  
Significant interactions and main effects were followed up with Newman-Keuls 
post-hoc tests. 
 
Results 
Lesion did not significantly affect body weight or hemodilution during the 
course of hemorrhage (Table 1).  Blood pressure, HR and RSNA of sham-
lesioned showed typical biphasic responses during acute hemorrhage 
characterized by a short normotensive phase during which sympathetic activity 
increased, followed by a rapid fall in all three variables (Figure 9).  After reaching 
their nadir between 6 and 8 minutes after the start of blood withdrawal, the three 
variables began to recover and reached a steady state within 20 minutes of 
hemorrhage termination.  The respiratory response was characterized by 
tachypnea that developed at the start of hemorrhage during the sympatholytic 
phase, which began to normalize prior to the end of hemorrhage.  Respiratory 
rate continued to decline slightly below baseline where it remained for the rest of 
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the recording period.  The integrated dEMG response was somewhat variable.  
In general, it rose initially during the primary compensatory phase of hemorrhage 
but declined back to baseline during the sympatholytic phase and fluctuated 
thereafter throughout the second compensatory phase.  In general, dEMG was 
elevated above baseline, but an overall ANOVA failed to show a significant effect 
of time in sham-lesioned animals. 
Hindbrain neurotoxic lesion did not significantly affect the BP or HR 
responses to acute hemorrhage or during second compensatory phase (Figure 
9).  Qualitatively, baseline sympathetic burst frequency or amplitude did not 
appear different between groups (data not shown).  The maximal rise in 
sympathetic activity during blood withdrawal did not differ between groups (106.6 
± 19.0 vs. 69.6 ± 23% of baseline for control and lesioned groups respectively).  
The sympatholytic response developed more quickly in the lesioned animals, but 
the nadirs of the two groups were similar.  Sympathetic activity in lesioned rats 
recovered to a lower steady state overall (P<0.01).  Respiratory rate in lesioned 
animals paralleled that of sham-lesioned animals during active blood loss but 
then declined to an overall lower level once blood loss was terminated (P<0.05).  
Integrated dEMG declined from the primary compensatory phase of hemorrhage 
and remained below baseline and below that of sham-lesioned rats throughout 
the second compensatory phase of hemorrhage (P<0.01). 
Acid base balance did not differ between groups prior to hemorrhage.  In 
sham-lesioned rats, a significant decrease in pH was only observed in the blood 
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sample taken 60 min after start of blood withdrawal (Table 2).  Lactate 
accumulation and loss of base excess (BE) developed within the first 10 minutes 
of blood loss (P<0.01).  In sham-lesioned animals, lactate and BE began to 
return to baseline by the end of the recording period.  Loss of BE and lactate 
accumulation were exaggerated in lesioned animals and remained so through 
the end of the experiment (P<0.01).  In accord, arterial pH of lesioned rats was 
significantly reduced compared to sham-lesioned rats at 10 and 60 minutes after 
the start of hemorrhage (P<0.05 and P<0.01 respectively). 
Arterial PO2 increased during the first 10 minutes of hemorrhage and 
remained elevated throughout the second compensatory phase of hemorrhage in 
sham-lesioned rats (P<0.01).  Lesioned rats showed a similar increase in arterial 
PO2 initially, that further increased and exceeded that of sham-lesioned animals 
during the second compensatory phase (P<0.01).  Arterial PCO2 declined initially 
during blood withdrawal (P<0.01) and recovered in the second compensatory 
phase similarly in both groups.  
Exposure to hyperoxic hypercapnia increased sympathetic activity and 
ventilation but reduced HR in sham-lesioned rats (Figures 10 and 11).  Increased 
ventilation was characterized by both increased rate and amplitude of phrenic 
nerve bursts with increasing CO2.  Lesion attenuated the ventilatory (P<0.05) and 
sympathetic (P<0.01) responses to 8% CO2.  However, the lesion did not affect 
bradycardia or tachypnic responses to increasing CO2.  Arterial pH and PCO2 did 
    
  
66
not differ between groups over the course of the chemoreflex experiment (Table 
3). 
Average spontaneous baroreflex gain of the HR reflex was increased in 
lesioned rats when assessed with the sequence method (P<0.05) when the IBI 
was related to systolic, mean or diastolic pressure (Table 4).  There was a 
tendency for an increased baroreflex gain in lesioned groups when assessed by 
the spectral method (P<0.06).  Similarly, the power of BP variability in the low 
frequency domain tended to be lower in lesioned animals, but the difference was 
not significant (P<0.07).  However, BP variability in the time domain was 
significantly reduced in lesioned rats when either systolic, mean or diastolic 
pressures were assessed (P<0.05).  The ratio of low frequency to high frequency 
HR variability (LF/HF) did not differ between groups. 
 
Immunohistochemistry: TPH / TH / 5HT 
Hindbrain neurotoxin injection resulted in a large reduction in the numbers 
of TPH-ir cells throughout the caudal serotonin-rich region of the brainstem 
(Figure 12).  The degree of depletion following neurotoxin was most extensive 
between 13.5 and 11 mm caudal from Bregma.  The hindbrain lesion did not 
affect TPH-ir positive cell numbers in midbrain nuclei (Figure 13). 
Tyrosine hydroxylase immunoreactive cells in the locus coeruleus and A1 
region showed no apparent difference in morphology following treatment with the 
neurotoxin (Figure 14A-D).  Tyrosine hydroxylase immunoreactive cell number in 
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the A2 and A5 regions was not affected by neurotoxin injection (Figure 14E).  
Cell counts in the locus coeruleus were not determined due to the intense 
staining and inability to differentiate individual cells.  The number of TH-ir cells in 
the A1 region was not determined since it was not possible to differentiate 
between noradrenergic cells of the A1 region and adrenergic cells of the C1 
region within the same section using DAB labeling techniques.  However, the 
apparent density of staining did not differ in either region (Figure 14A-D). 
Serotonin fiber density was reduced by more than 80% at three rostral-
caudal levels within the C1 region of the RVLM (Figure 15E-F and Table 5).  
Serotonin nerve terminal immunoreactivity in the NTS at the level of the 
commissural and medial subnuclei was diminished by 50-60% following targeted 
caudal hindbrain neurotoxin administration (Figure 15A-D and Table 5). 
 
 
 
    
  
68
 
Figure 7:  Illustration of catheter placement in a rat.  Two catheters were placed 
bilaterally in the femoral arteries and the third catheter was placed unilaterally in 
a femoral vein.  Catheters were occluded by a 23 ga wire and externalized at the 
nape of the neck and secured with sutures (not shown).  Figure modified from 
http://www.biologycorner.com/bio3/anatomy/rat_circulatory.html 
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Figure 8:  Simplified illustration of the placement of dual recording electrode and 
external catheters.  Dual recording electrode leads were placed around a renal 
sympathetic nerve fiber bundle (see above) and against the abdominal side of 
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the diaphragm to enable recording of RSNA and dEMG, respectively.  The 
electrode connector was externalized through the subcutaneous space at the 
nape of the neck along with the three vascular catheters.  Electrode and 
catheters were sewed and stabilized on the skin.  Top figure is modified from 
http://focosi.altervista.org/grafts.html 
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Table 1. Body weight at start of experiment and hematocrit and plasma protein 
concentration before and after hemorrhage 
      
Group BW Hematocrit (%) Plasma Protein (g/dL) 
  BL 60 min BL 60 min 
Control 
(15) 
377.2 ± 4.7 39.7 ± 0.6 30.6 ± 0.7** 5.6 ± 0.07 4.6 ± 0.07**
Lesion 
(10) 
389.7 ± 6.9 39.8 ± 1.7 29.5 ± 1.0** 5.8 ± 0.14 4.6 ± 0.08**
 
Values are group means ± SEM before baseline and 60 min after the start of 
hemorrhage.  Group n are shown in parentheses. 
 
Data were analyzed by 2-way ANOVA with repeated measures using Lesion and 
Time as factors.  Main effects and significant interactions were followed up with 
between- and within-group comparisons using Newman-Keul post-hoc test.    
**P<0.01 vs. baseline within group. 
 
An overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and Time on hematocrit (%) showed significant main effect of Time [F(1,23) = 
524.59, P<0.01] due to a decline of hematocrit with hemorrhage in both groups.   
 
An overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and Time on plasma protein showed a main effect of Time [F(1,23) = 222.51, 
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P<0.01] due to a decline in plasma protein concentration during hemorrhage in 
both groups.   
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Figure 9.  Mean arterial pressure (MAP), heart rate (HR), renal sympathetic 
nerve activity (RSNA), integrated diaphragmatic EMG (dEMG) and respiratory 
rate (RR) during hemorrhage (gray shaded region) and subsequent recovery in 
rats treated with vehicle (Control) and neurotoxin (Lesion) targeted to the caudal 
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raphe nuclei.  Data are group mean ± S.E.M.  Number of subjects in control 
group is 13 for MAP, HR and RR, 10 for RSNA and 11 for dEMG.  Number of 
subjects in lesion group is 8 for all parameters except RSNA which includes 7 
subjects.   
 
Data were analyzed by 2-way ANOVA with repeated measures using Lesion and 
Time as factors.  Main effects and significant interactions were followed up with 
between-group comparisons using Newman-Keul post-hoc test.  *, ** P<0.05, 
<0.01 sham-lesioned vs. lesioned animals, respectively. 
 
Overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and Time on MAP showed a main effect of Time [F (1,228) = 104.64, P<0.01] 
due to the decline and recovery of MAP over the course of hemorrhage and 
second compensatory phase.   
 
Overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and Time on HR showed a main effect of Time only [F (1,228) = 33.04, P<0.01] 
due to the decline and recovery of HR over the course of hemorrhage and the 
second compensatory phase.   
 
An overall 2-way ANOVA with repeated measures examining the effects of 
Lesion and Time on RSNA showed a Lesion x Time interaction [F (1,180) = 2.41, 
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P<0.01] due to the lack of recovery over time in lesioned rats.  Significant main 
effects of Lesion [F (1,180) = 13.85, P<0.01] and Time [F(1,180) = 14.37, 
P<0.01] was also found.  A main effect of Lesion was due to the overall lower 
RSNA in lesioned animals, while the main effect of Time was due to the decline 
and recovery in RSNA over the course of hemorrhage and the second 
compensatory phase.   
 
An overall 2-way ANOVA with repeated measures examining the effects of 
Lesion and Time on dEMG activity showed a main effect of Lesion [F (1,204) = 
10.61, P<0.05] due to the significant attenuation of dEMG in lesioned rats.   
 
An overall 2-way ANOVA with repeated measures examining the effects of 
Lesion and Time on RR showed a main effect of Lesion [F (1,228) = 4.93, 
P<0.05] and Time [F (1,228) = 17.88, P<0.05].  A main effect of Lesion was due 
to the slight, but significantly lower RR in lesioned animals, while the main effect 
of Time was due to the increase and subsequent decline of RR over the course 
of hemorrhage and the second compensatory phase compared to baseline.  
 
    
 
Table 2. Effects of the hemorrhage on blood gases and acid-base status in hindbrain lesion and sham-lesioned rats 
GROUP 
Time 
(min) 
pH 
PaO2 
(mmHg) 
A-a diff 
(mmHg) 
PaCO2 
(mmHg) 
BE 
(mmol/L) 
Lactate 
(mmol/L) 
0 7.53 ± 0.01 70.6 ± 1.3 31.2±1.6 38.2 ± 0.5 9.25 ± 1.0 0.96 ± 0.04
10 7.54 ± 0.02 87.1 ± 0.8## 24.8±1.3# 30.2 ± 0.7## 3.75 ± 1.1## 5.05 ± 0.25##
 
Control (8) 
60 7.49 ± 0.02## 86.8 ± 0.7## 14.9±1.4## 38.3 ± 1.0 5.87 ± 1.0 3.32 ± 0.32##
0 7.51 ± 0.01 71.4 ± 0.2 31.5±1.6 37.4 ± 1.1 7.4 ± 1.0 1.14 ± 0.1 
10 7.51 ± 0.01* 88.8 ± 1.6## 25.9±2.2 27.9 ± 2.4## -0.6 ± 2.16**## 7.56 ± 0.8**##
 
Lesion 
(5) 
60 7.45 ± 0.01**## 98.0 ± 3.6**## 9.8±2.9*## 33.5 ± 3.8 -1.0 ± 2.8**## 6.19 ± 0.92**##
  
Values are group means  SEM 0, 10 and 60 min after start of hemorrhage.  A-a diff, difference in alveolar and arterial O2 
pressure; PaO2, arterial blood O2 pressure; BE, base excess.  Values are group means ± SEM.  Group n are shown in 
parentheses.  Data were analyzed by 2-way ANOVA with repeated measures using Lesion and Time as factors.  
Between- and within-group differences were compared using Newman-Keuls post hoc tests.  *, ** P<0.05, 0.01 lesion vs. 
control at same sampling time.  #, ## P<0.05, 0.01 vs. baseline (time 0) within group.   
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An overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and Time on arterial pH showed a main effect of Time [F (1,22) = 40.88, P<0.01] 
due to an overall decrease in pH over time in both groups.  
 
An overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and Time on PaO2 over the course of hemorrhage showed a Lesion x Time 
interaction [F (1,22) = 9.35, P<0.01] due to the greater increase in PaO2 of 
lesioned rats over the course of hemorrhage.  A main effect of Lesion [F (1,22) = 
8.11, P<0.01] was due to a greater overall increase in PaO2 in lesioned rats.  A 
main effect of Time [F (1,22) = 145.74, P<0.01] was due to an overall increase in 
PaO2 in both groups.   
 
An overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and Time on arterial A-a difference over the course of hemorrhage showed a 
main effect of Time [F (1,22) = 71.23, P<0.01] due to an overall decrease of A-a 
difference over time in both groups.  
  
An overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and Time on PaCO2 over the course of hemorrhage showed a main effect of 
Time [F (1,22) = 20.40, P<0.01] due to the fall in PaCO2 observed during the 
primary compensatory phase of hemorrhage in both groups.   
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An overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and Time on BE over the course of hemorrhage showed a main effect of Lesion 
[F (1,22) = 6.41, P<0.01] due to a greater overall decrease of BE in lesioned rats.  
A main effect of Time [F (1,22) = 22.67, P<0.01] was due to an overall decrease 
of BE in both groups over time.   
 
An overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and Time on lactate over the course of hemorrhage showed a Lesion x Time 
interaction [F (1,22) = 5.78, P<0.01] due to the continued elevation in lactate 
level in lesion rats that persisted up to 60 min after initiation of hemorrhage, while 
lactate levels in control animals began to decline back to baseline in 
hemorrhaged rats.  A main effect of Lesion [F (1,22) = 6.92, P<0.01] was due to 
the overall greater elevation of lactate level in lesioned rats.  A main effect of 
Time [F (1,22) = 61.81, P<0.01] was due to increased lactate levels over time in 
both groups.  
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Figure 10. Three second segments of arterial pressure, raw renal sympathetic 
nerve activity (RSNA), integrated renal sympathetic activity (int. RSNA) and 
integrated diaphragmatic EMG (int. dEMG) during exposure to 100% O2 
(baseline), 5% CO2 + 95% O2 (5%) and 8%CO2 + 92% O2 (8%) in rats treated 
with vehicle (A) or 5,7-dihydroxytryptamine in the hindbrain (B). 
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Figure 11.  Summary data of mean arterial pressure (MAP), heart rate (HR), 
renal sympathetic nerve activity (RSNA), integrated diaphragmatic EMG (dEMG) 
and respiratory rate (RR) during exposure to increasing concentrations of 
ambient CO2 in rats treated with vehicle (Control) and 5,7-dihydroxytryptamine 
(Lesion) targeted to the caudal raphe.  Data are group mean ± S.E.M.  Number 
of subjects in control group is 15 for MAP and HR, 10 for RSNA, 8 for dEMG and 
11 for RR.  Number of subjects in lesion group is 14 for MAP and HR, 9 for 
RSNA, 8 for dEMG and 13 for RR.    
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Data were analyzed by 2-way ANOVA with repeated measures using Lesion and 
CO2 level as factors.  Main effects and significant interactions were followed up 
with between-group comparisons using Newman-Keul post-hoc test.  *, ** 
P<0.05, <0.01 sham-lesioned vs. lesioned animals, respectively. 
 
An overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and CO2 level on MAP showed a main effect of Lesion [F (1,54) = 5.23, P<0.05] 
due to the overall higher MAP in lesioned animals.  A main effect of CO2 level [F 
(1,54) = 7.38, P<0.01] was due to a reduction of MAP with increasing CO2.   
 
An overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and CO2 level on HR showed a main effect of CO2 level [F (1,54) = 62.59, 
P<0.01] due to an overall bradycardic effect of increasing CO2.   
 
An overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and CO2 levels on RSNA showed an interaction between Lesion and CO2 level [F 
(1,34) = 5.86, P<0.01] due to an attenuation of the sympathoexcitatory effect of 
CO2 in lesioned rats.  A main effect of Lesion [F (1,34) = 8.08, P<0.01] was due 
to the overall lower level of RSNA in lesioned animals.  A main effect of CO2 level 
[F (1,34) = 4.18, P<0.01] was due to the overall increase in RSNA over the 
course of the central chemoreflex challenge.   
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An overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and CO2 level on dEMG activity showed a Lesion and CO2 level interaction [F 
(1,28) = 3.65, P<0.05] due to the greater increase of dEMG during increasing 
CO2 in sham-lesioned rats.  Main effects of Lesion [F (1,28) = 5.56, P<0.01] and 
CO2 level [F (1,28) = 20.50, P<0.01] were also observed.  The main effect of 
Lesion was due to an overall higher dEMG in sham-lesioned rats, while the main 
effect of CO2 level was due to increased dEMG with increasing CO2.   
 
An overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and CO2 level on RR activity showed a main effect of CO2 level [F (1,44) = 
137.08, P<0.01] due to increasing RR activity in both groups during increasing 
CO2.  
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Table 3.  Arterial blood pH and PaCO2 at the end of 5 min exposure to hyperoxic, 
hypercapnia 
 pH PaCO2 
 Baseline 5% 8% Baseline 5% 8% 
Control (7) 7.50±0.01 7.46±0.01 7.36±0.01 43.0±0.8 50.8±0.6 64.3±0.6
Lesion (6) 7.50±0.01 7.46±0.01 7.37±0.01 42.8±0.6 50.7±1.2 64.4±1.2
  
Values are group means ± SEM in rats subjected to sham-lesioned (Control) or 
neurotoxin lesioned (Lesion) 2 weeks prior to exposure to hyperoxic hypercapnia.  
Group n are indicated in parentheses.  Two-way ANOVA with repeated 
measures were used to determine effects of Lesion and Ambient CO2 on pH and 
PaCO2.  There were no significant differences found between groups.   
    
 
Table 4.  Indices of baroreflex gain, heart rate and blood pressure variability in lesioned and control rats 
 
 
Up 
Sequences 
(ms/mmHg) 
Down 
Sequences 
(ms/mmHg)
All 
Sequences 
(ms/mmHg)
Alpha (LF) Alpha (HF)
LF power 
(mmHg2) 
 BP SDNN LF/HF  
          
SBP 0.98 ± 0.11 0.84 ± 0.06 0.94 ± 0.09 0.37 ± 0.04 0.75 ± 0.13 53.6 ± 11.8 7.62 ± 0.74 
MBP 1.18 ± 0.13 1.23 ± 0.09 1.21 ± 0.10 0.39 ± 0.05 0.98 ± 0.20 42.5 ± 9.1 6.56 ± 0.59 
Control 
(15) 
DBP 1.27 ± 0.15 1.18 ± 0.09 1.24 ± 0.11 0.42 ± 0.05 1.01 ± 0.20 38.9 ± 8.5 6.25 ± 0.55 
1.25 ± 0.23
SBP 1.40 ± 0.18* 1.13 ± 0.14* 1.30 ± 0.16* 0.48 ± 0.10 1.09 ± 0.23 33.3 ± 18.8 4.87± 0.88*
MBP 1.87 ± 0.27* 1.65 ± 0.18* 1.77 ± 0.22* 0.53 ± 0.11 1.51 ± 0.39 25.2 ± 14.1 4.06 ± 0.75*
Lesion 
(9) 
DBP 1.85 ± 0.26* 1.60 ± 0.15* 1.74 ± 0.20* 0.55 ± 0.12 1.53 ± 0.34 22.5 ± 12.6 3.89 ± 0.70*
0.71 ± 0.16
 
Spontaneous baroreflex gain was determined by the sequence method using ascending (up) only, descending only 
(down) or all sequences that met criteria outlined in the text.  Values are group means ± SEM.  Group n are indicated in 
parentheses.  * P<0.05, lesioned vs. sham-lesioned animals.  Gain was determined by the sequence method using 
systolic blood pressure (SBP), mean blood pressure (MBP), diastolic blood pressure (DBP).  Spectral coherence between 
IBI and BP variability are reported as coherence in the low frequency domain (alpha LF) or high 
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frequency domain (alpha HF).  Power of BP variability in the low frequency 
domain (LF power) and in the time domain (BP SDNN) and the ratio of low 
frequency to high frequency heart rate variability (LF/HF) are also included in the 
analysis.   
 
Gain using SBP on up sequences [df = 22, t = 2.18, P<0.05], down sequences [df 
= 22, t = 2.16, P<0.05] and all sequences [df = 22, t = 2.24, P<0.05] was higher 
in lesioned animals.  Gain using MBP on up sequences [df = 22, t = 2.64, 
P<0.05], down sequences [df = 22, t = 2.53, P<0.05] and all sequences [df = 22, t 
= 2.70, P<0.05] was higher in lesioned rats.  Gain using DBP on up sequences 
[df = 22, t = 2.23, P<0.05], down sequences [df = 22, t = 2.48, P<0.05] and all 
sequences [df = 22, t = 2.40, P<0.05] were higher in lesioned rats.  
 
Coherence of variability in IBI and BP did not differ regardless of whether SBP, 
MBP or DBP was used. 
 
No significant differences were found in the power of BP variability of the LF 
domain or in the HR variability LF/HF ratio between groups.  However, systolic 
BP SDNN [df = 22, t = 2.3474, P<0.05], DBP [df = 22, t = 2.6443, P<0.05] and 
MBP [df = 22, t = -2.6010, P<0.05] were significantly lower in lesioned rats.   
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Figure 12.  Typical tryptophan hydroxylase immunoreactivity (TPH-ir) is shown in 
the raphe pallidus (A,B), the raphe obscurus (C,D), the subependymal cells of 
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the parapyramidal region (E,F), the raphe magnus (G,H) and the parapyramidal 
cells (I,J) from 40 µM sections obtained from rats subjected to hindbrain injection 
of vehicle (A,C,E,G,I) or 5,7-dihydroxytryptamine (B,D,F,H,J).  Cell profiles of 
TPH-ir positive cells are shown for each serotonin-rich nucleus throughout the 
extent of the nucleus.  Data are group means ± SEM.  Group n are indicated in 
parentheses.   
 
Data were analyzed by 2-way ANOVA with repeated measures using Lesion and 
Distance from Bregma as factors.  Main effects and significant interactions were 
followed up with between-group comparisons using Newman-Keul post-hoc test.  
*, ** P<0.05, <0.01 sham-lesioned vs. lesioned animals, respectively. 
 
An overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and Distance from Bregma on TPH-ir positive cell numbers in RP showed a 
Lesion x Distance from Bregma interaction [F (1,324) = 2.60, P<0.01] due to 
lower numbers of TPH-ir positive cells in the region around the obex, but not at 
the caudal and rostral portion of the nucleus of lesioned rats compare to sham-
lesioned rats.  A main effect of Lesion [F (1,324) = 8.66, P<0.01] was due to an 
overall decrease in cell number in lesioned rats.  A main effect of Distance from 
Bregma [F (1,324) = 18.38, P<0.01] was due to the change in TPH-ir positive cell 
number along the nucleus.  
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An overall 2-way ANOVA with repeated measures examining the effects of 
Lesion and Distance from Bregma in the RO showed a Lesion x Distance from 
Bregma interaction [F (1,306) = 9.07, P<0.01] due to the significant effect of 
Lesion in the center of the nucleus with only a limited effect at the caudal end of 
the nucleus.  A main effect of Lesion [F (1,306) = 11.45, P<0.01] was due to the 
overall decreased number of TPH-ir positive cells in the nucleus of the lesioned 
rats.  A main effect of Distance from Bregma [F (1,306) = 32.85, P<0.01] was due 
to the change in number of TPH-ir positive cell throughout the extent of the 
normal nucleus.   
 
An overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and Distance from Bregma in the SUB region showed a Lesion x Distance from 
Bregma interaction [F (1,324) = 2.07, P<0.01] due to a decrease in TPH-ir 
positive cell number throughout the center of the nucleus, but not the most rostral 
and caudal ends of the nucleus.  Main effects of Lesion [F (1,324) = 5.58, 
P<0.01] and Distance from Bregma [F (1,324) = 17.01, P<0.01] were due to the 
decrease TPH-ir positive cell numbers in lesioned rats and differences in TPH-ir 
positive cell number over the length of the whole nucleus.   
 
An overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and Distance from Bregma on TPH-ir cell number in the RM showed a Lesion x 
Distance from Bregma interaction [F (1,252) = 4.38, P<0.01] due to the decrease 
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of TPH-ir positive cell numbers in the center of the nucleus in lesioned rats.  A 
main effect of Lesion [F (1,252) = 19.84, P<0.01] was due to the overall decrease 
in TPH-ir positive cell numbers in lesioned rats.  An effect of Distance from 
Bregma [F (1,252) = 19.78, P<0.01] was due to the change in TPH-ir positive cell 
number along the extent of the nucleus.   
 
An overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and Distance from Bregma on TPH-ir cell numbers in the PPY region showed a 
main effect of Lesion [F (1,216) = 12.58, P<0.01] due to an overall decrease in 
TPH-ir positive cell numbers in lesioned rats.  A main effect of Distance from 
Bregma [F (1,216) = 11.19, P<0.01] was due to the change in TPH-ir positive cell 
numbers along the extent of the whole nucleus.   
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Figure 13.  Representative images of the midbrain serotonergic nuclei 
demonstrating tryptophan hydroxylase immunoreactivity (TPH-ir) in the dorsal 
raphe (DR) (A,B), the median raphe (MR) (D,E) and the ventrolateral 
periaqueductal gray (G,H) in rats treated with vehicle (A,D,G, control) or 5,7-
dihydroxytryptamine (B,E,H, lesion) in the hindbrain raphe regions.  Also shown 
are total TPH-ir cells counted from sections throughout the two major midbrain 
nuclei, the DR and MR as well as the vlPAG averaged across groups.  Student’s 
t tests were performed.  There were no significant group differences found in 
TPH-ir positive cell number.  Group n are indicated in parentheses. 
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Figure 14.  Images of representative sections showing tyrosine hydroxylase 
immunoreactivity (TH-ir) in the locus coeruleus (A, B), and the ventrolateral 
medulla (C, D) in vehicle-treated (A, C) and 5,7- dihydroxytryptamine treated rats 
(B, D).  Cell profiles of TH-ir positive cells are shown for the A2 and A5 cell 
groups in control and lesioned rats (E).  Data are group means ± SEM.  Group n 
are indicated in parentheses.  Overall 2-way ANOVA with repeated measures 
were preformed to examine the effect of Lesion and Distance from Bregma on 
TH-ir positive numbers of each region (A2 and A5).  There was no significant 
difference found between groups.   
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Figure 15. Typical serotonin immunoreactivity in the terminal fields of the 
dorsomedial medulla at the level of the comNTS (A, B), the medial subnucleus of 
the NTS (C, D) and the C1 region of the RVLM (~11.8 mm caudal from Bregma; 
E-F) in sham-lesioned (A,C,E) and lesioned rats (B,D,F). 
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Table 5 Serotonin immunoreactivity in medullary terminal fields 
 
 comNTS mNTS RVLM (-11.8) RVLM (-12.1) RVLM (-12.8)
Control (12) 19.9 ± 6.2 16.6 ± 5.4 22.4 ± 9.1 17.4 ± 5.0-8 14.4 ± 3.4 
Lesion (10) 9.9 ± 3.9 ** 7.3 ± 5.5 ** 3.4 ± 2.5 ** 3.4 ± 2.6 ** 2.0 ± 1.1 ** 
% decrease 50.3% 56.0% 84.8% 80.5% 86.1% 
 
Data are expressed as percent of thresholded area occupied by thresholded 
signal.  Fiber density is reported for the commissural subnucleus of the NTS 
(comNTS), the medial subnucleus of the NTS (mNTS), and in 3 rostro-caudal 
planes of the RVLM at the indicated distance in mm caudal to Bregma.   
 
Serotonin fiber density was compared between groups by Student’s t-test.  
Values are group means ± SD.  Group n are indicated in parentheses.  * P<0.05, 
lesioned vs. sham-lesioned animals. 
 
Fiber density in the comNTS [df = 20, t = 4.55, P<0.01] and mNTS [df = 20, t = 
3.87, P<0.01] were significantly lower in lesioned rats.  Fiber content in the RVLM 
was reduced in lesioned rats at all levels tested (-11.8 mm) [df = 20, t = 6.41, 
P<0.01], (-12.12 mm) [df = 20, t = 7.95, P<0.01] and (-12.80 mm) [df = 20, t = 
11.07, P<0.01]. 
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Discussion 
Previously our lab found that serotonin cells of 5 serotonin-rich regions 
were selectively activated by hypotensive hemorrhage in unanaesthetized rats 
(Glasgow et al., 2009; Ruszaj et al., 2006).  These regions include 4 caudal 
medullary regions: RO, RM, SUB and the PPY.  In addition, more rostral 
serotonin cells in the vlPAG region were also selectively activated by acute 
hypotensive hemorrhage.  In the current study, selective destruction of serotonin 
cells in the same caudal raphe nuclei produced substantial loss of serotonin 
innervation of the RVLM (>80%) and NTS (>50%).  Lesion also slightly 
accelerated the sympatholytic response to blood loss and attenuated recovery of 
sympathetic activity and ventilation during the second compensatory phase of 
hemorrhage compared to sham-lesioned rats. 
These findings contradict several lines of evidence that propose that 
serotonin release contributes to the sympatholytic response to severe blood loss.  
In prior studies, systemic administration of the tryptophan hydroxylase inhibitor, 
p-CPA, was found to attenuate the hypotensive and bradycardic responses to 
severe hemorrhage in the pentobarbital-anesthetized cat (Elam et al., 1985).  
Systemic p-CPA treatment also prevented the sympatholytic response to severe 
blood loss in chloralose-anesthetized rats (Morgan et al., 1988).  A more recent 
study found that unilateral injection of a selective serotonin 5-HT1A-receptor 
antagonist in the pressor region of the RVLM prevented the sympatholytic 
response and delayed the depressor response to blood loss in rats hemorrhaged 
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under sodium pentobarbital anesthesia (Dean and Woyach, 2004).  Together, 
these studies have led to the view that blood loss stimulates serotonin release 
which acts on 5-HT1A-receptors expressed by bulbospinal pre-sympathetic 
neurons to cause membrane hyperpolarization and loss of tonic excitatory drive 
to sympathetic neurons. 
Similar to us, Evans et al. also failed to demonstrate any effect of 
serotonin depletion on the depressor response to simulated hemorrhage in 
unanaesthetized rabbits.  In their studies a similar regimen of p-CPA treatment 
that caused a 70% reduction in medullary serotonin content had no effect on the 
depressor response to caval vein occlusion (Evans et al., 1992).  It could be 
argued that a more substantial depletion of serotonin must be achieved to affect 
the depressor response to hemorrhage, particularly in the absence of anesthesia 
when serotonin cell activity is typically greater (Trulson, 1985).  However, even a 
very discrete (14 pmol), unilateral injection of 5-HT1A-receptor antagonist in the 
RVLM attenuated the sympatholytic response to blood loss in anesthetized rats 
(Dean and Bago, 2002).  Thus, if a similar mechanism mediates the onset of 
hypotension in the unanaesthetized animal, then even partial depletion of 
serotonin should be sufficient to observe some attenuation of the response.  In 
the present study, loss of more than 80% of serotonin nerve terminal 
immunoreactivity in the C1 region of the RVLM had no effect on the depressor 
response to blood loss.  Moreover, there was no correlation between the extent 
of serotonin depletion in the RVLM and the volume of blood loss that produced a 
    
  
96
40 mmHg drop in BP (data not shown).  Instead, serotonin lesion shortened the 
primary compensatory response to blood loss, suggesting that serotonin neurons 
facilitate responses that counteract sympathoinhibition in conscious rats. 
Prior work has shown that inactivation of cells in the ventromedial 
medullary raphe region interferes with normal recovery of BP and HR following 
blood loss (Henderson et al., 2000a).  Chemical inactivation of the ventromedial 
raphe region that lies caudal to the obex exaggerates hypotension and slows the 
secondary compensatory recovery of BP and HR, while inactivation of regions 
rostral to obex delays the sympatholytic phase of hemorrhage in urethane-
anesthetized rats (Heslop et al., 2002).  In the present study, hindbrain 
neurotoxin injections were effective in depleting serotonin cells rostral to obex, 
but had little effect on more caudal cells.  Taken together, the evidence is 
consistent with the view that neurons in the ventromedial medulla that mediate 
the depressor response during sympatholytic phase of hemorrhage are either not 
serotonergic, or contribute to a redundant serotonin-dependent pathway that 
mediates sympatholysis under anesthesia, while an alternative non-serotonergic 
pathway is activated in the unanaesthetized rats.  Alternatively, it is plausible that 
a non-serotonergic pathway that remains inactive under anesthesia compensates 
for serotonergic-mediated sympatholytic effects after lesion in unanaesthetized 
animals. 
It is not likely that loss of serotonin neurons inhibited sympathetic recovery 
during the secondary compensatory phase of hemorrhage by disrupting the 
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baroreflex.  Instead, our data indicate that medullary serotonin cells may actually 
reduce BRS.  Lesion of serotonin cells enhanced spontaneous baroreflex control 
of HR (Table 4).  Spontaneous baroreflex assessment by this method tends to be 
biased towards the vagal component of the reflex, given the more rapid 
cadiovagal reflex response to changes in BP.  Thus, the sequence method may 
not adequately reflect alterations in sympathetic baroreflex function.  While we 
did not directly test baroreflex control of sympathetic function, we did note a 
reduction in the SDNN of BP in lesioned animals.  Baroreflex-mediated 
oscillations in sympathetic vasomotor control provide an important buffer that 
limits BP variability (Julien et al., 1995).  Reduced fluctuations in BP suggest that 
sympathetic baroreflex control of vasomotor tone was enhanced in lesioned 
animals.  Indices of baroreflex gain and sensitivity using frequency analysis 
methods failed to demonstrate a significant effect of lesion, but this may have 
been due to the higher variability associated with spectral methods.  Interestingly, 
the gain of HR and renal sympathetic baroreflex responses to nitroprusside is 
increased following more discrete lesions of serotonin nerve terminals in the NTS 
with 5,7-DHT (Itoh et al., 1992).  In our study, we also observed significant loss of 
serotonin nerve terminals within the medial subnucleus of the NTS where the 
majority of baroreceptor afferents terminate. 
The attenuated recovery of sympathetic activity during the secondary 
compensatory phase of hemorrhage could have been due to enhanced 
baroreflex suppression of sympathetic activity during recovery of BP.  However, 
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this seems unlikely given that HR responses were similar in lesioned and sham-
lesioned animals.  Moreover, ventilation normally increases with decreasing 
pressure due to baroreceptor unloading, yet ventilation slowed with the onset of 
blood withdrawal in lesioned animals (Brunner et al., 1982).  Deficits in ventilation 
and sympathoexcitation seemed to parallel one another, suggesting that altered 
sympathetic function may have been a consequence of suppressed central 
respiratory drive. 
In accord, serotonin lesion may have disrupted peripheral chemoreflex 
function and thus ventilatory and sympathetic responses to hemorrhage.  
Hypoxia is a potent stimulus for c-Fos expression in serotonin neurons and 
produces patterns of activation similar to those observed with our hemorrhage 
protocol (Erickson and Millhorn, 1994; Glasgow et al., 2009; Ruszaj et al., 2006).  
Though we did not observe direct evidence of arterial blood hypoxia during the 
course of the study, arterial blood pH was reduced, suggesting that peripheral 
chemoreceptors could have been activated, particularly during recovery (Table 3).  
However, the role of serotonin neurons in modulating the sensitivity of the 
peripheral chemoreflex has not been well studied and remains controversial.  In 
humans, dietary tryptophan depletion does not affect chemoreflex activation or 
sensitivity (Struzik et al., 2002).  However, electrical or chemical stimulation of 
the medullary raphe decreased activation of chemoresponsive cells in the NTS 
during exposure to cyanide in rats (Perez and Ruiz, 1995).    Nucci and 
colleagues showed that blockade of 5-HT1A receptors in the RM increased 
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hypoxic ventilatory response in conscious rats, suggesting that serotonin 
neuronal activity in the caudal raphe suppresses hypoxic responses to 
chemoreceptor activation (Nucci et al., 2008).  These findings would seem to 
contradict the possibility that serotonin lesion decreased ventilatory and 
sympathetic activity during the 2nd compensatory phase of hemorrhage by 
suppressing chemoreflex activity.   
 More compelling data suggest that caudal serotonin cells are important in 
central chemoreception, particularly in the absence of anesthesia.  Recently it 
was found that the integrity of RM serotonin cells is necessary for normal 
ventilatory responses to hypercapnia in conscious rats (Dias et al., 2007).  We 
extended these findings by demonstrating that serotonin cells of the caudal raphe 
are necessary for both normal ventilatory and sympathetic responses to selective 
activation of the central chemoreceptors with hyperoxic hypercapnia.  Moreover, 
hypercapnia produces a similar pattern of serotonin c-Fos expression as that 
observed after our hemorrhage protocol (Miura et al., 1998).  In our hemorrhage 
study, we did not observe overt signs of respiratory acidosis.  In fact, PaCO2 fell 
during active blood loss, likely in response to the increased ventilation that 
developed during the initial stage of blood loss.  However, PaCO2 subsequently 
rose almost 30% during the post-hemorrhage recording period despite slightly 
higher ventilation and increased PaO2.  Thus, the rise in PaCO2 likely resulted 
from the buffering of metabolic acidosis.  Lesioned rats showed attenuated 
ventilatory and sympathetic responses during a similar rise in PaCO2, consistent 
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with the possibility that central chemoreceptor activation contributes to normal 
ventilatory and sympathetic responses to blood loss. 
Lesioned animals developed higher PaO2 by the end of hemorrhage 
despite evidence of reduced ventilation throughout recovery.  This may have 
resulted from reduced ventilation/perfusion mismatch, since lesioned animals 
also demonstrated a reduced estimated alveolar arterial oxygen pressure 
difference by the end of the recording period.  Lesioned animals also 
experienced more severe tissue hypoxia as evidenced by an exaggerated 
accumulation of lactate and lower pH following recovery from hemorrhage.  
These data suggest that lesioned animals had higher lung perfusion and/or 
reduced ventilatory mismatch than controls. It is not readily apparent how 
lesioned animals were able to maintain PaO2 despite lower ventilation.  It is 
possible that a lower extracellular pH in pulmonary tissue of serotonin lesioned 
animals may have reduced the stimulus for bronchiole constriction and facilitated 
correction of the ventilation/perfusion mismatch.  The cumulative evidence 
suggests that lesioned animals experienced more severe tissue hypoxia due, in 
part, to reduced delivery of blood to peripheral tissue.  Reduced blood delivery 
developed in lesioned rats despite normal BP recovery.  These data further 
suggest that lesioned animals maintained BP through a potentially detrimental 
increase in arterial resistance.  Though this idea remains to be confirmed with 
direct measures of cardiac output, the data do suggest that caudal hindbrain 
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serotonin neurons may help to preserve cardiac output following hemorrhage, 
possibly by facilitating sympathetic-dependent increases in venous return. 
It remains to be determined how arterial vascular resistance was elevated 
when sympathetic activity was attenuated.  We used renal sympathetic activity as 
an index of sympathetic vasomotor tone, despite its better characterized role in 
volume regulation.  It is clear that changes in renal sympathetic nerve activity 
often times do not track with changes in sympathetic drive to other vascular beds 
that are important in maintaining peripheral resistance.  In fact, renal sympathetic 
nerves provide little contribution to overall vasomotor tone and instead contribute 
more to volume regulation (Osborn and Fink, 2009).  Nevertheless, we have 
found that changes in renal sympathetic activity parallel those of splanchnic 
nerve activity during progressive blood loss and subsequent hemorrhagic shock 
(Tiniakov and Scrogin, 2009).  Thus, the uncoupling of BP recovery from RSNA 
recovery was surprising.  This would suggest that vasoactive hormones may 
have maintained BP in the absence of sympathetic-mediated vasoconstriction in 
lesioned rats. 
Both rostral and caudal raphe neurons of the ventromedial medulla 
provide major direct projections to pre-ganglionic sympathetic cells, including 
those that contribute to activation of brown adipose tissue and thermogenesis 
(Nakamura et al., 2004).  Though body temperature was not measured in our 
studies, a report in awake rabbits indicated that blood loss of a similar magnitude 
to that used in our studies resulted in a rapid decrease in core body temperature, 
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metabolism, and oxygen consumption (Henderson et al., 2000b).  Ambient 
cooling sufficient to reduce core temperature also reduces renal sympathetic 
activity in anesthetized rats (Kenney et al., 1999; Sabharwal et al., 2004).  Thus, 
a loss of raphe-mediated thermogenesis could have contributed to an 
exaggerated fall in core temperature and sustained inhibition of renal 
sympathetic activity following hemorrhage.  However, studies in hemorrhaged 
rabbits indicate that decreases in body temperature preceded decreased 
metabolism, suggesting instead that thermogenesis is suppressed during 
hypovolemia.  In accord, transient hypotensive hemorrhage reduces the 
threshold for shivering in barbiturate-anesthetized cats, as does hypoxia in 
conscious cats (Gautier et al., 1987; Little et al., 1980).  Anatomical data indicate 
that the majority of ventromedial raphe cells that express c-Fos following 
exposure to thermogenic stimuli are glutamatergic rather than serotonergic 
(Nakamura et al., 2004).  Thus, it seems unlikely that serotonin cell lesion 
attenuated recovery of renal sympathetic activity by preventing thermogenic 
responses to blood loss. 
It should be noted that 5,7-DHT destroys the entire cell and in so doing 
depletes not only serotonin, but also important co-transmitters that have been 
implicated in the control of ventilation, including thyrotropin releasing hormone 
and substance P (Gray et al., 1999; Greer et al., 1996).  It remains to be 
determined whether loss of serotonin per se contributes to the observed effects.  
Moreover, 5,7-DHT is not entirely selective for serotonin neurons.  The 
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neurotoxin has a high affinity for the serotonin reuptake transporter through 
which the toxin is thought to gain access to the cell to promote oxidative stress 
and retrograde degeneration (Tabatabaie et al., 1993).  The neurotoxin 5,7-DHT 
also has affinity for NE and dopamine transporter proteins (Horn et al., 1973).  
Noradrenergic neurons of the A1, A2 and A5 cell groups express NE reuptake 
transporter protein and also regulate sympathetic function (Lorang et al., 1994).  
However, in our study prior administration of nomifensine appeared to be 
effective in preventing cell death or morphologic changes of TH-ir cells.  Thus, it 
is unlikely that diminished sympathetic recovery was due to toxic effects on 
noradrenergic cells.  
In summary, the current study provides further evidence that serotonin 
does not contribute to the sympatholytic response to blood loss in 
unanaesthetized animals.  In addition, the data provide compelling evidence that 
caudal medullary serotonergic neurons contribute to normal ventilatory and 
sympathetic reflex responses to acidosis during the secondary compensatory 
phase of hypotensive hemorrhage, which may, in turn, facilitate beneficial 
hemodynamic responses to support microcirculation during hemorrhagic shock.
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CHAPTER IV 
5-HT1A-receptor agonists act on non-serotonergic cells to accelerate 
sympathetic recovery following hypotensive hemorrhage in 
conscious rats 
 
Abstract 
Substantial evidence suggests that serotonin contributes to the 
sympatholytic response to blood loss.  Yet, the 5-HT1A-receptor agonist, 8-OH-
DPAT, accelerates recovery of BP in animals subjected to hypotensive 
hemorrhage.  Here, we tested whether 8-OH-DPAT mediates its effects through 
activation of inhibitory 5-HT1A autoreceptors expressed on serotonergic neurons.  
Blood pressure, HR, and renal sympathetic responses to hypotensive 
hemorrhage and subsequent injection of 8-OH-DPAT (30 nmol/kg, i.v.) were 
measured in conscious rats subjected to global serotonergic lesion.    
Cerebroventricular injection of the serotonin neurotoxin, 5,7-DHT, reduced 
serotonin cell numbers (30-60%) in all serotonergic nuclei.  Global lesion did not 
affect the sympatholytic response to blood loss or the sympathoexcitatory 
response to 8-OH-DPAT following hypotensive hemorrhage.  Instead, 
sympathetic activity was attenuated after termination of hemorrhage in rats 
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subjected to global lesion (40.5 ± 24.6 vs. -11.0 ± 10.1 %baseline 25 min after 
start of hemorrhage, p<0.05).  These data indicate that serotonin neurons are not 
critical for the sympatholytic response to hemorrhage in conscious rats, and that 
the sympathoexcitatory effect of 8-OH-DPAT is likely not mediated by inhibition 
of serotonergic neurons.  Instead, the data confirm our prior findings that 
serotonin neurons contribute to the secondary compensation that follows 
hypotensive hemorrhage and that 8-OH-DPAT mediates the sympathoexcitatory 
effect following hypotensive hemorrhage by acting on non-serotonergic cells.   
 
Introduction 
Progressive hemorrhage leads to a complex, multiphasic autonomic 
response.  The primary compensatory phase of blood loss is mediated by arterial 
baroreceptor unloading, which activates sympathetic drive and increases HR.  
This process is also augmented by cardiopulmonary reflex activation (Osei-
Owusu and Scrogin, 2006; Quail et al., 1987; Schreihofer et al., 1994).  After 
significant blood loss, these compensatory responses suddenly cease, resulting 
in a sympatholytic phase characterized by rapid sympathetic withdrawal and 
cardiac vagal activation (Barcroft and Edholm, 1945; Osei-Owusu and Scrogin, 
2006; Schadt and Ludbrook, 1991).  This phase is similar to fainting and is 
therefore often referred to as the syncopal response.   If blood loss continues, 
circulatory shock develops. During this secondary compensatory phase 
autonomic compensation is slowly re-established, resulting in tachycardia and 
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sympathoexcitation (Tiniakov and Scrogin, 2006).  However, if blood loss 
persists, a decompensation phase develops.  During this phase, the vasculature 
becomes unresponsive to catecholamines, leading to a vascular decompensation 
that is difficult to treat (Liu et al., 2003).  
The sympatholytic syncopal response to blood loss is attenuated in 
anesthetized animals subjected to global serotonin depletion (Blum and Spath, 
1986; Elam et al., 1985; Morgan et al., 1988).  Similarly, systemic administration 
of the broad-spectrum serotonin receptor antagonist, methysergide, rapidly 
reverses the sympatholytic response to blood loss and improves survival of 
anesthetized cats subjected to severe hemorrhage (Elam et al., 1985).  However, 
subsequent studies have repeatedly failed to identify specific serotonin receptor 
antagonists that can prevent the sympatholytic response to blood loss in 
conscious animals (Evans et al., 1992; Scrogin et al., 2000).  Instead, the 
serotonin 5-HT1A-receptor agonist, 8-OH-DPAT, was found to mimic 
methysergide’s ability to delay the onset of the sympatholytic response in 
conscious rabbits and rats, as well as to reverse the response to acute 
hemorrhage in rats (Evans et al., 1992; Scrogin, 2003; Scrogin et al., 2000).  The 
cardiovascular effects of both 8-OH-DPAT and methysergide observed in 
hypovolemic rats are prevented by prior treatment with the selective 5-HT1A-
receptor antagonist, WAY-100635 (Scrogin et al., 2000).   
Subsequent studies have shown that injection of 8-OH-DPAT in the 
cisterna magna in the vicinity of dorsomedial brainstem rapidly reverses the 
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hypotensive response to hypovolemia (Scrogin, 2003).  In marked contrast, 
injection of the 5-HT1A-receptor antagonist, WAY-100635, directly into the 
pressor region of the RVLM attenuates the sympatholytic response to blood loss 
in anesthetized rats suggesting that 5-HT1A receptors in the RVLM mediates 
sympathoinhibition during hemorrhage (Dean and Bago, 2002).  Together, the 
data suggest that a so far unidentified population of hindbrain 5-HT1A receptors, 
distinct from those that promote sympathoinhibition in the RVLM, stimulate a 
paradoxical sympathoexcitatory response in hypovolemic animals.    
5-HT1A receptors are expressed by non-serotonergic targets of serotonin 
cells as well as by serotonergic cells themselves (Kheck et al., 1995; Riad et al., 
2000).  Agonist binding of somatodendritic 5-HT1A autoreceptors expressed in 
serotonergic neurons of the raphe nuclei inhibits the frequency of serotonergic 
neuron firing and reduces nerve terminal serotonin release (Sprouse and 
Aghajanian, 1987; Trulson, 1985).  Therefore, the possibility remains that 5-HT1A-
receptor agonists reverse the sympatholytic response to blood loss by inhibiting 
serotonin cell firing and thus reducing serotonin release from nerve terminals that 
mediate a sympatholytic effect during hemorrhage.  To test this hypothesis, 
cardiovascular responses to hemorrhage were measured in animals subjected to 
global serotonin cell lesion in order to remove inhibitory 5-HT1A autoreceptors.  It 
was reasoned that if serotonin cells mediate the sympatholytic response, their 
destruction would delay the response.  At the same time, removal of the 
autoinhibitory 5-HT1A receptor population would prevent or attenuate the 
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sympathoexcitatory effect of 8-OH-DPAT during hemorrhage if the agonist acts 
on autoreceptors to reverse downstream sympathoinhibitory effects of 
endogenous serotonin release.  In our previous study, neurotoxic lesion of 
serotonin cells limited to the caudal hindbrain did not delay the sympatholytic 
response, leaving the possibility open that more rostral serotonin cells contribute 
to this phase.  Therefore, in this study we attempted to lesion all serotonin 
neurons to investigate this hypothesis. 
 
Methods 
Animals  
Male Sprague-Dawley rats (300 - 350 g, Harlan, Indianapolis, IN) were 
given ad libitum access to food and water while being acclimated to the housing 
facility at least 1 wk prior to surgery.  The facility was maintained at a constant 
temperature of 22  2 C with a light/dark cycle of 12:12 hrs.  All experiments 
were approved by the Institutional Animal Care and Use committee and were 
conducted in accordance with the Guide for the Care and Use of Laboratory 
Animals as adopted and promulgated by the US National Institutes of Health. 
 
Surgery   
Neurotoxin studies: Rats were pre-treated with the dopamine and 
norepinephrine re-uptake blocker nomifensine (15 mg/kg).  Rats were then 
anesthetized with sodium pentobarbital (65 mg/kg, i.p.) and placed in a 
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stereotaxic apparatus, after which 5-µl injections of either vehicle (0.1% ascorbic 
acid) or 5,7-DHT (5 mM in 0.1% of ascorbic acid) were made in both the lateral 
ventricle (randomly determined left or right hemisphere) and the cisterna magna.  
For lateral ventricle injections, rats were positioned in the stereotaxic apparatus 
with the head leveled between Bregma and Lamda.  Injections were made 
through a burr hole positioned 1.6 mm lateral-, and 1.0 mm caudal to Bregma.  
The injector (25 ga. hypodermic needle) was lowered 3.8 mm ventral to the skull 
surface.  Neurotoxin or vehicle was injected into the lateral ventricle over 5 min. 
The needle was left in place for an additional 5 min.  For cisterna magna 
injection, the rat's nose was lowered to enable exposure of the occipital 
membrane.  The neck muscles were separated from the nuchal crest exposing 
the occipital bone.  The occipital membrane was pierced just caudal to the edge 
of the occipital bone and the needle was positioned approximately 1 mm below 
the membrane taking care not to pierce the underlying tissue.  Either 5,7-DHT (5 
mM in 0.1% ascorbic acid) or vehicle (0.1% ascorbic acid) was infused into the 
4th ventricle over 5 min, after which the injector was left in place for an additional 
5 min.  The injector was then removed slowly and the incision was sutured using 
non-absorbable 3-0 silk suture.   
Two weeks later rats injected with neurotoxin or vehicle were re-
anesthetized with sodium pentobarbital (65 mg/kg, i.p.) and implanted with 
vascular catheters (PE-50 heat-welded to a length of PE-10) one day prior to the 
experiment.  Catheters were placed bilaterally in the femoral arteries to enable 
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direct measurement of arterial pressure and simultaneous arterial blood 
withdrawal.  A third catheter was placed unilaterally in the femoral vein for drug 
injections.  Catheters were occluded with 25 ga wire and were externalized at the 
nape of the neck and secured with sutures.  During the same surgery, a renal 
sympathetic recording electrode was implanted as previously described (Scrogin, 
2003).  Briefly, a 1-2 mm segment of a sympathetic fiber bundle emanating from 
the aorticorenal ganglion was isolated and placed on a stainless steel, Teflon-
coated (bare diameter =.005 in., A-M Systems Inc., Everett, WA) bipolar 
electrode implanted through a left flank incision.  The electrode connector was 
externalized subcutaneously at the nape of the neck along with the three 
vascular catheters.  Viability of the nerve preparation was determined by auditory 
assessment of the bursting activity, after which the preparation was embedded in 
a quick drying, lightweight silicon (Kwik-sil, World Precision Instruments).  The 
flank incision was sutured closed in two layers with the electrode leads coiled 
within the subcutaneous space.  Animals were allowed to recover overnight prior 
to experimentation. 
 
Data Acquisition 
Arterial pressure, HR, and RSNA were recorded on a Macintosh G4 
Powerbook computer using PowerLab data acquisition software (Chart v. 5.2.1, 
ADinstruments, Colorado Springs, CO).  Arterial pressure was measured with a 
disposable pressure transducer (Transpac® IV, Abbott Labs, North Chicago, IL) 
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and a PowerLab bridge amplifier (ADinstruments, CO).  Heart rate was 
calculated using peak-to-peak detection of the pulse pressure wave.  
Sympathetic activity was sampled (4,000 Hz) and amplified (10-20,000x) with a 
PowerLab Bioamplifier (ADinstruments, CO).  The recorded neurogram was 
filtered (1-1000 Hz), rectified and integrated over a 20-ms time constant.  
Background noise in the electrode recording was determined at the end of each 
experiment by measuring the remaining signal following ganglionic blockade 
(hexamethonium chloride, 30 mg/kg, i.v.).  Background noise was subtracted 
from nerve activity values to provide a measurement of RSNA.  All 
measurements of RSNA were normalized to basal nerve activity determined over 
a 10 min period recorded directly prior to the start of hemorrhage.  Only RSNA 
data from animals with greater than a 2:1 signal to noise ratio were included in 
the data analysis. 
Spontaneous BRS was determined from 5-min segments of 
simultaneously recorded BP and HR collected prior to hemorrhage.  Data were 
analyzed with Nevrokard SA-BRS software v.3.2.4 to determine BRS by the 
sequence method (Padley et al., 2005).  Gain was determined as the average 
slope of linear regressions obtained from a minimum of 3 cardiac cycle 
sequences that satisfied the following constraints: 3 or more consecutive IBI with 
variation in the same direction that was >0.5 ms and that correlated (r2 >0.85) 
with systolic, diastolic or mean arterial BP variations of >0.5 mmHg, with a 3 beat 
delay.  These parameters were chosen based on prior analyses demonstrating 
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that they retrieved the most sequences with the highest gain in intact rats (Henze 
et al., 2008).  Cross-spectral analyses were performed on IBI and BP data using 
a 128-point fast Fourier transformation with a smoothed Hamming window.  
Coherence between IBI and BP variability was determined as the square root of 
the ratio of the IBI and BP power spectra with, 50% overlap, and zero padding of 
8.  Values are reported as the alpha index in the low frequency (0.06-0.6 Hz) and 
high frequency (0.6-3.0) domains.  In addition, BP variability was determined in 
the low frequency domain and in the time domain, the latter of which was 
determined as the standard deviation of BP between normal beats (SDNN). 
 
Protocols 
Hemodynamic Studies 
Rats subjected to prior global serotonin sham- or real lesions were 
connected to a withdrawal pump and an arterial pressure transducer through an 
overhead swivel system while resting in their home cage.  Lead wires from the 
recording electrode were also connected through the overhead swivel system.  
Vehicle- and toxin-treated rats were randomly assigned to receive either drug or 
saline during the experiment.  Each rat's venous catheter was connected to pre-
filled tubing containing 8-OH-DPAT or saline via the overhead swivel system.  
After 1-2 hrs habituation following instrumentation, arterial blood was withdrawn 
using an automated withdrawal pump set at a rate of 3.2 ml/min/kg for 6 min 
followed by a slower withdrawal rate of 0.52 ml/min for 4 additional minutes.  In 
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prior studies, this protocol was found to produce a consistent hypotensive 
response after approximately 3.5 min after which BP stabilized at 40-50 mmHg 
for the remaining period of blood withdrawal (Scrogin, 2003).  Exactly 7 min after 
the start of blood withdrawal, 8-OH-DPAT (30 nmol/kg/35 µl, iv.) or saline was 
injected followed by a 150 µl saline flush.  Data acquisition began 15 min prior to 
the experiment and continued during the 10 min of blood withdrawal and an 
additional 30 min following termination of hemorrhage.  Rats were then given a 
bolus of hexamethonium chloride (30 mg/kg, iv.) to block ganglionic transmission 
for determination of electrode noise.  After the experiment animals were 
anesthetized with sodium pentobarbital (65 mg/kg, iv.) and perfused 
transcardially with fixative to enable collection of brain tissue for 
immunohistochemical verification of serotonin lesion.  
 
Immunohistochemistry 
Following the hemorrhage protocol all rats were perfused transcardially 
with 90 ml sodium nitrite (0.1 M) in 6.7 mM phosphate buffered saline (PBS) 
followed by 90 ml 4% paraformaldehyde.  The brains were removed and post-
fixed for 1hr.  The brainstem was then blocked and post-fixed in 4% 
paraformaldehyde for an additional hour and subsequently dehydrated in 30% 
sucrose.  Brains sections were cut in 40 µm sections and collected serially into 6 
wells filled with PBS.  Sections were saved in cryoprotectant (30% sucrose + 
30% ethylene glycol in phosphate buffered saline) and stored at -20ºC. 
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For processing, brain sections were rinsed in PBS and incubated in 0.2% 
Triton X (40 min), 3% H202 (10 min) and sheep anti-TPH (1:1000, Chemicon).  To 
verify that the neurotoxin did not affect catecholamine containing neurons, 
additional sections were incubated in mouse-anti-TH (1:1000, Chemicon).  
Sections were washed and incubated in biotinylated anti-sheep or mouse 
antibody (1:1000, Vector) for 1hr.  Sections were then incubated with avidin-
biotin complex (Vector) for 50 min.  Immunoreactivity was exposed with nickel 
ammonium sulfate-intensified 3, 3’–diaminobenzadine tetrhydrochloride (DAB) 
chromagen.  Specificity of the primary antibodies was verified by characteristic 
labeling of known serotonergic and adrenergic regions of the brainstem.  
Omission of the primary antibodies completely prevented cell labeling. 
 
Microscopy 
Tryptophan hydroxylase immunoreactive cell numbers were determined in 
every 6th section throughout the anatomical extent of each serotonin-rich nucleus 
or region.  These included the three major regions of midbrain raphe, including 
the DR and MR nuclei and the vlPAG region.  The TPH-ir cell count was also 
determined in the RM, RO, RP, PPY and SUB regions (Steinbusch HW 1981).  
To determine if the neurotoxin affected noradrenergic neurons in the A2 and A5 
region, TH-ir cell numbers was counted bilaterally in these two regions.  
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Results 
Administration of 5,7-DHT into the cerebroventricles produced a diffuse 
decrease in TPH-ir throughout the entire midbrain and the medullary raphe as 
shown in Figures 16 and 17.    Multiple 2-way repeated measure ANOVAs were 
used to examine TPH-ir cell numbers between saline- or 8-OH-DPAT-injected 
animals subjected to lesions in each region.  There was no difference found 
between the two groups in any serotonin-rich region.  Therefore, cell number 
data were pooled to better represent the overall lesion effect.  Tryptophan 
hydroxylase immunoreactive positive cell numbers were significantly decreased 
in all raphe regions (Figure 17).  The lesion produced a 30 to 60% overall 
reduction of TPH-ir neurons in all serotonin-rich nuclei, including the midbrain 
raphe regions (Table 6).   
Tyrosine hydroxylase-ir cells in the A1 region showed no apparent 
difference in morphology following treatment with the neurotoxin.  Tyrosine 
hydroxylase-ir cell numbers in the A2 and A5 regions were not affected by 
neurotoxin injection.  Cell counts in the locus coeruleus region were not made 
due to the intense staining and inability to differentiate single cells (Figure 18).  
The number of TH-ir cells in the A1 region was not determined since it was not 
possible to differentiate between noradrenergic cells of the A1 region and 
adrenergic cells of the C1 region within the same section using DAB labeling 
techniques.  However, the apparent density of staining did not differ (Figure 18). 
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Global neurotoxin lesion had no effect on either the initial compensatory- or 
syncopal response to blood withdrawal (Figure 19).  As shown in Figure 19, 
baseline BP was slightly but not significantly lower in rats subjected to the more 
global lesion, but this was not a consistent finding since the two groups treated 
with 8-OH-DPAT showed no difference in baseline BP.  Neither the latency to 
onset of the hypotensive response, nor the nadir in pressure during hemorrhage 
was affected by the global lesion.  In rats treated with saline during hemorrhage, 
BP recovered to a slightly lower level in lesioned animals, which was similar to 
the slight reduction in BP seen in both groups given 8-OH-DPAT.  A 3-way 
ANOVA showed a significant interaction of Lesion x Time on MAP.  The source 
of the effect of Lesion and Time on MAP appeared to be that lesioned rats given 
saline showed a slight reduction of MAP in the plateau phase, which was very 
similar to the BP level observed in both groups given 8-OH-DPAT.  Thus, the two 
lesioned groups had a slightly lower recovery of BP compared to the pooled 
control group.  However, a follow up 2-way ANOVA assessing Lesion and Time 
in which groups were pooled across drug treatment failed to demonstrate a 
significant effect of Lesion.   
Similarly, the lesion did not affect the latency of the HR bradycardic 
response following the start of hemorrhage.  However, a spurious response in 
one lesioned rat led to a slight, but non-significant, attenuation in the extent of the 
bradycardic response.   
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The latency to onset of the sympatholytic RSNA response was also 
unaffected by lesion.  However, the plateau reached by the end of hemorrhage 
was significantly lower and the secondary compensatory recovery of sympathetic 
activity significantly less in lesioned rats than sham-lesioned rats.   
Systemic administration of 8-OH-DPAT following the onset of the 
sympatholytic response produced identical MAP pressor, HR and RSNA 
responses in lesioned and sham-lesioned animals that developed rapidly after 
administration.  In each case the parameters plateaued at the levels similar to 
that seen in saline-treated animals (Figure 19B).     
  Average spontaneous baroreflex gain of the HR reflex was not different 
in lesioned rats when assessed either with the sequence method or by the 
spectral method (Table 7).  However, BP variability in the time domain and in the 
low frequency domain were significantly reduced in lesioned rats when either 
mean or diastolic pressure was assessed (P<0.05).  The LF/HF ratio of HR 
variability also did not differ between groups. 
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Figure 16. Representative photomicrographs of the midbrain raphe nuclei 
demonstrating TPH-ir in the DR (A, B), the MR (C, D) and the vlPAG (E, F) in 
rats treated with vehicle (A, C, E) or 5,7-dihydroxytryptamine (B, D, F).  Also 
shown are cell profiles of TPH-ir neurons counted in one of every 6th 40 m 
section throughout the extent of the midbrain raphe nucleus. Data are group 
means ± SEM.  Group n are indicated in parentheses.   
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Data were analyzed by 2-way ANOVA with repeated measures using Lesion and 
Distance from Bregma as factors.  Main effects and significant interactions were 
followed up with between-group comparisons using Newman-Keul post-hoc test.  
*, **P<0.05, <0.01 lesion vs. control. 
 
An overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and Distance from Bregma of TPH-ir cell number in the DR showed a Lesion x 
Distance from Bregma interaction [F (1,130) = 15.16, P<0.01] due to the greater 
extent of depletion of TPH-ir cells in more rostral regions where the normal TPH-
ir cell density was greatest.  A main effect of Lesion [F (1,130) = 40.67, P<0.01] 
was due to the overall reduction of TPH-ir cell number in lesioned rats.  A main 
effect of Distance [F (1,130) = 116.51, P<0.01] was due to the change in number 
of TPH-ir cells over the extent of the nucleus.   
 
An overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and Distance from Bregma in the MR showed a Lesion x Distance interaction [F 
(1,156) = 12.46, P<0.01] due a more extensive lesion in the more rostral region 
of the nucleus where the normal TPH-ir cell density was greatest.  A main effect 
of Lesion [F (1,156) = 17.19, P<0.01] was due to an overall decrease in TPH-ir 
cell number in lesioned rats.  A main effect of Distance from Bregma [F (1,156) = 
49.19, P<0.01] was due to the change in TPH-ir cell number over the whole 
nucleus.   
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An overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and Distance from Bregma in the vlPAG showed a Lesion x Distance interaction 
[F (1,26) = 11.74, P<0.01] due to the greater extent of the lesion in the more 
rostral portion of the nucleus where the TPH-ir cell density was greatest.  A main 
effect of Lesion [F (1,26) = 21.51, P<0.01] was due to the overall decrease of 
TPH-ir cell numbers in lesion rats.  A main effect of Distance from Bregma [F 
(1,26) = 62.88, P<0.01] was due to the larger number of TPH-ir cell in the more 
rostral sections.   
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Figure 17.  Representative images of the caudal hindbrain showing TPH-ir in the 
raphe pallidus (A, B), the raphe obscurus (C, D), the subependymal region (E,F), 
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the raphe magnus (G,H) and the parapyramidal region (I, J) in sham-lesioned 
(A,C,E,G,I) and lesioned rats (B,D,F,H,J).  Cell profiles of TPH-ir positive cells 
are shown for each serotonin-rich caudal raphe nucleus throughout the extent of 
the nucleus in toxin- and vehicle-treated rats.  Data are group means ± SEM.  
Group n are indicated in parentheses.   
 
Data were analyzed by 2-way ANOVA with repeated measures using Lesion and 
Distance from Bregma as factors.  Main effects and significant interactions were 
followed up with between-group comparisons using Newman-Keul post-hoc test.  
*, ** P<0.05, <0.01 lesion vs. control. 
 
An overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and Distance from Bregma in the SUB region showed a Lesion x Distance from 
Bregma interaction [F (1,494) = 3.83, P<0.01] due to a decrease in TPH-ir cell 
numbers in lesioned rats throughout most of the nucleus that dissipated toward 
the rostral end of the nucleus.  A main effect of Lesion [F (1,494) = 122.24, 
P<0.01] was due to an overall lower TPH-ir cell number in lesioned rats.  A main 
effect of Distance from Bregma [F (1,494) = 47.87, P<0.01] was due to the 
variation in positive cell numbers over the extent of the nucleus.   
 
An overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and Distance from Bregma in the RP showed a Lesion x Distance from Bregma 
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interaction [F (1,468) = 6.87, P<0.01] due to the greater extent of TPH-ir positive 
cell loss in the more caudal portion of the nucleus.  A main effect of Lesion [F 
(1,468) = 47.84, P<0.01] was due to an overall decrease in TPH-ir cell number in 
lesioned rats.  A main effect of Distance from Bregma [F (1,468) = 61.24, P<0.01] 
was due to the variation in TPH-ir positive cell number throughout the length of 
the nucleus.   
 
An overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and Distance from Bregma in the RO showed a Lesion x Distance from Bregma 
interaction [F (1,416) = 11.49, P<0.01] due to the greater extent of TPH-ir 
positive cell loss in the center of the nucleus where the highest density of TPH-ir 
cells was found.  A main effect of Lesion [F (1,416) = 43.89, P<0.01] was due to 
an overall decrease in TPH-ir cell numbers in lesioned rats.  A main effect of 
Distance from Bregma [F (1,416) = 116.92, P<0.01] was due to the variation in 
TPH-ir positive cell number throughout the length of the nucleus.   
 
An overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and Distance from Bregma in the RM showed a Lesion x Distance from Bregma 
interaction [F (1, 390) = 2.93, P<0.01] due an overall lower TPH-ir cell number in 
lesioned rats in the center of the nucleus, but not in the rostral and caudal ends 
of the nucleus.  A main effect of Lesion [F (1,390) = 15.97, P<0.01] was due to 
an overall lower TPH-ir cell number in lesioned rats.  A main effect of Distance 
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from Bregma [F (1,390) = 66.57, P<0.01] was due to the variation in cell number 
throughout the length of the nucleus.   
 
An overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and Distance from Bregma in the PPY region showed a main effect of Lesion [F 
(1,338) = 19.57, P<0.01] due to decreased TPH-ir cell numbers in lesioned rats.  
A main effect of Distance from Bregma [F (1,338) = 57.39, P<0.01] was due to 
the variation in TPH-ir cell numbers through the length of the nucleus.   
 
 
 
    
 
Table 6 Tryptophan hydroxylase immunoreactive cell numbers in each serotonin-rich nucleus  
 
 DR MR VLPAG RM PPY RO RP SUB 
Control (12) 343 ± 22 260 ± 16 59 ± 8 341 ± 26 308 ± 15 389 ± 27 209 ± 12 214 ± 7 
Lesion (16) 148 ± 20 ** 151 ± 19** 20 ± 3** 215 ± 18 ** 208 ± 13 ** 206 ± 15 ** 125 ± 6 ** 119 ± 7 **
% decrease 56.8% 41.9% 66.1% 36.9% 32.5% 47.0% 40.2% 44.4% 
 
Data are expressed as group mean ± S.E.M.  Positive cell numbers are reported for the dorsal raphe (DR), median raphe 
(MR), ventrolateral of periaqueductral gray region (vlPAG), raphe magnus (RM), parapyramidal region (PPY), raphe 
obscurus (RO), raphe pallidus (RP), and subependymal region (SUB).  Values are group means  SD.  Group n are 
indicated in parentheses.   
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The total TPH-ir cell number of each region was compared between groups by 
Student’s t-test.  Significant decreases in TPH-ir cell numbers were found in all 
nuclei.  ** P<0.01, lesioned vs. sham-lesioned animals. 
 
Tryptophan hydroxylase immunoreactive cell number was lower in the DR [df = 
26, t = 6.37, P<0.01], MR [df = 26, t = 4.06, P<0.01], vlPAG [df = 26, t = 4.59, 
P<0.01], RM [df = 26, t = 4.06, P<0.01], PPY [df = 26, t = 6.44, P<0.01], RO [df = 
26, t = 6.32, P<0.01], RP [df = 26, t = 6.80, P<0.01] and SUB [df = 26, t = 9.55, 
P<0.01] of lesioned rats.   
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Figure 18.  Representative brain sections labeled for TH-ir in the locus coeruleus 
(A,B), rostroventrolateral region of the medulla (C,D), as well as the A2 regions 
(E,F) and A5 region (G,H), in sham-lesioned (A, C, E, G) and lesioned animals 
(B, D, F, H).  Tyrosine hydroxylase immunoreactive cell profiles are shown for 
sham-lesioned (control) and lesioned rats for the A2 and A5 adrenergic cell 
groups in the right graph.  Group n are indicated in parentheses.  Overall 2-way 
ANOVA with repeated measure were preformed to examine the effect of Lesion 
and Distance on TH-ir cell number of the A2 and A5 regions.  There were no 
significant differences found between groups.   
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Figure 19. Mean arterial pressure (MAP), heart rate (HR), and renal sympathetic 
nerve activity (RSNA) during hemorrhage (indicated by gray box) and 
subsequent recovery in rats treated with ascorbic acid (control) and 5,7-DHT 
(lesion) delivered to the cerebroventricles.  Number of subjects in control group 
given saline (A) is 9 for MAP and HR and 7 for RSNA.  Number of subjects in 
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lesion group given saline is 8 for MAP and HR and 6 for RSNA.  Number of 
subjects in control group given 8-OH-DPAT is 10 for MAP and HR and 9 for 
RSNA (B).  Number of subjects in lesion group given 8-OH-DPAT is 10 for MAP 
and HR and 8 for RSNA.  Data are group mean ± S.E.M.  Data were analyzed by 
3-way ANOVA with repeated measures using Lesion, Drug and Time as factors.   
Between-group differences were compared using Newman-Keuls post hoc tests.  
Group n are indicated in parentheses.  *,**P<0.05, 0.01 between control and 
lesion saline groups.  +,++P<0.05, 0.01 between control-saline and control-8-OH-
DPAT groups.  #,##P<0.05, 0.01 between lesion-saline and lesion-8-OH-DPAT 
groups. 
 
A 3-way ANOVA with repeated measures examining the effect of Lesion, Drug, 
and Time on MAP showed a Lesion x Time interaction [F (3,264) = 2.08, P<0.05].  
The source of the interaction was not apparent except for the slight reduction in 
BP recovery among lesioned rats given saline.  A follow up ANOVA that included 
only saline-treated groups failed to demonstrate a significant effect of Lesion.  
Likewise, an ANOVA in which control and lesioned animals were pooled across 
drug treatment and compared also failed to show a significant difference between 
groups.  The only apparent explanation is that the slight reduction in MAP during 
recovery in the lesioned group treated with saline was similar to the slight 
reduction in MAP recovery seen in both groups given 8-OH-DPAT.  The 
combination of the two lesion groups having reduced recovery may have reduced 
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the variability enough that there was a small difference between lesion and 
control at a few time points that led to an interaction, but no main effect of Lesion.  
A Drug x Time interaction [F (3,264) = 13.90, P<0.01] was also found due to the 
significant presser response to 8-OH-DPAT in both control and lesioned animals 
over time.  A main effect of Time [F (3,264) = 81.54,   P<0.01] was also observed 
due to the change in BP over the course of hemorrhage. 
 
A 3-way ANOVA with repeated measures examining the effect of Lesion, Drug, 
and Time on the HR response showed a Drug x Time interaction [F (3,264) = 
6.52, P<0.01] due to the tachycardia response to 8-OH-DPAT injection in both 
control and lesioned rats.  A main effect of Time [F (3,264) = 36.20, P<0.01] was 
due to the changes of HR over the course of hemorrhage.  
 
A 3-way ANOVA with repeated measures examining the effect of Lesion, Drug, 
and Time on RSNA showed a Lesion x Drug interaction [F (3,208) = 4.48, 
P<0.05] due to the attenuated recovery of sympathetic activity in lesioned rats 
that was masked by 8-OH-DPAT injection.  A Lesion x Time interaction [F (3,208) 
= 2.39, P<0.05] was also found due to the attenuation of sympathetic activity in 
saline-injected animals subjected to lesion.  A Drug x Time interaction [F (3,208) 
= 6.61, P<0.01] was also found due to the sympathetic excitatory effect to 8-OH-
DPAT in both control and lesioned rats.  A main effect of Drug [F (3,208) = 17.36, 
P<0.01] was due to the large sympathoexcitatory effect of drug in both lesioned 
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and control groups.  A main effect of Time [F (3,208) = 12.91, P<0.01] was due to 
the variation of RSNA over the course of hemorrhage in both groups.   
    
Table 7.  Spontaneous baroreflex gain, heart rate and blood pressure variability in lesion and control rats  
 
 
Up 
Sequences 
(ms/mmHg) 
Down 
Sequences 
(ms/mmHg) 
All 
Sequences 
(ms/mmHg) 
Alpha (LF) Alpha (HF) LF power (mmHg2)  BP SDNN LF/HF  
          
SBP 2.05 ± 0.18 1.61 ± 0.16 1.91 ± 0.15 0.75 ± 0.07 2.11 ± 0.20 9.88 ± 1.00 3.91 ± 0.16 
MBP 2.52 ± 0.24 2.44 ± 0.21 2.49 ± 0.21 0.82 ± 0.09 2.88 ± 0.30 8.26 ± 0.71 3.51 ± 0.13 
Control 
(19) 
DBP 2.42 ± 0.19 2.22 ± 0.19 2.33 ± 0.18 0.86 ± 0.10 2.76 ± 0.27 7.73 ± 0.67 3.43 ± 0.12 
0.76 ± 0.15 
SBP 2.29 ± 0.33 1.89 ± 0.27 2.15 ± 0.32 0.93 ± 0.13 2.02 ± 0.35 7.51 ± 1.19 3.49 ± 0.23 
MBP 2.67 ± 0.41 2.55 ± 0.35 2.63 ± 0.37 1.03 ± 0.14 2.70 ± 0.46 5.82 ± 0.71 * 3.02 ± 0.19 *Lesion (18) 
DBP 2.53 ± 0.30 2.33 ± 0.22 2.46 ± 0.26 1.07 ± 0.15 2.48 ± 0.34 5.31 ± 0.59 ** 2.95 ± 0.24 *
0.79 ± 0.12 
 
Spontaneous baroreflex gain was determined by the sequence method using ascending only (up), descending (down), or 
all sequences that met criteria outlined in the text.  Values are group means ± SEM.  Group n are indicated in 
parentheses.  Gain was determined by the sequence method using systolic blood pressure (SBP), mean blood pressure 
(MBP), and diastolic blood pressure (DBP).  Spectral coherence between IBI and pressure variability are reported as 
coherence in the low frequency domain (alpha LF) or high frequency domain (alpha HF).  Power of BP variability in the 
low frequency domain (LF power) and in the time domain (BP SDNN) and the ratio of low frequency to high frequency HR 
variability (LF/HF) are also included in the analysis.   
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Spontaneous baroreflex gain did not differ between groups.  Coherence of 
variability in IBI and BP variability as determined by alpha LF or the alpha HF did 
not differ regardless of whether SBP, MBP or DBP was used in the analysis. 
 
Power of BP variability in the LF domain was lower in lesioned rats when both 
MBP [df = 35, t = -2.60, P<0.05] and DBP [df = 35, t = -2.87, P<0.01] were used.  
Blood pressure SDNN were lower in lesioned rats when MAP [df = 35, t = -2.34, 
P<0.05] and DBP [df = 35, t = -2.27, P<0.05] were used.  
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Discussion 
We recently showed that rats subjected to selective lesion of the caudal 
hindbrain serotonin neurons have an attenuated recovery of sympathetic activity 
during the second compensatory phase following hypotensive hemorrhage.  
However, the initial depressor response to blood loss was not affected.  These 
data contradict several lines of evidence that suggest serotonin contributes to the 
sympatholytic response to hemorrhage.  However, it could be argued that 
serotonin cells in the midbrain raphe regions contribute to the depressor 
response to hemorrhage.  Therefore, the present study was carried out to 
determine if midbrain serotonergic neurons were involved in the depressor 
response to blood loss during sympatholytic phase in conscious rats.  We also 
determined whether 5-HT1A autoreceptors mediate the sympathoexcitatory effect 
of 8-OH-DPAT in hypovolemic rats.  Results from the present study further 
confirmed that serotonin neurons within the brain likely do not contribute to the 
depressor response to blood loss during the sympatholytic phase in conscious 
rats.  Nor does the sympathoexcitatory effect of 8-OH-DPAT in hypovolemic rats 
depend on 5-HT1A autoreceptors.  In the present study, cerebroventricular 
administration of neurotoxin destroyed up to 60% of the TPH-ir cells in all 
serotonin-rich nuclei including those in the midbrain, but had no effect on the 
depressor and sympatholytic responses to blood loss.  However, as seen in our 
previous study, serotonin cell destruction attenuated the secondary 
compensation following hemorrhage (Kung et al., 2010).  
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The C1 region of the RVLM contains pre-sympathetic neurons that 
regulate sympathetic output.  The cells also receive projections from raphe 
neurons in the midbrain.  Dean and Bago demonstrated that unilateral blockade 
of 5-TH1A receptors in the C1 region of the RVLM prevented the sympatholytic 
response to hypotensive hemorrhage in anesthetized rats, suggesting that the 
syncopal response is mediated, in part, by serotonin projections to the RVLM.  
Earlier, these same investigators noted that stimulation of the vlPAG produced 
sympatholysis and hypotension that was blocked by 5-HT1A receptor antagonist 
administration in the RVLM.  These investigators also noted that a small 
population of serotonergic cells of the vlPAG project to the pressor region of the 
RVLM.  Therefore it seemed reasonable to suggest that serotonergic projections 
from the vlPAG to the RVLM might contribute to the sympatholytic response to 
hemorrhage.   
In the present study, however, we found that greater than 65% depletion 
of serotonin neurons in the vlPAG had no effect on the sympatholytic response to 
blood loss in conscious rat.  It has been argued that greater than 80% depletion 
of modulatory monoamine neurons is necessary to observe a significant 
physiological effect given the propensity of healthy neurons remaining after 
lesion to send collateral projections to denervated terminal fields (Marshall, 1979; 
Zigmond and Stricker, 1973).  However, in our prior study we noted that 
neurotoxin targeted to the caudal hindbrain destroyed approximately 50% of the 
serotonin positive cell bodies, but eliminated over 80% of terminal field 
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innervation of the RVLM.  Nevertheless, the sympatholytic phase remained 
intact.  In these latter studies it is possible that loss of RVLM innervation by 
serotonergic cells was so extensive because the neurotoxin was injected very 
close to the region and so nerve terminal loss may have been due to both loss of 
cell bodies within the caudal raphe that project to the RVLM, as well as to 
degeneration of nerve terminals within the RVLM that directly took up the toxin.  
At the time that these studies were completed we had not yet perfected methods 
to quantify terminal field innervation by serotonin and the tissue was no longer 
available after the technique was perfected.  Therefore, it is impossible to 
determine whether the cerebroventricular injections of neurotoxin produced as 
thorough a nerve terminal loss in the RVLM as did the caudal raphe injection.  
However, very thorough denervation of the RVLM in prior studies did not delay 
the sympatholytic response to hemorrhage, likely ruling out a role for vlPAG 
innervation of the RVLM as a potential source for the sympatholytic response in 
conscious rats.  The current study extends these earlier findings by further 
indicating that serotonergic cells of the vlPAG that project elsewhere also 
probably do not mediate the sympatholytic response to hemorrhage in awake 
animals.   
Given the lack of an observable effect of 5,7-DHT on the sympatholytic 
response to hemorrhage found in the present study, it was not surprising that the 
sympathoexcitatory effect of 8-OH-DPAT was independent of intact serotonin 
cells.  We posited that if serotonin cells of the CNS were important in the 
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sympatholytic phase during hemorrhage in the unanaesthetized animal, then 
suppression of serotonin neuronal activity by activation of autoreceptors by 5-
HT1A-receptor agonists should have terminated or rapidly reversed the response.  
As demonstrated, 8-OH-DPAT, a potent 5-HT1A-receptor agonist, continued to 
produce sympathoexcitation in hemorrhaged animals subjected to wide-spread 
global serotonin lesion.  These data suggest that 8-OH-DPAT and other 5-HT1A-
receptor agonists with similar sympathoexcitatory effects in hypovolemic animals 
mediate their effects independently of serotonin neurons, either by activating 
post-synaptic 5-HT1A receptors present on non-serotonergic neurons or by 
activating other serotonergic or non-serotonergic receptor subtypes on non-
serotonergic neurons (Osei-Owusu and Scrogin, 2004; Scrogin, 2003).   
In previous work, pre-treatment with the relatively selective 5-HT1A-
receptor antagonist, WAY-100635, dose dependently reversed the increase in 
blood volume withdrawal necessary to initiate the sympatholytic response 
following administration of 8-OH-DPAT in conscious rats (Scrogin et al., 2000).   
These results, together with those of the present study suggest that 8-OH-DPAT 
mediates its autonomic effects via post-synaptic 5-HT1A receptors expressed on 
non-serotonergic neurons.  However, 8-OH-DPAT has also been shown to have 
appreciable agonist activity at 5-HT7 receptors and α1-adrenergic receptors that 
could account for its pressor effects in hemorrhage animals (Bard et al., 1993; 
Castillo et al., 1993; Damaso et al., 2007).  Indeed, we have noted a significant 
direct agonist effect of 8-OH-DPAT on α1-adrenergic receptors that contributes, 
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in part, to vasoconstriction in hemorrhaged animals (Osei-Owusu and Scrogin, 
2004; Tiniakov and Scrogin, 2006).  However, we also noted that a similar 
sympathoexcitatory effect of the 5-HT1A-receptor agonist, buspirone, was 
preserved after administration of the α1-adrenergic receptor antagonist, prazosin, 
as was a portion of its pressor effects (Osei-Owusu and Scrogin, 2004).  These 
data indicate that 5-HT1A-receptor agonists mediate their pressor effects in 
hemorrhaged animals through both direct α1-adrenergic mediated 
vasoconstriction as well as through non-α1-adrenergic receptors that are 
responsive to increased sympathetic drive.  Indeed blockade of α2-adrenergic 
receptors significant reduced the prolonged pressor effect of 8-OH-DPAT in rats 
subjected to hypovolemic shock.   
To date the role of 5-HT7-receptors in the hemodynamic response to 
hemorrhage has not be studied.  However, recent evidence indicates that 8-OH-
DPAT activates both 5-HT1A- and 5-HT7-receptors to provide a positive 
modulatory effect on glutamatergic activation of sympathetic nerves innervating 
brown adipose fat (Madden and Morrison, 2008).  Though such sympathetic 
activation is not thought to contribute substantially to BP control, it remains to be 
seen whether a parallel activation of 5-HT1A and 5-HT7 receptors might account 
for the hemodynamic effects of 8-OH-DPAT in hemorrhaged animals. 
The most surprising aspect of the present studies are the parallel effects 
of 8-OH-DPAT and endogenous serotonin in hypovolemic animals.  Both mediate 
the secondary compensatory sympathetic recovery after the sympatholytic 
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response to hemorrhage.  The observation that the sympathoexcitatory effect of 
8-OH-DPAT is not attenuated by serotonin cell loss suggests the intriguing 
possibility that post-synaptic 5-HT1A-receptors mediate sympathetic 
compensation to both 8-OH-DPAT and endogenous serotonin release.  Thus, 
exogenous administration of 5-HT1A-receptor agonists may act downstream of 
serotonin neurons to accelerate a component of the secondary compensatory 
response that is normally dependent on serotonin neurons.  Proof of this concept 
will require identification of the projection sites that mediate the excitatory effects 
of serotonin neurons in hypovolemic animals.   
Recent work has indicated that 8-OH-DPAT produces a robust increase in 
venous tone and cardiac output in rats subjected to hypovolemic shock (Tiniakov 
et al., 2007).  This effect appears to be mediated by a preferential increase in 
sympathetic-dependent venous tone, since total peripheral resistance is 
unaffected.  Presently, it is not known whether endogenous serotonin neurons in 
the hindbrain promote a selective sympathetic-dependent venoconstriction during 
hypovolemia as does 8-OH-DPAT.  However, the BP and HR responses of 
animals subjected to global serotonin lesion were not different from sham-
lesioned animals subjected to hemorrhage despite a dramatic attenuation of 
sympathetic recovery.  These data suggest that an alternative means of raising 
BP must compensate for the lack of serotonin-dependent sympathetic activation.  
The most likely means of raising perfusion pressure in the absence of 
sympathetic activation is through release of vasoactive hormones.  However, 
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vasoactive hormones tend to act predominantly on the arterial side of the 
vasculature and may promote excessive arterial resistance to preserve perfusion 
pressure (Hernandez et al., 1991; Tiniakov and Scrogin, 2006).  This presents 
the intriguing possibility that serotonin neurons are activated during hypovolemia 
in order to mobilize venous pools of blood and thus preserve cardiac output and 
peripheral blood flow and consequently oxygenation of peripheral tissue.   
The sympathoexcitatory effect of 8-OH-DPAT and other 5-HT1A agonists in 
hypovolemic animals is somewhat paradoxical given their profound 
sympathoinhibitory effect in euvolemic animals.  Serotonin 5-HT1A receptors are 
primarily coupled to Gαi and Gαo proteins that inhibit production of cAMP, open 
K+ channels, or inhibit calcium influx (Fargin et al., 1989; Innis et al., 1988; 
Penington and Kelly, 1990).  As such, their activation results almost exclusively 
in membrane hyperpolarization and reduced neurotransmitter release (Pan et al., 
1993).  In accord, 5-HT1A agonists produce profound sympathoinhibitory effects 
by inhibition of pre-motor sympathetic neurons of the RVLM in euvolemic animals 
(Fozard et al., 1987; Laubie et al., 1989; Nosjean and Guyenet, 1991; Osei-
Owusu and Scrogin, 2004).  Thus, our data suggest that the sympathoexcitatory 
effects of 5-HT1A-receptor agonists likely result from disinhibition of some 
sympathoexcitatory pathway that is normally not active in the euvolemic animal 
or that is suppressed during hypotensive hemorrhage.  8-OH-DPAT acts as a full 
agonist in behavioral and biochemical assessment within several regions of the 
brain including the brainstem and so should produce the same functional effect 
    
  
141
via 5-HT1A receptors as the endogenous ligand serotonin (Dabrowska and 
Brylinski, 2006).  Therefore, it seems reasonable to suggest that endogenous 
serotonin release and 5-HT1A receptor activation disinhibits cells that can activate 
sympathetic drive through an alternative pathway than the RVLM.  Such 
alternative pathways could include direct projections of the parvocellular neurons 
of the paraventricular nucleus of the hypothalamus to the pre-ganglionic 
sympathetic cells in the spinal cord (Caverson et al., 1984; Ootsuka and 
Blessing, 2005).   In any event, the mechanisms by which 5-HT1A-receptor 
agonists and endogenous serotonin increase sympathetic activity in hypovolemic 
animals remain unknown.  Results herein appear to rule out a role for 5-HT1A-
receptor-mediated inhibition of serotonin cell activity.   
As indicated by our previous finding, it is not likely that loss of serotonin 
neurons inhibited sympathetic recovery following hemorrhage by disrupting the 
baroreflex (Kung et al., 2010).  Instead, our data indicate that serotonin lesion 
increases BRS.  Reduced low frequency fluctuations in BP suggest that 
sympathetic baroreflex control of vasomotor tone was enhanced in lesioned 
animals.  Interestingly, lesion of caudal raphe serotonin neurons did not affect LF 
variation in BP but did influence baroreflex gain assessed by the sequence 
method.  This latter method also reflects the vagal component of the reflex to a 
greater degree then does LF BP variability.  It is possible that parenchymal 
injections of neurotoxin targeted to the caudal hindbrain leads to a loss of 
serotonin fibers that innervate structures involved in cardiovagal control, while 
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the more diffuse application of neurotoxin used here does not adequately lesion 
these projections.  Thus, projections to structures involved in sympathetic 
baroreflex control may be more vulnerable to neurotoxin exposure given through 
the cisterna magna such as the structures lining the ventral floor of the 4th 
ventricle.  Although in the current study we did not measure serotonin nerve 
terminal density in the NTS, it is to be expected that serotonin nerve terminals in 
the floor of the 4th ventricle would be more severely affected by cisterna magna 
injections than injections that targeted the more ventral and caudal raphe 
neurons.  
It is unlikely that augmented baroreflex control contributed to the reduced 
sympathetic compensation observed with hemorrhage in animals subjected to a 
more global serotonin lesion. Tests of BRS or BP variability cannot reveal 
whether alterations in baroreflex gain results from changes in sensitivity to 
increased BP or to baroreceptor unloading.  However, a general augmentation of 
baroreflex control would likely not have caused the loss of sympathetic recovery 
observed in these studies.  Instead a more responsive baroreflex would have 
produced an exaggerated sympathetic response during baroreceptors unloading 
as in hypovolemia.  
Of interest too are prior findings that indicate that the extent of the 
sympathoexcitatory response to 8-OH-DPAT is dependent on the integrity of 
sinoaortic nerves that convey baroreceptor and peripheral chemosensory 
afferents to the central nervous system (Osei-Owusu and Scrogin, 2006).  
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Hemorrhaged rats subjected to prior sinoarotic denervation had a dramatically 
attenuated sympathoexcitatory responses to 8-OH-DPAT (Osei-Owusu and 
Scrogin, 2006).  Here we found that 5-HT1A-receptor agonists administrate 
accelerated sympathetic recovery after hemorrhage at the same rate and to the 
same extent whether baroreflex function was augmented or not.  Together the 
data suggest the intriguing possibility that the sympathoexcitatory effects of 8-
OH-DPAT may be dependent upon chemosensory afferent activity rather than 
baroreceptor activity.  This hypothesis remains to be confirmed with further tests. 
In summary, the current study shows that cerebroventricular 
administration of neurotoxin successfully destroyed 30-60% of TPH-ir neurons in 
all serotonin-rich nuclei, including the midbrain serotonergic nuclei.  Utilizing this 
method, we further confirmed that serotonergic neurons in the CNS most likely 
do not contribute to the sympatholytic depressor response to blood loss in 
conscious rats.  Instead, the present study suggests that 8-OH-DPAT and 
endogenous serotonin mediate the secondary compensatory phase of 
sympathetic recovery following hemorrhage.  Since serotonin lesion does not 
affect the sympathoexcitatory effect of 8-OH-DPAT after the sympatholytic 
phase, it is possible that both endogenous serotonin and 8-OH-DPAT act on 
post-synaptic 5-HT1A-receptors to mediate this secondary sympathoexcitatory 
response. 
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CHAPTER V 
Serotonergic neurons activate 5-HT1A receptors in the NTS to stimulate 
recovery of sympathetic activity after hypotensive hemorrhage in 
conscious rats 
 
Abstract 
Previously we have found that hindbrain serotonin neurons and 5-HT1A-
receptor agonists mediate sympathetic recovery during the secondary 
compensatory phase following hypotensive hemorrhage, and this phenomenon 
may be related to altered chemoreflex function.  Here we tested if serotonin 
projections to the NTS facilitate sympathetic and respiratory recovery from 
hypotensive hemorrhage.  We also tested whether 5-HT1A receptors in the NTS 
are responsible for the secondary compensatory response to hypotensive 
hemorrhage and for the sympathoexcitatory effect of 5-HT1A-receptor agonists 
observed in hemorrhaged animals.   
Blood pressure, HR, RSNA and dEMG activity were recorded during 
hypotensive hemorrhage in rats subjected to sham (n=8) or selective (n=9) 
denervation of serotonin nerve terminals in the caudal NTS.  Neurotoxin injection 
reduced serotonin immunoreactivity in the NTS (93%, P<0.01), but not in the 
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pressor region of the RVLM.  Lesion reduced the initial sympathoexcitation (36.4 
± 17.5 vs. +153.8 ± 36.6 % baseline, P<0.05) during primary compensatory 
phase, but not the subsequent sympatholytic phase to blood loss.  During the 
secondary compensatory phase, sympathetic and ventilatory recovery  was also 
reduced in lesioned rats (+6.2 ± 13.2 vs. +127.9 ± 48.7 %baseline RSNA, P<0.05 
and -32.4 ± 4.6 vs. +45.7 ± 18.9 %baseline integrated dEMG 35 min after start of 
hypotensive hemorrhage, P<0.05), while BP and HR were not affected.  Lesion 
also reduced sympathetic and ventilatory responses to peripheral chemoreflex 
activation (+368 ± 63 vs. +618 ± 140 %baseline RSNA, P<0.01; +17 ± 21 vs. 
+104 ± 26 %baseline ΔTV, P<0.01), but increased HR (-4.6 ± 0.3 vs. -3.1 ± 0.3 
Δbpm/ΔmmHg, P<0.01) and sympathetic (-14.1 ± 2.6 vs. -9.1 ± 1.2 
Δ%baseline/ΔmmHg, P<0.01) baroreflex gain .  These data indicate that 
serotonin neuronal innervation of the caudal NTS is necessary for normal 
recovery during hemorrhage and that this effect may be related to the function of 
the peripheral chemoreflex. 
 
Introduction 
Progressive blood loss produces a multiphasic hemodynamic response to 
blood loss, the mechanisms of which are not well understood.  The primary 
compensation that develops during blood loss is mediated by arterial 
baroreceptor unloading in unanaesthetized animals (Ludbrook and Ventura, 
1996; Schadt and Ludbrook, 1991).  Prior work has suggested that serotonin 
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contributes to the sympatholytic response that initiates the rapid depressor 
response during blood loss in anesthetized animals (Elam et al., 1985; Morgan et 
al., 1988).  In contrast, we recently found that selective destruction of the majority 
of caudal hindbrain serotonergic neurons tended to exaggerate the sympatholytic 
response to blood loss in conscious rats, and, in fact, significantly reduced the 
secondary compensatory recovery (Kung et al., 2010; Ruszaj et al., 2006).  
Lactic acidosis was exaggerated in lesioned animals, despite the elevated 
arterial blood oxygen levels and normal BP recovery (Kung et al., 2010).  These 
data suggest that greater tissue hypoxia develops in lesioned animals subjected 
to hemorrhage as a consequence of reduced blood delivery to peripheral tissues.  
Taken together, the evidence further suggests that caudal raphe serotonin 
neurons help to maintain perfusion pressure by preserving cardiac output during 
recovery from hypotensive hemorrhage, possibly by facilitating sympathetic-
mediated increases in venous tone.  
The mechanism by which serotonin facilitates the secondary 
compensatory response following blood loss is not known.  We found that 
serotonin lesion enhanced indices of cardiac and sympathetic baroreflex control, 
suggesting that in the intact animal serotonin does not facilitate sympathetic 
recovery by augmenting responses to baroreceptor unloading.   We also noted a 
significant impairment of sympathetic and ventilatory responses to central 
chemoreceptor stimulation (i.e., hyperoxic, hypercapnia) in conscious rats 
subjected to serotonin cell lesion.  In hemorrhage studies, we further 
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demonstrated that arterial PaCO2 rose following the initial hypotensive phase of 
hemorrhage, precisely when sympathetic activity began to recover in intact rats 
(Kung et al., 2010).  Thus, serotonin may play a role in conveying important 
sensory information to brainstem nuclei that control appropriate sympathetic and 
ventilatory responses to blood loss.  Our data further suggest that, in the 
absence of serotonin neurons, BP recovery from hypotensive hemorrhage is 
mediated by potentially detrimental increases in arterial resistance rather than by 
beneficial increases in cardiac output.  Currently, the central neural pathways 
that determine how perfusion pressure is maintained (i.e., changes in 
capacitance vs. resistance) during hypovolemia are largely unknown.  Such 
information could spur the development of adjuvant therapies that positively 
influence the distribution of volume given during resuscitation from hypovolemic 
shock.   
Recent work has suggested that sympathetic-mediated recovery of 
perfusion pressure in intact conscious rats is largely dependent upon excitatory 
glutamatergic projections to the VL-LPBN of the brainstem (Blair and Mickelsen, 
2006).  The NTS provides the largest glutamatergic projection to the VL-LPBN 
(Dutschmann et al., 1998).  Moreover, the NTS receives significant projections 
from serotonergic neurons of the caudal medullary raphe (Schaffar et al., 1988; 
Thor and Helke, 1987).  Therefore, we determined if selective destruction of 
serotonin nerve terminals within regions of the NTS that receive cardiovascular 
and chemosensory afferents attenuated recovery of renal sympathetic activity 
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and ventilation following hemorrhage.  We further determined whether loss of 
serotonin nerve terminals in this region altered sympathetic responses to 
baroreflex and peripheral chemoreflex activation, since both are engaged during 
hypotensive hemorrhage (Evans et al., 1993a; Henry et al., 1998; Scislo and 
O'Leary, 1998).    
Our work has also shown that administration of the 5-HT1A-receptor 
agonist, 8-OH-DPAT, given into the cisterna magna produces a very rapid and 
robust increase in sympathetic activity in animals subjected to hypotensive 
hemorrhage and improves venous tone and acid base balance in rats subjected 
to hypovolemic shock (Scrogin, 2003; Tiniakov and Scrogin, 2006).  Given our 
recent evidence demonstrating the importance of serotonin cells in sympathetic 
recovery and acid base balance during the secondary compensatory phase 
following hemorrhage, these data suggest that activation of 5-HT1A-receptors on 
the dorsal surface of the hindbrain would contribute to sympathetic recovery 
following hemorrhage.  To address this question we attempted to determine 
whether pharmacological blockade of 5-HT1A receptors in the NTS attenuated 
recovery of sympathetic drive following hypertension and/or the 
sympathoexcitatory effects of 8-OH-DPAT in hypovolemic animals. 
    
  
149
Methods 
Animals  
Male Sprague-Dawley rats (300 - 350 g, Harlan, Indianapolis, IN) were 
acclimated to the housing facility while given ad libitum access to food and water 
for at least 1 wk prior to surgery.  The facility was maintained at a constant 
temperature of 22  2C with a light/dark cycle of 12:12 hrs.  All experiments 
were approved by the Institutional Animal Care and Use committee and were 
conducted in accordance with the Guide for the Care and Use of Laboratory 
Animals as adopted and promulgated by the US National Institutes of Health. 
 
Surgery   
Neurotoxin Study: Regions of the NTS that receive arterial baro- and 
peripheral chemoreceptor afferents, i.e. the medial, dorsolateral and commissural 
subnuclei, were targets for selective serotonin nerve terminal lesion.  All rats 
were pre-treated with the dopamine and norepinephrine re-uptake blocker, 
nomifensine (15 mg/kg in 20% ß-cyclodextran), at least 30 min prior to 
neurotoxin injection to prevent toxin-induced destruction of adrenergic cells.  
Rats were anesthetized with sodium pentobarbital (65 mg/kg, i.p.), intubated with 
an endotracheal tube, and placed in a stereotaxic apparatus with the nose bar 
positioned 11 mm below a flat skull position.  The back of the skull was exposed, 
and a small portion of the occipital bone was removed to expose the dorsal 
surface of the brainstem at the level of calamus scriptorus.  The occipital 
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membrane was incised and a glass micropipette injector, pulled and broken back 
to an outer diameter of ~20 µm, was centered at the caudal tip of calamus 
scriptorus.  The injector was filled with either 5,7-dihydroxytryptamine (5,7-DHT; 
5 mM in 0.1% ascorbic acid) or vehicle.  Bilateral 100-nl injections of neurotoxin 
or vehicle were made 0.5 mm ventral to calamus scriptorus at five rostro-caudal 
planes along the NTS:  1, 0.5, 0, - 0.5, - 1 mm relative to calamus scriptorus.  
Injections were made ± 0.7 and 0.35 mm from the midline for the two most rostral 
injection planes and ± 0.25 mm from the midline for the caudal three injections 
planes for a total of 10 injections.  The neck muscle and skin were closed in 
separate layers.   
 
NTS cannulation 
A single cannula was positioned over the commissural subnucleus of the 
NTS (comNTS) while the animals were anesthetized under sodium pentobarbital 
(65 mg/kg).  Animals were placed in a stereotaxic apparatus with the nose bar 
positioned 11 mm below a flat skull position.  The back of the skull was exposed 
and a small portion of the occipital bone was removed to expose the brainstem.  
The dura and pia mater were then carefully removed and the blunt end of a piece 
of 23 ga. hypodermic needle (13 mm long) was lowered perpendicularly at the 
mid-line.  The injector was lowered until it touched the caudal tip of calamus 
scriptorus on the brainstem.  The cannula was then secured in place by 
surrounding it with dental acrylic which in turn surrounded a jeweler’s screw that 
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was secured to the skull.  The cannula was fitted with a dummy injector (30 ga., 
13 mm long) to prevent occlusion.  The skin was stapled closed around the guide 
cannula. 
 
Catheters and Electrode Implantation: 
One week later, all rats were re-anesthetized with sodium pentobarbital 
(65 mg/kg, i.p.) and implanted with bilaterally femoral arterial catheters (PE-50 
heat-welded to a length of PE-10) to enable direct measurement of arterial 
pressure and simultaneous arterial blood withdrawal.  A third catheter was placed 
unilaterally in the femoral vein for drug injections.  Catheters were externalized at 
the nape of the neck and secured with sutures.   
Following catheter implantation, dual recording electrode leads were 
implanted as described previously  to enable measurement of renal sympathetic 
nerve activity and dEMG  (Kung and Scrogin., 2009; Kung et al., 2010; Scrogin, 
2003).  A short segment of a sympathetic fiber bundle from the aorticorenal 
ganglion was exposed through a left flank incision, isolated and placed on a 
stainless steel, Teflon-coated wire (bare diameter =.005 in., A-M Systems Inc., 
Everett, WA).  The electrode connector was externalized at the nape of the neck 
with the vascular catheters.  Viability of the nerve preparation was determined by 
auditory assessment of the bursting activity, after which the preparation was 
embedded in a quick drying, lightweight silicon (Kwik sil, World Precision 
Instruments).  The flank incision was sutured closed in two layers with the 
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electrode leads coiled within the subcutaneous space.  A second set of lead 
wires were tied into the abdominal side of the diaphragm through a 2 cm lateral 
laparotomy using 6-0 nylon.  The leads wires that exited from the abdominal 
muscle layer were coiled in the subcutaneous space.  The incisions were closed 
in layers.  Animals were allowed to recover overnight prior to the experiment. 
 
Data Acquisition 
Arterial pressure, HR, RSNA and dEMG were recorded on a Macintosh 
G4 Powerbook computer using PowerLab data acquisition software (Chart v. 
5.2.1, ADinstruments, Colorado Springs, CO).  Arterial pressure was measured 
with a disposable pressure transducer (Transpac® IV, Abbott Labs, North 
Chicago, IL) and a PowerLab bridge amplifier (ADinstruments, CO).  Heart rate 
was calculated using peak-to-peak detection of the pulse pressure wave.  
Sympathetic activity and dEMG were sampled (4,000 Hz) and amplified (10-
20,000x) with PowerLab Bioamplifiers (ADinstruments, CO).  The recorded 
neurograms were filtered (1-1000 Hz), rectified and integrated over a 20-ms time 
constant.  Background noise in the RSNA recordings was determined at the end 
of each experiment by measuring the remaining signal following ganglionic 
blockade (hexamethonium chloride, 30 mg/kg, iv.).  Background noise was 
subtracted from nerve activity values to provide a measurement of RSNA.  
Background noise in the dEMG was determined during expiration, when phrenic 
motor nerve activity was absent.  Measurements of RSNA and dEMG obtained 
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during the experiment were normalized to basal nerve activity, and dEMG 
determined over a 10 min period directly prior to the start of interventions.  Only 
RSNA and dEMG data from animals with greater than a 2:1 signal to noise ratio 
in the respective neurograms were included in the data analysis.  Respiratory 
rate was determined by peak to peak detection of the integrated dEMG signal. 
Spontaneous BRS was determined from 5-min segments of BP and HR 
determined prior to hemorrhage.  Data were analyzed with Nevrokard SA-BRS 
software v.3.2.4 to determine BRS by the sequence method  (Osei-Owusu P & 
Scorgin K  2006).  Gain was determined as the average slope of linear 
regressions obtained from a minimum of 3 sequences that satisfied the following 
constraints: 3 or more consecutive IBI with variation in the same direction that 
was >0.5 ms and correlated (r2 >0.85) with systolic, diastolic or mean arterial BP 
variations of >0.5 mmHg, with a 3 beat delay.  These parameters were chosen 
based on prior analyses from our lab demonstrating that they retrieved the most 
sequences with the highest gain in normal Sprague-Dawley rats of approximately 
the same age as the rats used in the present study (Henze M et al 2008).  Cross-
spectral analyses were performed on IBI and BP data using a 128-point fast 
Fourier transformation with a smoothed Hamming window.  Coherence between 
IBI and BP variability was determined as the square root of the ratio of the IBI 
and BP power spectra with, 50% overlap, and zero padding of 8.  Values are 
reported as the alpha index in the low (0.06 - 0.6 Hz) and high frequency (0.6 - 
3.0 Hz) domains.  In addition, BP variability was determined in the low frequency 
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domain (LF power) and in the time domain, the latter of which was determined as 
the standard deviation of BP between normal beats (BP SDNN).  Heart rate 
variability in the frequency domains was also determined using the IBI power 
spectra criteria described above.  Heart rate variability was determined as the 
power in the LF domain divided by that in the HF domain (LF/HF).  Frequency 
domains were defined as described above for the alpha indices.  
 
Protocols 
Protocol 1:  Peripheral chemoreflex testing 
On the day of the experiment, one of the rat's arterial catheters was 
connected to the BP transducer through saline-filled polyethylene tubing via an 
overhead swivel system to enable recordings while the rat rested in its home 
cage.  The RSNA and dEMG leads were connected to the appropriate amplifiers 
via lead wires extending from the same swivel.  The rats were allowed to rest, 
unrestrained in their home cage for at least 1 hr after connection to the recording 
instruments.  Increasing doses (3, 30 and 100 µg/kg) of KCN were given at 40 to 
50 min intervals while all variables were measured continuously.  Ten to 15 min 
after connecting the drug-filled catheter, drug was injected over 30 sec.  After 10 
minutes, the tubing was changed and the rat allowed to rest prior to the next 
injection.   
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Protocol 2 : Hypotensive hemorrhage 
At least 24 hrs after chemoreflex testing, the same group of rats were 
again connected to a withdrawal pump and an arterial pressure transducer 
through an overhead swivel system.  After 1 hr of habituation arterial blood was 
withdrawn using an automated withdrawal pump set at a rate of 3.2 ml/min/kg for 
6 min and adjusted to a slower withdrawal rate of 0.52 ml/min for 4 additional 
minutes.  Data acquisition was begun 15 min prior to the experiment and 
continued throughout hemorrhage and for an additional 50 min following 
termination of hemorrhage.  At the end of the experiment rats were given 
hexamethonium chloride (30 mg/kg, iv.) for determination of background noise in 
the sympathetic recording.  Animals were then rapidly anesthetized with sodium 
pentobarbital (65 mg/kg, iv.) and quickly perfused transcardially with 90 ml of 
sodium nitrite (50 mM) in 0.1 mM phosphate buffered saline (PBS) followed by 
90 ml 4% of formaldehyde.  The brains were removed and post-fixed for 1 hour.  
The brainstem was blocked and post-fixed for an additional hour and 
subsequently dehydrated in 30% sucrose.  Brains sections were cut in 40 µm 
sections and collected serially into 6 wells.  Sections were saved in 
cryoprotectant (30 % sucrose + 30 % ethylene glycol in phosphate buffered 
saline) and stored at -20°C for immunohistochemical verification of serotonin 
lesion.    
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Protocol 3:  Baroreflex control of HR and RSNA 
 Separate groups of rats prepared as described in the surgical methods 
were connected to the recording instruments as described in the above 
protocols.  An additional length of PE-50 tubing was connected to the venous 
catheter for drug administration.  After at least 1 hr of habituation BP, HR, RSNA 
and dEMG were measured during a variable infusion of sodium nitroprusside (3-
25 µg/sec) to produce a ramp BP decrease from baseline to 50-60 mmHg over 3 
minutes.  The drug was cleared from the tubing after which the rats were allowed 
to rest for at least 1hr.  A variable infusion of phenylephrine (3 – 13 µl/min, iv.) 
was given to produce a smooth ramp increase in BP from baseline to 160 mmHg 
over 3 minutes.  At the end of the experiment rats were given hexamethonium 
chloride (30 mg/kg, iv.) for determination of background noise in the sympathetic 
recording.  The rats were then anesthetized with sodium pentobarbital (65 mg/kg, 
iv.) and perfused transcardially as described at the end of protocol 2 to enable 
collection of brain tissue for immunohistochemical verification of serotonin lesion.    
 
Protocol 4:  Hypotensive hemorrhage and 5-HT1A receptor manipulation  
Rats were implanted with the NTS cannula as described above.  One 
week after cannula placement, rats were instrumented with catheters and a dual 
recording electrode as describe above.  The next day, they were connected to 
the recording instruments via an overhead swivel to allow for recording of MAP, 
HR, RSNA and dEMG while they rested unrestrained in their home cage.  After 
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at least one hour habituation, hemorrhage was initiated as described previously 
(Kung et al., 2010).  Seven minutes after the start of hemorrhage an injector 
needle (30 ga. 14 mm long) connected to tubing with the appropriate drug or 
saline was inserted into the NTS guide cannula such that the injector tip 
extended 1 mm below the end of the guide cannula to reach the caudal NTS.  
Animals were injected with the selective 5-HT1A-receptor antagonist, WAY-
100635 (0.1 nmol) or saline (100 nl), at the rate of 1 µl/min.  The 5-HT1A-receptor 
agonist 8-OH-DPAT (30 nmol/kg) or saline was then administered iv. at the end 
of blood withdrawal (i.e., 10 minutes after the start of hemorrhage).  At the end of 
the experiment rats were given hexamethonium chloride (30 mg/kg, iv.) for 
determination of background noise in the sympathetic recording electrode.  At 
least one hour after the end of the experiment, the excitatory amino acid, D,L-
homocysteic acid, DLH (10 nmol), was injected into the NTS at the rate of 1 
µl/min to determine whether the injector location targeted areas involved in 
primarily baroreflex or chemoreflex responses, the former of which is 
characterized by sympathoinhibition and BP decreases and the latter by 
sympathetic activation and bradycardia.  Lastly, 250 nl of fluorescent latex beads 
(0.05-0.2 µm) were injected through the guide cannula at a rate of 0.5 μl/min to 
verify the location of injection.  At the end of experiment, rats were perfused as 
described above and the brains were sectioned and mounted in order to visualize 
the injection sites.  
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Immunohistochemistry 
Serotonin nerve terminal density was determined by quantifying the 
percent area of interest occupied by serotonin immunoreactivity in brains of rats 
subjected to sham or real serotonin cell lesion.  Quantification was performed in 
coronal sections obtained from 5 rostral-caudal planes through the portion of the 
NTS where the majority of baro- and chemosensory afferents terminate.  Nerve 
terminal density was also determined in the underlying dorsomedial nucleus of 
the vagus (DMX) at the same 5 planes.  Additional measurements were taken in 
3 planes or the C1 region of the RVLM.   
Rabbit anti-serotonin antibody (1:200,000, Immunostar) was pre-incubated 
with 6 mM reduced L-glutathione (Sigma) in 1mM tris-EDTA buffer (pH 8) for 1 hr 
at room temperature prior to incubation with tissue.  One in six sections from 
lesioned- and sham-lesioned rats was incubated in 0.2% Triton X and the 
primary antibody for 48 hr at 4°C.  Sections were then washed and incubated in 
6% donkey serum, 0.2%Triton X, donkey anti-rabbit Dylight 649 (1:200, Jackson 
ImmunoResearch) for 2 hr.  Sections were rinsed in PBS, mounted on gel-coated 
slides and immediately coverslipped with fluoromount (Sigma).  Sections were 
stored at 4°C for 7 days prior to microscopy.   
Additional NTS sections were double-labeled for serotonin- and TH-ir to 
qualitatively assess adrenergic cell density and morphology in regions where the 
serotonin lesion was effective.  In this case the above protocol was followed 
except that mouse anti-TH antibody (1:2500 Chemicon) was used in the primary 
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incubation step and donkey anti-mouse Cy3 (1:200, Jackson ImmunoResearch) 
was used in the second incubation.   
Brain sections from rats subjected to protocols 1, 2 and 3 were also 
processed to expose TPH-ir in order to verify that retrograde degeneration of 
nerve terminals that took up toxin in the NTS did not extend to the cell bodies 
and thus affect collateral innervation of other terminal fields.   In this case, one of 
every six sections was incubated with sheep anti-TPH primary antibody (1:1000, 
Chemicon) over night at room temperature.  Sections were then incubated with 
biotinylated goat anti-sheep IgG (1:1000, Vector) for 1 hr at room temperature 
followed by incubation with avidin-biotin complex (Vector) for 50 min.  
Immunoreactivity was exposed with nickel ammonium sulfate-intensified 3, 3’–
diaminobenzadine tetrhydrochloride (DAB) chromagen to produce a black 
nuclear label.  To quantify noradrenergic neurons, one of every six sections was 
incubated in mouse-anti-TH (1:1000, Chemicon).  Sections were washed and 
incubated in the appropriate biotinylated IgG made in goat for 1 hr and incubated 
with avidin-biotin complex as described above.  The specificity of the primary 
antibodies was verified by characteristic labeling of known serotonergic and 
adrenergic cell groups of the brain stem.  Omission of the primary antibodies 
completely prevented cell labeling. 
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Microscopy 
Tryptophan hydroxylase immunoreactivity in lesion studies 
Tryptophan hydroxylase-ir cells were counted in every 6th section 
throughout the anatomical extent of those serotonin-rich nuclei known to project 
to the comNTS.  These regions included the RM, the RO, and the RP (Schaffar 
et al., 1988; Thor and Helke, 1987) 
 
Serotonin immunoreactivity in NTS/DMX terminal fields 
Tissue from equal numbers of lesioned and control rats were processed in 
parallel in two separate cohorts.  All images were acquired at the same exposure 
length, exactly 7 days after tissue processing.  Serotonin immunoreactive fiber 
content in the NTS was determined unilaterally at the level of the medial and 
commissural subnuclei at 5 rostral-caudal planes situated approximately 13.1, 
13.3, 13.6, 13.8, and 14.1 mm ±120 m caudal to Bregma.  Serotonin 
immunoreactive fiber content was also determined in the RVLM at 3 levels; 11.8, 
12.2 and 12.8 mm ±120 m caudal to Bregma.   
Immunoreactive fiber content was determined as described previously 
with modifications (Kung et al., 2010).  Briefly, images were taken with an 
Olympus inverted IX81 epifluorescence microscope with a motor driven stage 
and a 10x objective.  Measurements were determined from composite images of 
thirty 1 µm deconvolved optical sections taken from each tissue section.  
Deconvolution was performed with Vaytek Microtome software using the rapid 
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nearest neighbor method within each image.  Background intensity of the 
composite image, i.e., the intensity of unlabeled neuropil was averaged from at 
least 4 different brains, and was subtracted from each image.  Threshold 
intensity was set approximately 1.5 times background and was held constant for 
each region measured.  An area of interest (AOI) was outlined in all 5 levels of 
NTS and DMX regions as describe above using the selection tools in NIH Image 
J software.  Serotonin immunoreactive fiber content was also determined in the 
RVLM at 3 levels as described above.  For measurements in the RVLM, an AOI 
900 pixels in width and 800 pixels in height was placed 450 pixels from the 
midline such that the right lower corner touched the right ventrolateral 
subependymal surface of the section.  Using this method, AOIs were consistently 
centered over the pressor region of the RVLM as determined previously by the 
density and orientation of PNMT-positive cells which make up the C1 bulbospinal 
neurons that project to pre-ganglionic sympathetic cells of the spinal cord (Kung 
et al., 2010).  The percent area of the thresholded image that was occupied by 
thresholded signal was then determined.   
 
Tyrosine hydroxylase immunoreactivity in lesion studies  
The numbers of TH-ir cells were counted in every 6th section throughout 
the rostro-caudal extent of the A2 adrenergic nucleus bilaterally.   
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NTS cannula injection location 
The brains from animals subjected to protocol 3 were sectioned (40µm), 
mounted and immediately coverslipped with fluoromount (sigma).  Sections were 
photographed for evaluation of injection site. 
 
Data Analysis 
Blood pressure, HR, RSNA, integrated dEMG (used as an index of minute 
ventilation), and RR were averaged into 30 sec bins and compared between 
groups at 5 min intervals from the start of blood withdrawal through the 50 min 
post-hemorrhage period using 2-way ANOVA with repeated measures.  
Serotonin immunoreactive nerve terminal fiber content was determined in each 
plane as described above under microscopy and compared between groups by 
2-way ANOVA with repeated measures.  The effect of neurotoxin injection on 
TH-ir and TPH-ir cell numbers was compared through the anatomical extent of 
the relevant nuclei by 2-way ANOVA with repeated measures.  Significant 
interactions and main effects were followed up with Newman-Keuls post-hoc 
tests.   
 
Baroreflex 
Heart rate and RSNA data from phenylephrine and nitroprusside exposure 
were combined and sorted into ascending order of BP.  The resulting data were 
subjected to curve fitting to a 4 parameter logistical equation: HR= A/[1 + eB(MAP-
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C)] + D, where A is the range of HR or RSNA over the resulting sigmoidal curve, 
B is a gain parameter, C is MAP at the inflection point of the resulting curve, and 
D is the asymptotic minimum.  The resulting parameters were used to determine 
maximal gain, (-B)(A)/4.56 as described by Howe et al (Howe et al., 1989).  
Parameters were compared between groups by Student’s t-test.  Instantaneous 
gain (Y) over the range of MAP was determined by taking the first derivative of 
each curve.  Gain at baseline BP, i.e., set point gain, was determined for each 
animal by solving for Y at baseline BP in the best fit of the derivative curve 
according to the Gaussian expression Y= (k/s)e[(x-m)/s^2], where Y is instantaneous 
gain, X is the set point BP, k is kurtosis, s is skewness, and m is MAP at 
midrange (MAP50).   
 
Peripheral Chemoreflex 
Maximal depressor, pressor and bradycardic responses were determined 
during the initial biphasic hemodynamic response to KCN injection.  Sympathetic 
and respiratory responses were somewhat variable in time of onset.  However, 
KCN injection produced a consistent transient apneic response that was followed 
by increased dEMG and sympathetic activity at all doses tested.  Therefore, two 
sets of RSNA data points were collected: responses were averaged over 2.5 sec 
prior to the termination of apnea (apneic period) and 3.0 sec after termination of 
apnea.  These time frames were chosen based on the average duration of apnea 
in control animals and in an effort to minimize the contribution of baroreflex 
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unloading on the post apneic measurements.  Such baroreflex effects were 
clearly evident beyond 3 sec after the post-apneic period.  For ventilatory 
parameters, the area under the curve of the integrated dEMG signal was 
determined for the 3-4 largest breaths and averaged to provide a measure of 
tidal volume (TV).  Tidal volume of the 3-4 largest breaths taken during the post 
apneic period were averaged and compared to a 3 sec average TV determined 
prior to drug injection.  The percent difference was taken as the change in TV in 
response to drug.  The RR was determined from the breathing period and 
multiplied by the TV to provide an index of minute ventilation (MVI).  The change 
in MVI during the post-apneic period was determined as % change from 
baseline.   
 
Results 
Rats subjected to sham lesion showed a typical biphasic response during 
hemorrhage characterized by a short normotensive primary compensatory phase 
during which sympathetic activity and HR increased, followed by a sympatholytic 
phase which included rapid falls in BP, HR and sympathetic activity (Figure 20).  
After reaching their nadir between 6 and 8 minutes after the start of blood 
withdrawal, all three variables began to enter the secondary compensatory phase 
and reached a steady state within 20 minutes of hemorrhage termination.  The 
respiratory response was characterized by tachypnea during blood withdrawal 
and recovery to baseline during the secondary compensatory phase.  The 
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integrated dEMG response was somewhat variable.  In general, it rose during the 
initial blood withdrawal and declined back to baseline in parallel with the fall in 
BP.  Ventilation (i.e., dEMG) subsequently remained at baseline for the next 15 
min after which it began to increase and remained elevated for the remainder of 
the secondary compensatory recovery period. 
Neurotoxin lesion in the NTS did not significantly affect BP or HR 
responses to hemorrhage or during the secondary compensatory phase.  
Qualitatively, baseline sympathetic burst frequency or amplitude did not appear 
different between groups (data not shown).  The maximal rise in sympathetic 
activity during blood withdrawal was significantly lower in lesioned rats (153.8 ± 
36.5 vs. 36.4 ± 17.5 %baseline, P<0.01).  Though the primary 
sympathoexcitatory response was attenuated in lesion rats, the nadir of the 
sympatholytic response was not different between groups.  Sympathetic activity 
also recovered to a lower steady state in lesioned rats (P<0.01).  Integrated 
dEMG of lesioned animals declined from the start of hemorrhage and remained 
below baseline and below that of control rats during the secondary compensatory 
phase (P<0.01).  Respiratory rate did not differ between groups. 
Potassium cyanide (KCN) injection in sham-lesioned rats produced 
immediate bradycardia and apneic responses accompanied by a biphasic BP 
response (Figure 21).  The BP response was characterized by an immediate 
depressor response followed quickly by a pressor response, with the pressor 
response being most obvious at the highest dose tested.  The pressor response 
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was accompanied by a transient burst of increased sympathetic activity.  
Sympathetic activation occurred simultaneously with increased ventilation 
characterized by a more rapid pace and larger TV.  Lesioned rats subjected to 
KCN injection exhibited a significantly attenuated depressor response regardless 
of dose and a slightly lower pressor response at the highest dose (P<0.01).  
Lesioned animals also showed a significant smaller increase in TV (P<0.01) and 
MVI at the highest doses (P<0.01).  Lesion did not affect the magnitude of the 
bradycardic response or the RR response to KCN (Figures 22).   
Average spontaneous baroreflex gain of the HR reflex did not differ 
between groups when assessed with the sequence and spectral methods (Table 
8).  However, the power of BP variability in the low frequency domain was 
significantly lower in lesioned animals when either systolic (P<0.01), mean 
(P<0.05) or diastolic pressure (P<0.05) were assessed.  However, BP variability 
in the time domain was not different when either systolic, mean or diastolic 
pressures were assessed.  The LF/HF ratio of HR variability was also 
significantly lower in lesioned rats (P<0.05).   
Maximal gain of both HR and RSNA baroreflex curves generated using 
pharmacological manipulations of BP were significantly elevated in lesioned 
animal (p<0.05) (Figure 23).  In addition, HR baroreflex gain at the set point (or 
baseline MAP) was significantly higher in lesioned animals (P<0.05).  The HR 
range was significantly lower in lesioned animals (P<0.01), while the lower 
plateau was elevated (P<0.01) (Table 9).  Diaphragmatic EMG activity was found 
    
  
167
to increase with decreasing pressure in sham-lesioned rats, while ventilatory rate 
decreased slightly but not significantly (Figure 24).  Diaphragmatic EMG 
decreased only slightly when BP was increased above baseline.  Lesioned 
animals showed no change in ventilation with either increasing or decreasing 
pressure.   
Neurotoxin injected into the NTS resulted in large reductions in the content 
of serotonin-ir fibers throughout the medial and commissural subnuclei of the 
NTS and the neighboring region of the DMX (Figure 25-26A, B).  However, the 
NTS neurotoxin injection did not affect serotonin-ir fiber content in the RVLM 
(Figure 25-26C).  Lesion did not affect TPH-ir cell number in the serotonin-rich 
nuclei in the caudal raphe that have been shown to project to the NTS (Figure 27 
A-H).  Tyrosine hydroxylase immunoreactive cells in the A2 region showed no 
apparent difference in morphology following treatment with the neurotoxin (Figure 
27, I and J).  Likewise, TH-ir cell number in the A2 region was not affected by 
neurotoxin injection (Figure 27).   
Representative sections showing NTS cannula placement are shown in 
Figure 28 along with the responses to DLH injection in one rat treated with 
vehicle in the NTS and saline iv.  Responses from 2 additional rats treated with 
saline in the NTS and 8-OH-DPAT systemically are also shown.  Rarely did DLH 
produce the expected chemoreflex-like response, suggesting that the drug was 
not reaching chemosensitive neurons.  Contrary to results shown in Chapter IV, 
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systemic injection of 8-OH-DPAT had no sympathoexcitatory effect whether 
given after the 5-HT1A-receptor antagonist or saline in the NTS (Figure 29).   
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Figure 20.  Mean arterial pressure (MAP), heart rate (HR), renal sympathetic 
nerve activity (RSNA), integrated diaphragmatic EMG (dEMG) and respiratory 
rate (RR) during hemorrhage (gray shaded region) and subsequent recovery in 
rats treated with vehicle (Control) and 5,7-dihydroxytryptamine (Lesion) targeted 
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to the NTS.  Number of subjects in control group is 8 for all parameters.  Number 
of subjects in lesion group is 8 for AP, HR and RSNA and 9 for DEMG and RR.   
 
Data were analyzed by 2-way ANOVA with repeated measures using Lesion and 
Time as factors.  Main effects and significant interactions were followed up with 
between-group comparisons using Newman-Keuls post hoc tests.  Data are 
group mean ± S.E.M.  *, ** P<0.05, <0.01 compare between groups. 
 
Overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and Time on MAP showed a main effect of Time [F (1,156) = 17.43, P<0.01] due 
to the decline and recovery of MAP over the course of hemorrhage and the 
secondary compensatory phase.  There was no effect of Lesion on the MBP 
response to hemorrhage. 
 
Overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and Time on HR showed a main effect of Time [F (1,156) = 10.94, P<0.01] due to 
the decline and recovery of HR over the course of hemorrhage and the 
secondary compensatory phase.  There was no effect of Lesion on the HR 
response to hemorrhage. 
 
An overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and Time on RSNA showed a main effect of Lesion [F (1,168) = 14.32, P<0.01] 
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due to an overall attenuation of sympathetic activity in lesioned animals.  A main 
effect of Time [F (1,168) = 6.05, P<0.01] was due to the decline and recovery of 
RSNA over the course of hemorrhage and the secondary compensatory phase. 
 
An overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and Time on dEMG activity showed a Lesion x Time interaction [F (1,180) = 1.84, 
P<0.05] due to the attenuation of dEMG activity in lesioned rats that remained 
low throughout the experiment, while sham-lesioned animals showed a dramatic 
rise initially with hemorrhage that subsided with hypotension and rose again in 
the end of the secondary compensatory phase.  A main effect of Lesion [F 
(1,180) = 35.05, P<0.05] was due to an overall attenuation of dEMG activity in 
lesioned rats.  A main effect of Time [F (1,180) = 2.09, P<0.05] was due to the 
change in RSNA over the course of hemorrhage and the secondary 
compensatory phase.   
 
An overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and Time on RR showed a main effect of Time [F (1,180) = 4.40, P<0.01] due to 
the fluctuation of RR throughout the course of hemorrhage.  There was no main 
effect of Lesion on RR response to hemorrhage. 
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Figure 21.  Representative recordings of arterial pressure, heart rate (HR), renal 
sympathetic activity (RSNA), integrated renal sympathetic activity (int. RSNA), 
integrated diaphragmatic EMG (int. dEMG) and respiratory rate (RR) during 
exposure to KCN 30 µg/kg (at arrows) in rats subjected to sham-lesioned (A) or 
serotonin nerve terminal lesion in the NTS (B). 
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Figure 22.  Summary data of change in MAP for both pressor (+ΔMAP) and 
depressor (-ΔMAP) responses, heart rate (HR), renal sympathetic nerve activity 
(RSNA), tidal volume (TV), absolute respiratory rate (RR) and change in minute 
ventilation index (MVI) in response to increasing doses of KCN (3, 30 and 100 
µg/kg iv.) in rats treated with vehicle (control) or 5,7-dihydroxytryptamine (lesion) 
targeted to the NTS.  Subject n in the control group was 9 for HR and MAP, and 
8 for all other parameters.  Number of subjects in the lesion group was 12 for 
MAP and HR, 8 for RSNA, and 7 for TV, RR and MVI.   
 
Data were analyzed by 2-way ANOVA with repeated measures using Lesion and 
Dose of KCN as factors.  Main effects and significant interactions were followed 
up with between-group comparisons using Newman-Keuls post hoc tests.  Data 
are group mean ± S.E.M.  *, ** P<0.05, <0.01 compare between groups. 
 
An overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and Dose on the presser response to KCN showed a main effect of Dose [F 
(1,38) = 25.35, P<0.01] due to the dose-dependent increase in the presser 
response to KCN. 
 
An overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and Dose on HR showed a main effect of Dose [F (1,38) = 11.01, P<0.01] due to 
the larger bradycardic effect with increasing dose.   
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An overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and Dose on the depressor response showed a main effect of Lesion [F (1,38) = 
18.53, P<0.01] due to the overall smaller depressor response over the range of 
the doses, though the difference between groups was only significant at the 
lowest dose.   
 
An overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and Dose on RSNA showed significant main effects of Lesion [F (1,34) = 4.79, 
P<0.05] and Dose [F (1,34) = 25.20, P<0.01].  A main effect of Lesion was due to 
overall attenuation of the sympathetic response in the post-apneic period in 
lesioned animals.  The main effect of Dose was due to a larger post-apneic 
increase in activity with increasing dose.  
 
An overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and Dose on TV showed a Lesion x Dose interaction [F (1,26) = 8.09, P<0.01] 
due to a significant attenuation of TV in lesioned animals at the highest dose 
tested, but not at the lower doses.  A main effect of Lesion [F (1,28) = 5.37, 
P<0.05] was due to the smaller increase in TV during the post-apneic period in 
lesioned animals.  A main effect of Dose [F (1,28) = 4.74, P<0.05] was due to an 
overall increase in TV during the post-apneic period in both groups with 
increasing dose.   
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An overall 2-way ANOVA with repeated measures examine the effects of Lesion 
and Dose on RR showed no main effects or interaction.   
 
An overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and Dose on MVI showed a Lesion x Dose interaction [F (1,28) = 5.31, P<0.01] 
due to a significant attenuation of MVI in lesioned animals at the highest dose 
tested, but not at the lower doses.  A main effect of Lesion [F (1,28) = 4.54, 
P<0.05] was due to the smaller increase in MVI during the post-apneic period in 
lesioned animals.  A main effect of Dose [F (1,28) = 18.45, P<0.01] was due to 
an overall increase in MVI with increasing doses.   
 
 
 
 
 
 
 
 
    
Table 8.  Spontaneous baroreflex gain, heart rate and blood pressure variability in lesion and control rats 
 
Up 
Sequences 
(ms/mmHg) 
Down 
Sequences 
(ms/mmHg) 
All 
Sequences 
(ms/mmHg) 
Alpha (LF) Alpha (HF) LF power (mmHg2)  BP SDNN LF/HF  
          
SBP 2.13 ± 0.19 2.03 ± 0.26 2.12 ± 0.20 0.71 ± 0.10 2.39 ± 0.40 14.11 ± 2.11 4.50 ± 0.29
MBP 2.32 ± 0.15 2.79 ± 0.31 2.60 ± 0.21 0.82 ± 0.12 3.18 ± 0.56 10.61 ± 1.65 3.83 ± 0.22Control (13) 
DBP 2.33 ± 0.20 2.50 ± 0.25 2.45 ± 0.22 0.88 ± 0.13 2.73 ± 0.36 9.35 ± 1.52 3.49 ± 0.18
0.91 ± 0.20 
    
SBP 2.28 ± 0.23 2.18 ± 0.37 2.24 ± 0.25 0.72 ± 0.10 2.52 ± 0.54 7.73 ± 0.67 ** 3.78 ± 0.23
MBP 2.85 ± 0.25 2.95 ± 0.40 2.92 ± 0.31 0.80 ± 0.11 3.25 ± 0.47 6.50 ± 0.58 * 3.33 ± 0.24
Lesion 
(14) 
DBP 2.70 ± 0.27 2.49 ± 0.24 2.56 ± 0.26 0.84 ± 0.12 3.00 ± 0.40 6.04 ± 0.56 * 3.27 ± 0.27
0.71 ± 0.16 *
Spontaneous baroreflex gain was determined from the sequence method using ascending only (up) descending only 
(down) or all sequences that met criteria outlined in the text.  Values are group means ± SEM.  Group n are indicated in 
parentheses.  Gain was determined by the sequence method using systolic blood pressure (SBP), mean blood pressure 
(MBP), diastolic blood pressure (DBP).  Spectral coherence between IBI and BP variability are reported as coherence in 
the low frequency domain (alpha LF) or high frequency domain (alpha HF).  Power of BP variability in the low frequency 
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domain (LF power) and in the time domain (BP SDNN) and the ratio of LF to HF 
heart rate variability (LF/HF) are also included in the analysis.   
 
All variables were compared between groups by Student’s t-test.  *, ** P<0.05, 
P<0.01, lesioned vs. sham-lesioned animals.  
 
Power of BP variability in the LF power and LF/HF were lower in the lesioned 
group when MBP and DBP were assessed.  Significant differences between 
groups were found in LF power and LF/HF ratio using Student’s t-test.  LF power 
in SBP [df = 25, t = 2.95, P<0.05], MBP [df = 25, t = 2.40, P<0.05] and DBP [df = 
25, t = 2.09, P<0.05] were significantly lower in lesioned animals.  LF/HF ratio [df 
= 25, t = 2.37, P<0.05] was also lower in lesioned animals.   
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Figure 23.  Heart rate (HR) and renal sympathetic nerve activity (RSNA) 
baroreflex responses to pharmacological BP manipulations in vehicle-treated and 
lesioned rats.  Average of fitted curves for HR and RSNA baroreflex are shown 
for vehicle-treated (control) and lesioned rats (A).  Average instantaneous gain of 
HR and RSNA are shown in vehicle-treated (control) and lesioned rats (B).   
 
Student’s t-tests were performed to test the difference of baseline and maximal 
gain of HR and RSNA baroreflex between lesioned and control animals.  Data 
are group mean ±SEM.  Group n are indicated in parentheses.  *P<0.05 vs. 
control at set-point gain.  + P<0.05 vs. control at maximum gain.    
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Both maximal [df = 9, t = 3.10, P<0.05] and baseline gain [df = 9, t = 2.75, 
P<0.05] of the HR response were elevated in lesioned animals.  Maximal gain [df 
= 9, t = 1.82, P<0.05] of RSNA reflex was also elevated in lesioned rats.  
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Table 9.  HR and RSNA baroreflex parameters 
 
 Range (bpm) 
Maximal gain
(Δbpm/ 
ΔmmHg) 
MAP50 
(mmHg) 
Lower 
plateau 
(bpm) 
Set point gain
(Δbpm/ 
ΔmmHg) 
Control 
HR 
(6) 
342 ± 31 -3.1 ± 0.3 120 ± 7 189 ± 15 -2.83 ± 0.41 
Lesion 
HR 
(5) 
255 ± 9 ** -4.6 ± 0.3 * 112 ± 2 264 ± 16 ** -4.29 ± 0.30 *
 Range (%baseline) 
Maximal gain 
(Δ%baseline/ 
ΔmmHg 
MAP50 
(%baseline) 
Lower 
plateau 
(%baseline)
Set point gain
(Δ%baseline/ 
ΔmmHg) 
Control 
RSNA 
(6) 
398 ± 30 -9.1 ± 1.2 88 ± 4 14 ± 6 -6.06 ± 1.35 
Lesion 
RSNA 
(5) 
396 ± 43 -14.1 ± 2.6 * 93 ± 2 34 ± 14 -7.40 ± 1.80 
 
Between group differences in range, maximum gain, lower plateau and set point 
gain of HR and sympathetic baroreflex responses were determined using 
Student’s t-tests.  Values are group means  SEM.  *, **P<0.05, 0.01 vs. control 
in HR and RSNA.  Group n are indicated in parentheses.  MAP50 = mean arterial 
pressure at mid-range of the curve.  The range of HR was smaller [df = 9, t = 
2.42, P<0.05] in lesioned animals.  Maximum gain [df = 9, t = 3.10, P<0.05] of HR 
was elevated with lesion.  Heart rate plateau [df = 9, t = -3.28, P<0.01] and the 
set point gain [df = 9, t = 2.75, P<0.05] was higher in lesioned rats.  Maximum 
gain [df = 9, t = 1.82, P<0.05] of the RSNA baroreflex response was significantly 
higher in lesioned rats.  There was no difference found in MAP50 for both HR and 
    
  
182
RSNA baroreflex.  There was no difference found in range, lower plateau and set 
point gain for RSNA baroreflex. 
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Figure 24.  Integrated dEMG and respiratory rate (RR) changes during 
pharmacological BP manipulations (i.e., baroreflex testing) of vehicle-treated and 
lesioned rat.  Averages of dEMG (A) and RR (B) at baseline, ±10 and ±20 mmHg 
are shown for sham-lesioned and neurotoxin-injected animals.   
 
Data were analyzed by 2-way ANOVA with repeated measures using Lesion and 
ΔMAP as factors.  Main effects and significant interactions were followed up with 
between-group comparisons using Newman-Keuls post hoc tests.  Data are 
group mean ± S.E.M.  Group n are indicated in parentheses.  
 
Two-way ANOVA with repeated measure used to examine the effect of NTS 
serotonin Lesion and ΔMAP on change in dEMG showed a main effect of Lesion 
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[F (1,36) = 15.21, p<0.01] due to the significant decrease of dEMG in lesioned 
rats particularly at the lowest BP.     
 
A 2-way ANOVA with repeated measure preformed to examine the effect of NTS 
serotonin Lesion and ΔMAP on RR showed no main effects or interaction.  
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Figure 25.  Representative examples of serotonin immunoreactivity in 5 coronal 
planes of the NTS and DMX.  The location of each section in relationship to 
Bregma is indicated in the left images (caudal to Bregma in mm).  Images on the 
left were obtained from a representative sham-lesioned animal.  Images on the 
right were taken from a representative lesioned animal at approximately the 
same coronal planes as the images on the left.  The first 5 pairs of images are of 
the NTS/DMX region.  The last image pair shows the C1 region of the RVLM.  
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Figure 26.  Quantification of serotonin nerve terminal content of vehicle-treated 
and lesioned rats from the 5 rostral-caudal coronal planes of the NTS (A) and 
DMX (B).  The 5-HT-ir nerve terminal content is also shown in 3 rostral-caudal 
planes within the C1 region of the RVLM (C).   
 
Data were analyzed by 2-way ANOVA with repeated measures using Lesion and 
Distance from Bregma as factors.  Main effects and significant interactions were 
followed up with between-group comparisons using Newman-Keuls post hoc 
tests.  Data are group mean ± S.E.M.  Group n are indicated in parentheses.  *, 
** P<0.05, P<0.01 between groups. 
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An overall 2-way ANOVA with repeated measures examining the effect Lesion 
and Distance from Bregma on 5-HT-ir nerve terminal content in the NTS showed 
a Lesion x Distance from Bregma interaction [F (1,104) =9.31, P<0.001] due to 
the more extensive lesion of 5-HT-ir nerve terminals in the central regions of the 
caudal NTS where nerve terminal content was greatest in sham-lesioned rats.  A 
main effect of Lesion [F (1,104) = 53.62, P<0.01] was due to the lower 5-HT-ir 
serotonin nerve terminal content in lesioned animals.  A main effect of Distance 
from Bregma [F (1,104) = 9.30, P<0.01] was due to the change of 5-HT-ir nerve 
terminal content in both groups throughout the NTS.   
 
An overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and Distance from Bregma on the 5-HT-ir nerve terminal content in the DMX 
showed a Lesion x Distance from Bregma interaction [F (1,104) = 6.22, p<0.01] 
due to the more extensive lesion in the more rostral central region of the nucleus 
where 5-HT-ir nerve terminal density is normally highest.  A main effect of Lesion 
[F (1,104) = 40.35, P<0.01] was due to the lower 5-HT-ir nerve terminal content 
in lesioned animals.  A main effect of Distance from Bregma [F (1,104) = 6.25, 
P<0.01] was due to the variation of 5-HT-ir nerve terminal content in both groups 
over the extent of the DMX.   
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An overall 2-way ANOVA with repeated measures examining the effect of Lesion 
and Distance from Bregma on the 5-HT-ir nerve terminal content in the RVLM 
region showed no effect of lesion.   
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Figure 27. Cell profiles of TPH-ir cell number are shown for the serotonin-rich 
nuclei that provide major projections to the NTS.  Cell profiles of TH-ir cells are 
shown for the A2 region throughout the extent of the nucleus.  Examples of TPH-
ir cells are shown for vehicle-treated (control) (A,C,E,G) and lesioned rats 
(B,D,F,H) in the serotonin-rich nuclei known to project to the NTS including the 
raphe obscurus (A-B), raphe pallidus (C-D), raphe magnus (E-F) and 
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parapyramidal region (G-H).  Examples of the A2 region of the NTS showing TH-
ir cells (green) and serotonin-ir fibers (red) are shown for control (I) and lesioned 
(J) rats.   
 
Data were analyzed by 2-way ANOVA with repeated measures using Lesion and 
Distance from Bregma as factors.  Main effects and significant interactions were 
followed up with between-group comparisons using Newman-Keuls post hoc 
tests.  Data are group mean ± S.E.M.  Group n are indicated in parentheses.  
 
Overall 2-way ANOVA with repeated measures was preformed to examine the 
effect of Lesion and Distance from Bregma of TPH-ir cell numbers in each 
serotonin-rich nucleus and TH-ir cell number in the A2 region.  There was no 
significant difference found between groups.   
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Figure 28.  Three representative histology pictures of NTS injection sites are 
shown (top).  Their respective DLH responses of arterial pressure, heart rate 
(HR) and renal sympathetic nerve activity (RSNA) are shown below.  Arrows 
indicated DLH injection.  There was no obvious DLH response even with correct 
placement of cannula in the NTS.  
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Figure 29.  Mean arterial pressure (MAP), heart rate (HR), renal sympathetic 
nerve activity (RSNA) during hemorrhage and subsequent recovery in rats 
injected with saline or Way-100635 in the NTS (first arrow) followed by 
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hemorrhage and subsequent systemic injection of saline or 8-OH-DPAT (second 
arrow).  Data are group means ± S.E.M.  Group n are indicated in parentheses.  
Three way-ANOVA used to examine the effects of 5-HT1A receptor blockade, 8-
OH-DPAT and Time on HR, MAP and RSNA showed a main effect of Time on 
HR [F (1,108) = 16.82, P<0.01], MAP [F (1,108) = 21.74, P<0.01] and RSNA [F 
(1,108) = 16.07, P<0.01] due to variation of the two variables in all four groups 
over time.   
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Discussion 
Selective lesion of serotonin nerve terminals in the caudal aspect of the 
dorsomedial brainstem, where arterial baro- and chemoreceptors projections 
terminate, attenuated compensatory sympathetic and ventilatory responses to 
blood loss.  The same lesion augmented HR and sympathetic arterial baroreflex 
gain but attenuated ventilatory responses to lower pressure.  Sympathetic and 
ventilatory responses to acute arterial chemoreceptor stimulation with KCN were 
also attenuated by the lesion.  These findings indicate that serotonergic axon 
terminals in the NTS and/or surrounding region release neurotransmitters critical 
for normal ventilatory and sympathetic responses to hypovolemia.  The data 
further suggest that the attenuated sympathetic and ventilatory responses to 
blood loss in animals with reduced serotonin innervation of the dorsomedial 
medulla may be related to deficient processing of peripheral chemoreceptor 
afferent input in the NTS. 
The NTS receives serotonin-positive projections from multiple sites, 
including the nodose ganglia, the DR, as well as the caudal raphe nuclei 
including the RO, RM and RP (Schaffar et al., 1988; Thor and Helke, 1987).  In 
addition, 5-HT-ir positive cell soma have been detected in the AP and 
mediolateral portions of the NTS itself (Calza et al., 1985).  In a prior study, we 
found virtually the same pattern of suppressed ventilatory and sympathetic 
responses during recovery from hemorrhage in rats subjected to lesion of caudal 
raphe serotonin cells that we also observed here after a more discrete lesion of 
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serotonin nerve terminals in the NTS (Kung et al., 2010).  As such, it seems most 
likely that caudal hindbrain serotonergic projections to the NTS or surrounding 
regions contribute to normal ventilatory and sympathetic responses after 
hemorrhage.  It remains to be determined if altered arterial baroreflex and 
chemoreflex responses observed with NTS serotonin nerve terminal lesions are 
mediated by loss of axonal projections from the caudal raphe.    
Selective lesion of serotonin-producing cells in the nodose ganglia using 
5,7-DHT results in transient hypertension and a persistent increase in BP 
variability, suggesting that these cells facilitate baroreflex control of BP (Orer et 
al., 1991).  In contrast, others have found that BP is normal and that BP 
variability is reduced 2 weeks after injection of 5,7-DHT directly into the NTS (Itoh 
et al., 1992).  The data suggest that 5-HT-ir nerve terminals in the NTS that 
originate from cells in the nodose ganglion may facilitate baroreflex control, while 
serotonin projections from cells within the AP/NTS region or caudal raphe may 
instead suppress baroreflex gain.  In preliminary studies we found that by 10-12 
days after NTS injection of 5,7-DHT, TPH-ir positive cell bodies in the caudal 
raphe began to degenerate (data not shown).  Serotonergic cells of the caudal 
raphe send collaterals to a wide range of targets.  Thus, it is unclear whether 
prior studies performed 2 weeks after neurotoxin injection in the NTS faithfully 
assessed a specific role for NTS serotonergic projections in baroreflex control.   
In the current study, both HR and RSNA baroreflex gain was increased 7 
days after neurotoxin injection in the NTS.  These findings were observed in the 
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absence of any evidence of caudal raphe serotonin cell loss, or loss of 5-HT-ir 
nerve terminal density in the C1 region of the RVLM, the latter of which contains 
or lies near to important serotonergic targets that control ventilatory rhythm 
generation as well as pre-motor neurons of the sympathetic nervous system.  
Because of this it is unlikely that increased baroreflex gain after NTS lesion was 
the result of degeneration of serotonin cell bodies and subsequent loss of 
collateral projections outside the NTS to alternative sites involved in arterial 
baroreflex control.  
In our previous study, we noted that caudal raphe serotonin cell lesion 
also enhanced baroreflex control of HR (Kung et al., 2010).  Indices of improved 
baroreflex control included a greater average increase in the gain of fluctuations 
in HR interval in response to spontaneous changes in BP.  In the current study, a 
serotonin nerve terminal lesion limited to the NTS and its immediate surrounding 
region did not affect spontaneous baroreflex gain, but instead reduced BP 
variability in the LF domain.  Assessments of spontaneous baroreflex gain reflect 
the activity of both the vagal and sympathetic components of baroreflex control 
(Cerutti et al., 1991; Japundzic et al., 1990; Pagani et al., 1986).  In contrast, low 
frequency BP oscillations result primarily from the baroreflex-mediated waxing 
and waning of sympathetic vasoconstriction.  The reduced power of low 
frequency BP oscillations observed with NTS lesion reflects a greater precision in 
sympathetic BP control, i.e., BP deflections away from the set-point produce a 
more robust sympathetic correction leading to reduced maximum and minimum 
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BP deviations.  Taken together the data suggest that serotonin nerve terminals in 
the NTS may have a greater effect on the sympathetic control of BP, while 
caudal raphe derived serotonin innervation of other regions may suppress other 
targets that influence cardiovagal control of BP. 
Enhanced arterial baroreflex function was probably not responsible for 
deficits in the sympathetic secondary compensation in NTS-lesioned animals.  
Indeed, the primary sympathetic compensatory response to blood loss that is 
presumed to be mediated by baroreceptor unloading was almost completely 
abolished by the lesion.  Surprisingly, BP was maintained during the primary 
compensatory phase despite the absence of significant sympathetic 
compensation.  In prior studies, we noted that sinoaortic denervation and the 
commensurate loss of sympathetic compensation during blood loss resulted in a 
slightly earlier onset of hypotension (Osei-Owusu and Scrogin, 2006).  In the 
present study, it is likely that alternative vasoconstrictor mechanisms mediated 
by the intact baroreflex, such as vasoconstrictor hormone release, helped to 
maintain BP in the absence of sympathoexcitation.  Alternatively, it is plausible 
that serotonin nerve terminals in the NTS selectively influence renal sympathetic 
drive during baroreflex activation and that changes in RSNA may not accurately 
reflect sympathetic-dependent increases in vascular resistance that maintain BP 
during baroreceptor unloading with hemorrhage.  However, this seems unlikely 
since lesioned rats showed a robust increase in RSNA during baroreceptor 
unloading with nitroprusside. 
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The attenuated sympathetic compensation observed during the initial 
phase of blood withdrawal was paralleled by a similar absence of ventilatory 
response in lesioned rats.  The attenuation of sympathetic compensatory 
responses during the primary compensatory phase may have been due, in part, 
to a deficit in respiratory drive that normally develops during the early phase of 
hemorrhage.  This possibility is supported by observations that NTS lesion 
attenuated the post-apneic sympathetic and ventilatory responses to KCN in the 
same animals.  Suppressed chemoreflex sensitivity commonly accompanies 
increased baroreflex function in many models. (Gao et al., 2004; Haider et al., 
2009; Wang et al., 2006).  Thus, it is possible that increased BRS suppressed 
sympathetic responses to chemoreflex activation in lesioned rats.  However, we 
observed that the ventilatory response to baroreceptor unloading during 
nitroprusside infusion was virtually abolished by the NTS lesion.  As such there 
appears to be a primary deficit in the ability to increase ventilation following 
serotonin lesion in the NTS that is independent of sympathetic baroreflex 
responses.   
Serotonin has been implicated in a wide range of roles in ventilatory 
function.  However, little is known about its role in arterial chemoreflex control at 
the level of the NTS.  Contrary to our findings, corroborating reports indicate that 
the bradycardic response to peripheral chemoreceptor activation is inhibited by 
either serotonin or 5-HT3 receptor agonist injection into the comNTS (Sevoz et 
al., 1997).  This effect appears to be selective for the cardiovagal component of 
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the reflex since neither ventilatory nor sympathetic responses to KCN injection or 
infiltration of the carotid body with CO2 were influenced by local application of 
serotonin or 5-HT3 receptor agonists in the NTS.  In the present study there was 
no effect of serotonin nerve terminal lesion on the bradycardic response to 
chemoreflex stimulation.  In our studies the bradycardic response was profound 
even at the lowest dose tested.  Thus, the effects of serotonin nerve terminal 
lesion on the HR component of the chemoreflex response may have been 
obscured by the very large effect at the doses tested.  Alternatively, the 
endogenous serotonin release that occurs within the NTS during chemoreceptor 
activation may not be sufficient to activate a 5-HT3 receptor-dependent inhibition 
of the bradycardic reflex.  In any case, these data further confirm that 
sympathetic activity and ventilation are tightly coupled during reflex activation of 
ventilatory response, while the bradycardic response to chemosensory afferent 
stimulation is somehow modulated differently. 
Additional evidence suggests that serotonin released from the caudal 
raphe may actually have an inhibitory effect on ventilatory responses to hypoxia 
rather than a facilitatory effect as our data suggest.  For instance chemical 
stimulation of the RM region suppressed activation of chemosensitive NTS 
neurons during systemic KCN injection in anesthetized rats (Netzer et al., 2009).  
A second study showed no effect of caudal raphe suppression on ventilatory 
responses to hypoxia in awake rats (Taylor et al., 2005).  In the latter study, 
dialysis of the 5-HT1A-receptor agonist, 8-OH-DPAT, into various regions of the 
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caudal raphe successfully attenuated ventilatory responses to central 
chemoreflex activation with hyperoxic hypercapnia, presumably by selectively 
inhibiting serotonin neurons via 5-HT1A autoreceptors.  However, the same 
strategy had no effect on minute ventilation during 60 min of hypoxia, suggesting 
that caudal raphe serotonin cells do not contribute to peripheral chemoreflex 
responses.  However, drug diffusion during dialysis may have also activated 
inhibitory 5-HT1A-receptors expressed on non-serotonergic cells in regions that 
regulate motoric responses to chemosensory reflex information.  Thus, it is still 
not entirely clear how the high density of serotonin innervation of the comNTS 
influences afferent input from chemosensory afferents.  It remains to be 
determined whether disruption of chemoreflex sensitivity directly contributes to 
the loss of sympathetic and ventilatory compensation during both the early phase 
of active blood loss or to the deficit in compensation after blood loss is 
terminated.   
In our prior studies, we noted that the initial sympathoexcitatory response 
to hemorrhage was truncated in rats subjected to caudal hindbrain serotonin cell 
lesion, while the early ventilatory response to active blood withdrawal was 
abolished.  In these studies, 5-HT-ir nerve terminal content in the comNTS was 
decreased by 50-60%.  In the present study, both sympathetic and ventilatory 
responses to early hemorrhage were completely abolished when 5-HT-ir nerve 
terminal content in the NTS was reduced by over 90%.  These data support the 
view that loss of serotonin innervation of the NTS region was responsible for the 
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attenuated sympathetic response to hemorrhage after lesion of serotonin cells in 
the caudal raphe.  The data also suggest that separate pathways may activate 
the initial ventilatory and sympathetic responses to blood loss but that an 
underlying coupling between ventilatory drive and sympathetic activity also 
contributes to the primary compensatory phase.  In this scenario, the ventilatory 
response appears to be more sensitive to loss of serotonin innervation in the 
NTS than the sympathetic response.  However, more thorough loss of serotonin 
innervation in the NTS may suppress ventilation to such a degree that the 
coupling between sympathetic activity and ventilation overcomes the baroreflex-
mediated sympathetic response to blood loss.   
These findings further support the view that loss of peripheral chemoreflex 
responses may contribute to deficits in sympathetic compensation during 
hemorrhage.  In anesthetized dogs, hemorrhage produces a local decrease in 
carotid body PaO2 that stimulates carotid sinus afferents during the sympatholytic 
phase of blood loss (Schertel et al., 1994).  With continued blood loss or 
prolonged hypovolemia ventilatory responses normally increase PaO2.  However, 
reduced blood flow may continue to compromise delivery of O2 to the carotid 
body and thus prolong chemoreceptor activation.  Moreover, the development of 
metabolic acidosis may provide an additional stimulus to activate the carotid 
sinus nerves.  In our prior studies, animals subjected to the same hemorrhage 
procedure as performed in the current study showed evidence of increased 
lactate within 10 minutes of blood withdrawal (Kung et al., 2010).  At the same 
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time ventilation began to increase despite lower PaCO2 and higher PaO2.  
Together these data suggest that peripheral chemoreceptor activation in 
response to metabolic acidosis may contribute to ventilatory and sympathetic 
recovery following hemorrhage in intact animals, and that loss of serotonin in the 
NTS may interfere with the ability of the peripheral chemoreflex to elicit 
appropriate compensatory responses.    
Serotonin nerve terminals contain multiple neurotransmitters that may 
facilitate chemoreflex responses to hypoxia.  For instance substance P is co-
localized in a subset of serotonin-containing cells within the NTS (Thor and 
Helke, 1987).  Substance P is also released in the NTS in response to hypoxia in 
conscious animals (Abdala et al., 2006).  However, administration of a substance 
P antagonist in the NTS does not affect either BP or HR responses to KCN 
(Zhang et al., 2000).  Thyrotropin releasing hormone is also co-localized in 
serotonin neurons and has also been implicated in ventilatory function (Hedner et 
al., 1981).  As yet, it is not possible to determine whether the attenuation of 
compensatory responses to hemorrhage or chemosensory activation in response 
to serotonin nerve terminals is due to loss of serotonin per se.   
 In our prior study, animals subjected to serotonin cell lesion developed 
more severe tissue hypoxia following hemorrhage despite their having higher 
PaO2 compared to sham-lesioned animals (Kung et al., 2010).  As in the present 
study, lesioned animals also exhibited normal BP.  Together with the evidence 
from the current study, these findings suggest that serotonin nerve terminals in 
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the NTS may be critical for appropriate distribution of blood volume during acute 
hypovolemic states.  In the absence of such innervation, the animal defends 
perfusion pressure by increasing peripheral resistance, which in turn contributes 
to exaggerated tissue hypoxia.  The presence of serotonin in the NTS may help 
the animals defend perfusion pressure through a sympathetic-mediated increase 
in venous tone and or cardiac output and thereby facilitate perfusion of peripheral 
tissue.  It remains to be determined whether serotonin innervation of the NTS 
mediates these effects by altering sympathetic responses to peripheral 
chemoreflex activation.   
 We have shown previously that endogenous serotonin and 8-OH-DPAT 
act on 5-HT1A receptors located at the postsynaptic non-serotonergic neurons to 
positively mediate the sympathetic activity during the secondary compensatory 
phase following blood loss.    In the current study, animals subjected to NTS 
cannulation did not respond to iv. injection of 8-OH-DPAT.  These data were 
intriguing and further implicate the NTS as a potential site of action for 
systemically administered 8-OH-DPAT.  Specifically, it is plausible that NTS 
cannula placement may have compromised blood flow to the area, thus reducing 
the delivery of systemic 8-OH-DPAT to its site of action.  Future experiments that 
effectively knock down 5-HT1A receptors in the NTS region will help to further 
clarify the role of 5-HT1A receptors in the sympathetic, ventilatory responses 
during hypoxia and the secondary compensatory phase of hypotensive 
hemorrhage.     
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Chapter VI 
General Discussion 
Our studies contradict several earlier studies suggesting that serotonin 
contributes to the sympatholytic phase of hemorrhage (Dean and Woyach, 2004; 
Elam et al., 1985; Morgan et al., 1988) and suggest instead that serotonin 
contributes to the secondary compensatory sympathoexcitation that develops 
with circulatory shock. 
The contradictory results may be due to the fact that anesthesia was used 
in the majority of prior studies.   The confounding effect of anesthesia is a vexing 
problem when conducting studies examining sympathetic and ventilatory reflex 
responses, since reflex regulation of both is highly influenced by GABA 
neurotransmission.  Several of the most common anesthetic types have effects 
on GABA neurotransmission and so can lead to suppression or even 
abolishment of the reflex responses normally seen in unanaesthetized 
preparations.  Anesthesia can sometimes result in completely different reflex 
responses in awake and anesthetized animals (Bloms-Funke et al., 1999; Heym 
et al., 1984; Montgomery et al., 1982; Seyde et al., 1985).   
Nevertheless, these are the first studies to show evidence that serotonin 
neurons are necessary for normal sympathetic recovery from hypotensive 
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hemorrhage.  Moreover, these studies provide the first evidence that central 
serotonin neurons may be important in protecting perfusion pressure during 
hypovolemia by maintaining cardiac output rather than by promoting potentially 
damaging increases in peripheral resistance.  Serotonin-dependent maintenance 
of cardiac output is paralleled by sympathetic recovery, suggesting that 
sympathetic nerves may increase cardiac output.  This could be due to either 
stimulation of cardiac contractility or to increases in venous return.  Though 
studies in this dissertation did not specifically test either possibility, serotonin 
lesion did not affect HR, suggesting that sympathetic drive to the heart was 
probably normal.  Thus it seems more likely that serotonin activates a 
sympathetic-dependent increase in venous return.  This possibility is particularly 
intriguing given prior evidence from our lab that the 5-HT1A-receptor agonist 8-
OH-DPAT raises cardiac output in hemorrhaged animals by selectively 
increasing venoconstriction (Tiniakov et al., 2007).  Evidence in the present study 
also demonstrated that the sympathoexcitatory effect of 8-OH-DPAT was most 
likely due to activation of 5-HT1A-receptors on non-serotonergic neurons, which 
further suggests the possibility that endogenous serotonin acts on 5-HT1A-
receptor to mediate the secondary compensatory sympathetic recovery following 
hemorrhage.   
Indeed, we have observed several parallels between serotonin-dependent 
sympathoexcitation and the sympathetic excitation produced by 8-OH-DPAT in 
hemorrhaged animals.  Both are associated with reductions in lactate 
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accumulate, which indicates improved tissue oxygenation.  Both are related to 
increases in cardiac output.  Furthermore studies from our laboratory also 
suggest that 8-OH-DPAT increases venous tone (Tiniakov and Scrogin, 2006), 
which coincides with evidence that serotonin improves tissue perfusion without 
further raising BP or HR.   
Our evidence now brings to light a novel possibility that serotonin acts on 
receptors in the NTS to mediate sympathoexcitation following hemorrhage.  This 
finding is consistent with the possibility that the effects are mediated by 5-HT1A 
receptors, since studies from our laboratory indicate that 8-OH-DPAT injections 
in the IVth cerebroventricle produce the most rapid and robust increase in 
sympathetic activity compared to other injections sites in more rostral portions of 
the cerebroventricular system (Scrogin, 2003).  The IVth ventricle injections were 
made just rostral to portions of the NTS that control cardiorespiratory function.  
Injections given here were able to initiate sympathoexcitatory responses within 
20 sec of drug administration.  It is highly unlikely that the drug could have 
diffused down the spinal column to act directly within the spinal cord to produce 
sympathoexcitation to promote such a rapid response.   
Furthermore, our studies demonstrated that disruption of the integrity of 
the NTS was sufficient to prevent normal sympathoexcitatory responses to 8-OH-
DPAT given into the systemic circulation.  Specifically, rats implanted with NTS 
cannula and subsequently injected with saline had almost no response to 
systemic 8-OH-DPAT.  Though these results were inconclusive, they do suggest 
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the possibility that placement of the guide cannula somehow disrupted normal 
circulatory perfusion of the area such that systemic administration of 8-OH-DPAT 
was not able to reach the site of action in the NTS.  Future studies utilizing more 
sophisticated methods, such as specific knock-down 5-HT1A receptors, will be 
needed to determine whether systemic 8-OH-DPAT administration must reach 
the NTS to mediate its sympathoexcitatory effect in hypovolemic animals. 
Studies in this thesis support the view that serotonin facilitates both 
peripheral and central chemoreflex responses to promote sympathetic activation 
during hemorrhage.   The importance of caudal raphe serotonin neurons in 
central chemoreception in awake animals is now well established.  Our studies 
extend these findings by demonstrating the importance of these neurons in 
determining the distribution of blood volume in hypovolemia.  It remains to be 
determined if appropriate central chemoreception is necessary for beneficial 
hemodynamic responses to hemorrhage.  This question can be answered by 
lesioning caudal serotonergic neurons then subjecting rats to hypotensive 
hemorrhage and measurement of cardiac output during recovery. 
Findings from this study that serotonin may facilitate responses to 
peripheral chemoreflex activation are highly novel.  Previous data suggests that 
serotonin neurons either have no effect on ventilatory responses to hypoxia or 
that they are inhibitory (Herman et al., 2000; Olson, 1987; Sevoz et al., 1997).  
The explanation for this disagreement with the literature is not evident.  However, 
most prior studies have manipulated serotonin levels in the NTS by activation or 
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inhibition of caudal raphe neurons, which not only project to the NTS, but also 
send collateral projections to a myriad of other targets that, could interfere with 
the expression of the chemoreflex response.  Ours is the sole study to examine 
peripheral chemoreflex sensitivity after selectively manipulating serotonin nerve 
terminals at the level of the NTS and its immediate surrounding area.  Our 
immunohistochemical data suggest that serotonergic projections to other targets 
were not impaired following NTS lesion.  However, direct measures of serotonin 
release, possibly through microdialysis would be required to confirm this 
assumption.   
An anatomical substrate for serotonin's facilitation of peripheral 
chemoreflex responses and subsequent improvement of the hemodynamic 
response to hypovolemia has not so far been described.  Our studies have 
shown that the sympathoexcitatory effects of 8-OH-DPAT are dependent upon 
intact sinoaortic innervation.  The carotid sinus and aortic arch both give rise to 
chemo and baroreceptor afferents that convey sensory input to the NTS.  
Evidence that these sensory afferents are required for the full expression of the 
sympathoexcitatory effect of 8-OH-DPAT is intriguing, given evidence that 
serotonin also acts in the NTS to facilitate chemoreflex responses.  Additional 
future studies that selectively denervate carotid bodies then measure 
sympathetic and ventilatory recovery after 8-OH-DPAT injection during 
hemorrhage will be necessary to further clarify and separate out the role of 
chemo or baroreceptor afferents during hemorrhage.    
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Also significant are findings that 8-OH-DPAT promotes a profound 
sympathoinhibition in euvolemic animals.  This effect is most likely due to 
activation of 5-HT1A receptors in the RVLM.  In fact, 5-HT1A receptors are coupled 
to Gαi and Gαo proteins of the heterotrimeric G-protein  complex, and their 
activation promotes membrane hyperpolarization (Albert et al., 1996; Boess and 
Martin, 1994).  Together the evidence suggests that during hemorrhage 8-OH-
DPAT likely disinhibits a sympathoexcitatory process that is activated by 
hypovolemia through carotid sinus and/or aortic arch afferents.  Recent evidence 
has actually shown that the inhibitory neurotransmitter GABA is released into the 
comNTS during exposure to hypoxia (Tabata et al., 2001).  This effect is 
dependent upon intact carotid bodies.  Thus, our evidence coupled with findings 
in the literature has led us to propose a model by which endogenous serotonin 
and exogenous 5-HT1A-receptor agonists may mediate sympathoexcitation 
following blood loss.  In this model Figures 30 and 31, the carotid bodies are 
activated by either reduced carotid body blood flow or the metabolic acidemia 
that accompanies hypotensive hemorrhage or hemorrhagic shock.  Subsequent 
activation of second order NTS neurons promotes sympathoexcitation and 
increased ventilation.  As peripheral chemoreceptor activation persists, GABA 
neurons in the NTS are activated, which suppress the chemoreflex response.  
Serotonin release in the NTS could act on 5-HT1A receptors expressed on GABA 
neurons to attenuate this inhibition, allowing for greater sympathoexcitation to 
continue.  In the hypovolemic animal, the 5-HT1A receptor dependent 
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sympathoexcitation promotes selective venoconstriction.  However, in the 
absence of 5-HT1A receptor-dependent sympathoexcitation, the organism 
attempts to defend arterial pressure by increasing vasoconstrictor hormones that 
act primarily on the arterial side of the vasculature, promoting a potentially 
detrimental hemodynamic response to hypovolemia that could exacerbate 
ischemia.  Thus, exogenous 5-HT1A-receptor agonists may be useful as adjuvant 
treatment of hypovolemic shock by helping to facilitate appropriate sympathetic 
and hemodynamic responses to hemorrhage.  Future studies that examine the 
role of GABA in unanaesthetized rats can utilize the working heat-brainstem 
preparation to measure single unit extracellular recording of the chemosensitive 
cells in the comNTS and determine whether they are sensitive to direct exposure 
to serotonin or 5-HT1A agonist.   
 
Important Implication  
Our findings have significant implications for the current treatment of 
hypovolemic shock for obvious reasons.  5-HT1A agonists giving during blood 
loss may provide a thermodynamically beneficial way to improve perfusion 
pressure when given as an adjuvant to volume resuscitation.  However, it is 
possible that only a subset of the population may be responsive to this treatment. 
Patients treated chronically with selective serotonin reuptake inhibitors 
show a desensitization of 5-HT1A autoreceptors 5-HT1A receptors on the non-
serotonergic neurons as well (Stahl, 1998).  Therefore, therapeutically 5-HT1A 
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receptors may not work well and may not be able to exert their 
sympathoexcitatory effect during blood loss in those patients.   
Sudden infant death syndrome is postulated to result from abnormalities in 
brainstem control of autonomic function and breathing during a critical 
developmental period.  It is also reported that abnormalities of serotonin receptor 
binding in serotonin-rich nuclei may promote the abnormal peripheral and 
central- chemosensitivity that has been described in infants with apnea (Duncan 
et al., 2010; Gdovin et al., 2010; Liu and Wong-Riley, 2010).  Serotonin has also 
been implicated in obstructive sleep apnea that results in increased sensitivity of 
the peripheral chemoreflex and potentially detrimental increases in sympathetic 
drive to the heart (Ling, 2008; Phillips et al., 2009).  Therefore, manipulation of 
serotonin neuronal transmission from caudal raphe nuclei to the NTS could 
provide improved therapeutic treatments to modulate sympathetic and ventilation 
activities in these devastating pathologies.  
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Figure 30. Hypothetical model to explain the effects of peripheral- and central- 
chemoreflex activation and modulation of sympathetic and ventilatory drive 
during hypotension hemorrhage. 
    
  
214
 
Figure 31. Detailed NTS circuitry within the hypothetical model. During 
hemorrhage, glutamate is released from peripheral chemoreflex afferent 
terminals and acts on receptors in the NTS to increase sympathetic and 
ventilatory drives.  With continued hypoxia GABA neurons are stimulated by 
chemoreceptor afferents which suppresses the ventilatory and sympathetic 
response to hemorrhage.  When CO2 and H+ concentration increase, serotonin is 
released from caudal raphe neurons and acts on 5-HT1A receptors in the NTS. 
These receptors are Gi/Go coupled and thus may disinhibit GABA release.  
Therefore, during hemorrhage both central- and peripheral- chemoreflexes may 
modulate sympathetic drive and ventilation during hypotension hemorrhage.  
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